id	sid	tid	token	lemma	pos
aiua-9638	1	1	stesura	stesura	PROPN
aiua-9638	1	2	seveso	seveso	PROPN
aiua-9638	1	3	221archivio	221archivio	PROPN
aiua-9638	1	4	italiano	italiano	NOUN
aiua-9638	1	5	di	di	X
aiua-9638	1	6	urologia	urologia	PROPN
aiua-9638	1	7	e	e	PROPN
aiua-9638	1	8	andrologia	andrologia	NOUN
aiua-9638	1	9	2021	2021	NUM
aiua-9638	1	10	;	;	PUNCT
aiua-9638	1	11	93	93	NUM
aiua-9638	1	12	,	,	PUNCT
aiua-9638	1	13	2	2	NUM
aiua-9638	1	14	original	original	ADJ
aiua-9638	1	15	paper	paper	NOUN
aiua-9638	1	16	no	no	DET
aiua-9638	1	17	conflict	conflict	NOUN
aiua-9638	1	18	of	of	ADP
aiua-9638	1	19	interest	interest	NOUN
aiua-9638	1	20	declared	declare	VERB
aiua-9638	1	21	.	.	PUNCT
aiua-9638	2	1	dence	dence	NOUN
aiua-9638	2	2	worldwide	worldwide	ADV
aiua-9638	2	3	,	,	PUNCT
aiua-9638	2	4	that	that	PRON
aiua-9638	2	5	affects	affect	VERB
aiua-9638	2	6	the	the	DET
aiua-9638	2	7	quality	quality	NOUN
aiua-9638	2	8	of	of	ADP
aiua-9638	2	9	life	life	NOUN
aiua-9638	2	10	(	(	PUNCT
aiua-9638	2	11	qol	qol	NOUN
aiua-9638	2	12	)	)	PUNCT
aiua-9638	2	13	of	of	ADP
aiua-9638	2	14	patients	patient	NOUN
aiua-9638	2	15	and	and	CCONJ
aiua-9638	2	16	their	their	PRON
aiua-9638	2	17	partner	partner	NOUN
aiua-9638	2	18	’s	’s	NOUN
aiua-9638	2	19	.	.	PUNCT
aiua-9638	3	1	it	it	PRON
aiua-9638	3	2	is	be	AUX
aiua-9638	3	3	estimated	estimate	VERB
aiua-9638	3	4	that	that	SCONJ
aiua-9638	3	5	about	about	ADV
aiua-9638	3	6	322	322	NUM
aiua-9638	3	7	million	million	NUM
aiua-9638	3	8	men	man	NOUN
aiua-9638	3	9	would	would	AUX
aiua-9638	3	10	suffer	suffer	VERB
aiua-9638	3	11	from	from	ADP
aiua-9638	3	12	ed	ed	PROPN
aiua-9638	3	13	global	global	ADJ
aiua-9638	3	14	by	by	ADP
aiua-9638	3	15	the	the	DET
aiua-9638	3	16	year	year	NOUN
aiua-9638	3	17	2025	2025	NUM
aiua-9638	3	18	(	(	PUNCT
aiua-9638	3	19	1	1	NUM
aiua-9638	3	20	)	)	PUNCT
aiua-9638	3	21	.	.	PUNCT
aiua-9638	4	1	ed	ed	NOUN
aiua-9638	4	2	primarily	primarily	ADV
aiua-9638	4	3	affects	affect	VERB
aiua-9638	4	4	men	man	NOUN
aiua-9638	4	5	older	old	ADJ
aiua-9638	4	6	than	than	ADP
aiua-9638	4	7	40	40	NUM
aiua-9638	4	8	years	year	NOUN
aiua-9638	4	9	of	of	ADP
aiua-9638	4	10	age	age	NOUN
aiua-9638	4	11	.	.	PUNCT
aiua-9638	5	1	ed	ed	NOUN
aiua-9638	5	2	prevalence	prevalence	NOUN
aiua-9638	5	3	ranges	range	VERB
aiua-9638	5	4	between	between	ADP
aiua-9638	5	5	1	1	NUM
aiua-9638	5	6	-	-	SYM
aiua-9638	5	7	10	10	NUM
aiua-9638	5	8	%	%	NOUN
aiua-9638	5	9	in	in	ADP
aiua-9638	5	10	men	man	NOUN
aiua-9638	5	11	younger	young	ADJ
aiua-9638	5	12	than	than	ADP
aiua-9638	5	13	40	40	NUM
aiua-9638	5	14	years	year	NOUN
aiua-9638	5	15	(	(	PUNCT
aiua-9638	5	16	international	international	ADJ
aiua-9638	5	17	consultation	consultation	NOUN
aiua-9638	5	18	committee	committee	PROPN
aiua-9638	5	19	for	for	ADP
aiua-9638	5	20	sexual	sexual	ADJ
aiua-9638	5	21	medicine	medicine	NOUN
aiua-9638	5	22	)	)	PUNCT
aiua-9638	5	23	.	.	PUNCT
aiua-9638	6	1	the	the	DET
aiua-9638	6	2	prevalence	prevalence	NOUN
aiua-9638	6	3	increases	increase	VERB
aiua-9638	6	4	with	with	ADP
aiua-9638	6	5	age	age	NOUN
aiua-9638	6	6	in	in	ADP
aiua-9638	6	7	a	a	DET
aiua-9638	6	8	range	range	NOUN
aiua-9638	6	9	from	from	ADP
aiua-9638	6	10	2	2	NUM
aiua-9638	6	11	%	%	NOUN
aiua-9638	6	12	to	to	PART
aiua-9638	6	13	9	9	NUM
aiua-9638	6	14	%	%	NOUN
aiua-9638	6	15	in	in	ADP
aiua-9638	6	16	men	man	NOUN
aiua-9638	6	17	between	between	ADP
aiua-9638	6	18	the	the	DET
aiua-9638	6	19	ages	age	NOUN
aiua-9638	6	20	of	of	ADP
aiua-9638	6	21	40	40	NUM
aiua-9638	6	22	and	and	CCONJ
aiua-9638	6	23	49	49	NUM
aiua-9638	6	24	years	year	NOUN
aiua-9638	6	25	,	,	PUNCT
aiua-9638	6	26	20	20	NUM
aiua-9638	6	27	-	-	SYM
aiua-9638	6	28	40	40	NUM
aiua-9638	6	29	%	%	NOUN
aiua-9638	6	30	in	in	ADP
aiua-9638	6	31	men	man	NOUN
aiua-9638	6	32	aged	age	VERB
aiua-9638	6	33	60	60	NUM
aiua-9638	6	34	-	-	SYM
aiua-9638	6	35	69	69	NUM
aiua-9638	6	36	years	year	NOUN
aiua-9638	6	37	and	and	CCONJ
aiua-9638	6	38	>	>	X
aiua-9638	6	39	50	50	NUM
aiua-9638	6	40	%	%	NOUN
aiua-9638	6	41	in	in	ADP
aiua-9638	6	42	men	man	NOUN
aiua-9638	6	43	older	old	ADJ
aiua-9638	6	44	than	than	ADP
aiua-9638	6	45	70	70	NUM
aiua-9638	6	46	years	year	NOUN
aiua-9638	6	47	(	(	PUNCT
aiua-9638	6	48	2	2	NUM
aiua-9638	6	49	)	)	PUNCT
aiua-9638	6	50	.	.	PUNCT
aiua-9638	7	1	to	to	ADP
aiua-9638	7	2	the	the	DET
aiua-9638	7	3	ed	ed	NOUN
aiua-9638	7	4	onset	onset	NOUN
aiua-9638	7	5	contributes	contribute	VERB
aiua-9638	7	6	several	several	ADJ
aiua-9638	7	7	environmental	environmental	ADJ
aiua-9638	7	8	and	and	CCONJ
aiua-9638	7	9	lifestyle	lifestyle	NOUN
aiua-9638	7	10	risk	risk	NOUN
aiua-9638	7	11	factors	factor	NOUN
aiua-9638	7	12	such	such	ADJ
aiua-9638	7	13	as	as	ADP
aiua-9638	7	14	diabetes	diabetes	NOUN
aiua-9638	7	15	mellitus	mellitus	NOUN
aiua-9638	7	16	,	,	PUNCT
aiua-9638	7	17	hypertension	hypertension	NOUN
aiua-9638	7	18	,	,	PUNCT
aiua-9638	7	19	hyperlipidaemia	hyperlipidaemia	NOUN
aiua-9638	7	20	,	,	PUNCT
aiua-9638	7	21	obesity	obesity	NOUN
aiua-9638	7	22	,	,	PUNCT
aiua-9638	7	23	metabolic	metabolic	NOUN
aiua-9638	7	24	syndrome	syndrome	NOUN
aiua-9638	7	25	,	,	PUNCT
aiua-9638	7	26	depression	depression	NOUN
aiua-9638	7	27	,	,	PUNCT
aiua-9638	7	28	smoking	smoking	NOUN
aiua-9638	7	29	and	and	CCONJ
aiua-9638	7	30	limited	limited	ADJ
aiua-9638	7	31	or	or	CCONJ
aiua-9638	7	32	absence	absence	NOUN
aiua-9638	7	33	of	of	ADP
aiua-9638	7	34	physical	physical	ADJ
aiua-9638	7	35	exercise	exercise	NOUN
aiua-9638	7	36	(	(	PUNCT
aiua-9638	7	37	3	3	NUM
aiua-9638	7	38	-	-	SYM
aiua-9638	7	39	7	7	NUM
aiua-9638	7	40	)	)	PUNCT
aiua-9638	7	41	.	.	PUNCT
aiua-9638	8	1	penile	penile	NOUN
aiua-9638	8	2	erection	erection	NOUN
aiua-9638	8	3	is	be	AUX
aiua-9638	8	4	a	a	DET
aiua-9638	8	5	complex	complex	NOUN
aiua-9638	8	6	of	of	ADP
aiua-9638	8	7	events	event	NOUN
aiua-9638	8	8	controlled	control	VERB
aiua-9638	8	9	by	by	ADP
aiua-9638	8	10	vascular	vascular	ADJ
aiua-9638	8	11	,	,	PUNCT
aiua-9638	8	12	hormonal	hormonal	ADJ
aiua-9638	8	13	and	and	CCONJ
aiua-9638	8	14	neuronal	neuronal	ADJ
aiua-9638	8	15	systems	system	NOUN
aiua-9638	8	16	(	(	PUNCT
aiua-9638	8	17	8)	8)	NUM
aiua-9638	8	18	.	.	PUNCT
aiua-9638	9	1	for	for	ADP
aiua-9638	9	2	what	what	PRON
aiua-9638	9	3	concerns	concern	VERB
aiua-9638	9	4	the	the	DET
aiua-9638	9	5	vascular	vascular	ADJ
aiua-9638	9	6	component	component	NOUN
aiua-9638	9	7	the	the	DET
aiua-9638	9	8	endothelium	endothelium	NOUN
aiua-9638	9	9	plays	play	VERB
aiua-9638	9	10	a	a	DET
aiua-9638	9	11	major	major	ADJ
aiua-9638	9	12	role	role	NOUN
aiua-9638	9	13	through	through	ADP
aiua-9638	9	14	the	the	DET
aiua-9638	9	15	nitric	nitric	ADJ
aiua-9638	9	16	oxide	oxide	NOUN
aiua-9638	9	17	(	(	PUNCT
aiua-9638	9	18	no	no	NOUN
aiua-9638	9	19	)	)	PUNCT
aiua-9638	9	20	pathway	pathway	NOUN
aiua-9638	9	21	.	.	PUNCT
aiua-9638	10	1	indeed	indeed	ADV
aiua-9638	10	2	,	,	PUNCT
aiua-9638	10	3	the	the	DET
aiua-9638	10	4	activation	activation	NOUN
aiua-9638	10	5	of	of	ADP
aiua-9638	10	6	the	the	DET
aiua-9638	10	7	no	no	DET
aiua-9638	10	8	pathway	pathway	NOUN
aiua-9638	10	9	causes	cause	VERB
aiua-9638	10	10	relaxation	relaxation	NOUN
aiua-9638	10	11	of	of	ADP
aiua-9638	10	12	smooth	smooth	ADJ
aiua-9638	10	13	muscle	muscle	NOUN
aiua-9638	10	14	in	in	ADP
aiua-9638	10	15	the	the	DET
aiua-9638	10	16	penile	penile	NOUN
aiua-9638	10	17	corpus	corpus	NOUN
aiua-9638	10	18	cavernous	cavernous	ADJ
aiua-9638	10	19	,	,	PUNCT
aiua-9638	10	20	leading	lead	VERB
aiua-9638	10	21	to	to	ADP
aiua-9638	10	22	increased	increase	VERB
aiua-9638	10	23	inflow	inflow	NOUN
aiua-9638	10	24	of	of	ADP
aiua-9638	10	25	blood	blood	NOUN
aiua-9638	10	26	(	(	PUNCT
aiua-9638	10	27	9	9	NUM
aiua-9638	10	28	)	)	PUNCT
aiua-9638	10	29	.	.	PUNCT
aiua-9638	11	1	no	no	PRON
aiua-9638	11	2	is	be	AUX
aiua-9638	11	3	synthesized	synthesize	VERB
aiua-9638	11	4	within	within	ADP
aiua-9638	11	5	the	the	DET
aiua-9638	11	6	endothelium	endothelium	NOUN
aiua-9638	11	7	starting	start	VERB
aiua-9638	11	8	by	by	ADP
aiua-9638	11	9	endothelial	endothelial	ADJ
aiua-9638	11	10	nitric	nitric	ADJ
aiua-9638	11	11	oxide	oxide	NOUN
aiua-9638	11	12	synthase	synthase	NOUN
aiua-9638	11	13	(	(	PUNCT
aiua-9638	11	14	enos	enos	PROPN
aiua-9638	11	15	)	)	PUNCT
aiua-9638	11	16	and	and	CCONJ
aiua-9638	11	17	activates	activate	VERB
aiua-9638	11	18	the	the	DET
aiua-9638	11	19	soluble	soluble	ADJ
aiua-9638	11	20	guanylyl	guanylyl	NOUN
aiua-9638	11	21	cyclase	cyclase	NOUN
aiua-9638	11	22	(	(	PUNCT
aiua-9638	11	23	sgc	sgc	PROPN
aiua-9638	11	24	)	)	PUNCT
aiua-9638	11	25	that	that	PRON
aiua-9638	11	26	leads	lead	VERB
aiua-9638	11	27	to	to	ADP
aiua-9638	11	28	the	the	DET
aiua-9638	11	29	formation	formation	NOUN
aiua-9638	11	30	of	of	ADP
aiua-9638	11	31	cyclic	cyclic	PROPN
aiua-9638	11	32	guanosine	guanosine	NOUN
aiua-9638	11	33	monophosphate	monophosphate	NOUN
aiua-9638	11	34	(	(	PUNCT
aiua-9638	11	35	cgmp	cgmp	PROPN
aiua-9638	11	36	)	)	PUNCT
aiua-9638	11	37	.	.	PUNCT
aiua-9638	12	1	the	the	DET
aiua-9638	12	2	cgmp	cgmp	PROPN
aiua-9638	12	3	levels	level	NOUN
aiua-9638	12	4	are	be	AUX
aiua-9638	12	5	tightly	tightly	ADV
aiua-9638	12	6	controlled	control	VERB
aiua-9638	12	7	by	by	ADP
aiua-9638	12	8	phosphodiesterases	phosphodiesterase	NOUN
aiua-9638	12	9	(	(	PUNCT
aiua-9638	12	10	pdes	pde	NOUN
aiua-9638	12	11	)	)	PUNCT
aiua-9638	12	12	(	(	PUNCT
aiua-9638	12	13	10	10	NUM
aiua-9638	12	14	)	)	PUNCT
aiua-9638	12	15	.	.	PUNCT
aiua-9638	13	1	nowadays	nowadays	ADV
aiua-9638	13	2	,	,	PUNCT
aiua-9638	13	3	medical	medical	ADJ
aiua-9638	13	4	interventions	intervention	NOUN
aiua-9638	13	5	for	for	ADP
aiua-9638	13	6	ed	ed	PROPN
aiua-9638	13	7	management	management	NOUN
aiua-9638	13	8	include	include	VERB
aiua-9638	13	9	oral	oral	ADJ
aiua-9638	13	10	drugs	drug	NOUN
aiua-9638	13	11	,	,	PUNCT
aiua-9638	13	12	intrapenile	intrapenile	NOUN
aiua-9638	13	13	therapies	therapy	NOUN
aiua-9638	13	14	(	(	PUNCT
aiua-9638	13	15	intra	intra	ADJ
aiua-9638	13	16	-	-	ADJ
aiua-9638	13	17	urethral	urethral	ADJ
aiua-9638	13	18	suppositories	suppository	NOUN
aiua-9638	13	19	and	and	CCONJ
aiua-9638	13	20	intracavernous	intracavernous	ADJ
aiua-9638	13	21	injections	injection	NOUN
aiua-9638	13	22	)	)	PUNCT
aiua-9638	13	23	and	and	CCONJ
aiua-9638	13	24	penile	penile	ADJ
aiua-9638	13	25	prosthesis	prosthesis	NOUN
aiua-9638	13	26	implantation	implantation	NOUN
aiua-9638	13	27	(	(	PUNCT
aiua-9638	13	28	11	11	NUM
aiua-9638	13	29	)	)	PUNCT
aiua-9638	13	30	.	.	PUNCT
aiua-9638	14	1	the	the	DET
aiua-9638	14	2	most	most	ADV
aiua-9638	14	3	widely	widely	ADV
aiua-9638	14	4	used	use	VERB
aiua-9638	14	5	therapeutic	therapeutic	ADJ
aiua-9638	14	6	approach	approach	NOUN
aiua-9638	14	7	relies	rely	VERB
aiua-9638	14	8	on	on	ADP
aiua-9638	14	9	the	the	DET
aiua-9638	14	10	use	use	NOUN
aiua-9638	14	11	of	of	ADP
aiua-9638	14	12	phosphodiesterase	phosphodiesterase	NOUN
aiua-9638	14	13	type	type	NOUN
aiua-9638	14	14	5	5	NUM
aiua-9638	14	15	(	(	PUNCT
aiua-9638	14	16	pde5	pde5	NOUN
aiua-9638	14	17	)	)	PUNCT
aiua-9638	14	18	inhibitors	inhibitor	NOUN
aiua-9638	14	19	(	(	PUNCT
aiua-9638	14	20	12	12	NUM
aiua-9638	14	21	-	-	SYM
aiua-9638	14	22	13	13	NUM
aiua-9638	14	23	)	)	PUNCT
aiua-9638	14	24	.	.	PUNCT
aiua-9638	15	1	the	the	DET
aiua-9638	15	2	pde5	pde5	PROPN
aiua-9638	15	3	response	response	NOUN
aiua-9638	15	4	rate	rate	NOUN
aiua-9638	15	5	is	be	AUX
aiua-9638	15	6	about	about	ADV
aiua-9638	15	7	70	70	NUM
aiua-9638	15	8	%	%	NOUN
aiua-9638	15	9	.and	.and	PUNCT
aiua-9638	16	1	it	it	PRON
aiua-9638	16	2	is	be	AUX
aiua-9638	16	3	significantly	significantly	ADV
aiua-9638	16	4	lower	low	ADJ
aiua-9638	16	5	in	in	ADP
aiua-9638	16	6	difficult	difficult	ADJ
aiua-9638	16	7	-	-	PUNCT
aiua-9638	16	8	to	to	ADP
aiua-9638	16	9	-	-	PUNCT
aiua-9638	16	10	treat	treat	VERB
aiua-9638	16	11	subpopulations	subpopulation	NOUN
aiua-9638	16	12	(	(	PUNCT
aiua-9638	16	13	14	14	NUM
aiua-9638	16	14	)	)	PUNCT
aiua-9638	16	15	.	.	PUNCT
aiua-9638	17	1	many	many	ADJ
aiua-9638	17	2	studies	study	NOUN
aiua-9638	17	3	have	have	AUX
aiua-9638	17	4	also	also	ADV
aiua-9638	17	5	shown	show	VERB
aiua-9638	17	6	that	that	SCONJ
aiua-9638	17	7	the	the	DET
aiua-9638	17	8	dropout	dropout	NOUN
aiua-9638	17	9	rate	rate	NOUN
aiua-9638	17	10	with	with	ADP
aiua-9638	17	11	pde5	pde5	NOUN
aiua-9638	17	12	inhibitors	inhibitor	NOUN
aiua-9638	17	13	therapy	therapy	NOUN
aiua-9638	17	14	is	be	AUX
aiua-9638	17	15	still	still	ADV
aiua-9638	17	16	more	more	ADJ
aiua-9638	17	17	than	than	ADP
aiua-9638	17	18	50	50	NUM
aiua-9638	17	19	%	%	NOUN
aiua-9638	17	20	after	after	ADP
aiua-9638	17	21	one	one	NUM
aiua-9638	17	22	year	year	NOUN
aiua-9638	17	23	(	(	PUNCT
aiua-9638	17	24	15	15	NUM
aiua-9638	17	25	)	)	PUNCT
aiua-9638	17	26	.	.	PUNCT
aiua-9638	18	1	emerging	emerge	VERB
aiua-9638	18	2	shreds	shred	NOUN
aiua-9638	18	3	of	of	ADP
aiua-9638	18	4	evidence	evidence	NOUN
aiua-9638	18	5	propose	propose	VERB
aiua-9638	18	6	an	an	DET
aiua-9638	18	7	increasing	increase	VERB
aiua-9638	18	8	role	role	NOUN
aiua-9638	18	9	of	of	ADP
aiua-9638	18	10	herbal	herbal	NOUN
aiua-9638	18	11	-	-	PUNCT
aiua-9638	18	12	based	base	VERB
aiua-9638	18	13	dietary	dietary	ADJ
aiua-9638	18	14	supplements	supplement	NOUN
aiua-9638	18	15	and	and	CCONJ
aiua-9638	18	16	nutraceuticals	nutraceutical	NOUN
aiua-9638	18	17	in	in	ADP
aiua-9638	18	18	the	the	DET
aiua-9638	18	19	management	management	NOUN
aiua-9638	18	20	of	of	ADP
aiua-9638	18	21	ed	ed	NOUN
aiua-9638	18	22	,	,	PUNCT
aiua-9638	18	23	for	for	ADP
aiua-9638	18	24	their	their	PRON
aiua-9638	18	25	anti	anti	ADJ
aiua-9638	18	26	-	-	ADJ
aiua-9638	18	27	oxidant	oxidant	ADJ
aiua-9638	18	28	,	,	PUNCT
aiua-9638	18	29	anti	anti	ADJ
aiua-9638	18	30	-	-	ADJ
aiua-9638	18	31	inflammatory	inflammatory	ADJ
aiua-9638	18	32	and	and	CCONJ
aiua-9638	18	33	anti	anti	ADJ
aiua-9638	18	34	-	-	ADJ
aiua-9638	18	35	proliferative	proliferative	ADJ
aiua-9638	18	36	properties.(16	properties.(16	NOUN
aiua-9638	18	37	)	)	PUNCT
aiua-9638	18	38	.	.	PUNCT
aiua-9638	19	1	objective	objective	NOUN
aiua-9638	19	2	:	:	PUNCT
aiua-9638	19	3	to	to	PART
aiua-9638	19	4	assess	assess	VERB
aiua-9638	19	5	the	the	DET
aiua-9638	19	6	efficacy	efficacy	NOUN
aiua-9638	19	7	of	of	ADP
aiua-9638	19	8	the	the	DET
aiua-9638	19	9	combination	combination	NOUN
aiua-9638	19	10	of	of	ADP
aiua-9638	19	11	tadalafil	tadalafil	PROPN
aiua-9638	19	12	5	5	NUM
aiua-9638	19	13	mg	mg	NOUN
aiua-9638	19	14	and	and	CCONJ
aiua-9638	19	15	nutritional	nutritional	ADJ
aiua-9638	19	16	supplements	supplement	NOUN
aiua-9638	19	17	composed	compose	VERB
aiua-9638	19	18	by	by	ADP
aiua-9638	19	19	panax	panax	PROPN
aiua-9638	19	20	ginseng	ginseng	PROPN
aiua-9638	19	21	,	,	PUNCT
aiua-9638	19	22	moringa	moringa	PROPN
aiua-9638	19	23	oleifera	oleifera	NOUN
aiua-9638	19	24	and	and	CCONJ
aiua-9638	19	25	rutin	rutin	NOUN
aiua-9638	19	26	on	on	ADP
aiua-9638	19	27	erectile	erectile	ADJ
aiua-9638	19	28	function	function	NOUN
aiua-9638	19	29	in	in	ADP
aiua-9638	19	30	men	man	NOUN
aiua-9638	19	31	with	with	ADP
aiua-9638	19	32	mild	mild	ADJ
aiua-9638	19	33	and	and	CCONJ
aiua-9638	19	34	moderate	moderate	ADJ
aiua-9638	19	35	vasculogenic	vasculogenic	ADJ
aiua-9638	19	36	ed	ed	NOUN
aiua-9638	19	37	.	.	PUNCT
aiua-9638	20	1	methods	method	NOUN
aiua-9638	20	2	:	:	PUNCT
aiua-9638	20	3	we	we	PRON
aiua-9638	20	4	prospectively	prospectively	ADV
aiua-9638	20	5	enrolled	enrol	VERB
aiua-9638	20	6	86	86	NUM
aiua-9638	20	7	patients	patient	NOUN
aiua-9638	20	8	divided	divide	VERB
aiua-9638	20	9	into	into	ADP
aiua-9638	20	10	two	two	NUM
aiua-9638	20	11	groups	group	NOUN
aiua-9638	20	12	a	a	DET
aiua-9638	20	13	(	(	PUNCT
aiua-9638	20	14	45	45	NUM
aiua-9638	20	15	)	)	PUNCT
aiua-9638	20	16	,	,	PUNCT
aiua-9638	20	17	b	b	X
aiua-9638	20	18	(	(	PUNCT
aiua-9638	20	19	33	33	NUM
aiua-9638	20	20	)	)	PUNCT
aiua-9638	20	21	in	in	ADP
aiua-9638	20	22	this	this	DET
aiua-9638	20	23	multicenter	multicenter	NOUN
aiua-9638	20	24	randomized	randomize	VERB
aiua-9638	20	25	,	,	PUNCT
aiua-9638	20	26	doubleblind	doubleblind	NOUN
aiua-9638	20	27	,	,	PUNCT
aiua-9638	20	28	placebo	placebo	NOUN
aiua-9638	20	29	-	-	PUNCT
aiua-9638	20	30	controlled	control	VERB
aiua-9638	20	31	trial	trial	NOUN
aiua-9638	20	32	.	.	PUNCT
aiua-9638	21	1	drop	drop	VERB
aiua-9638	21	2	out	out	ADP
aiua-9638	21	3	was	be	AUX
aiua-9638	21	4	8	8	NUM
aiua-9638	21	5	patients	patient	NOUN
aiua-9638	21	6	(	(	PUNCT
aiua-9638	21	7	3	3	NUM
aiua-9638	21	8	patients	patient	NOUN
aiua-9638	21	9	in	in	ADP
aiua-9638	21	10	group	group	PROPN
aiua-9638	21	11	a	a	PROPN
aiua-9638	21	12	and	and	CCONJ
aiua-9638	21	13	5	5	NUM
aiua-9638	21	14	in	in	ADP
aiua-9638	21	15	group	group	NOUN
aiua-9638	21	16	b	b	PROPN
aiua-9638	21	17	)	)	PUNCT
aiua-9638	21	18	.	.	PUNCT
aiua-9638	22	1	at	at	ADP
aiua-9638	22	2	screening	screen	VERB
aiua-9638	22	3	visit	visit	NOUN
aiua-9638	22	4	patients	patient	NOUN
aiua-9638	22	5	underwent	undergo	VERB
aiua-9638	22	6	clinical	clinical	ADJ
aiua-9638	22	7	examination	examination	NOUN
aiua-9638	22	8	,	,	PUNCT
aiua-9638	22	9	blood	blood	NOUN
aiua-9638	22	10	test	test	NOUN
aiua-9638	22	11	(	(	PUNCT
aiua-9638	22	12	hormonal	hormonal	ADJ
aiua-9638	22	13	and	and	CCONJ
aiua-9638	22	14	metabolic	metabolic	NOUN
aiua-9638	22	15	profile	profile	NOUN
aiua-9638	22	16	)	)	PUNCT
aiua-9638	22	17	and	and	CCONJ
aiua-9638	22	18	filled	fill	VERB
aiua-9638	22	19	out	out	ADP
aiua-9638	22	20	the	the	DET
aiua-9638	22	21	iief-5	iief-5	NUM
aiua-9638	22	22	questionnaire	questionnaire	NOUN
aiua-9638	22	23	and	and	CCONJ
aiua-9638	22	24	the	the	DET
aiua-9638	22	25	sep-2	sep-2	ADJ
aiua-9638	22	26	,	,	PUNCT
aiua-9638	22	27	sep-3	sep-3	PUNCT
aiua-9638	22	28	.	.	PUNCT
aiua-9638	23	1	patients	patient	NOUN
aiua-9638	23	2	were	be	AUX
aiua-9638	23	3	randomized	randomize	VERB
aiua-9638	23	4	by	by	ADP
aiua-9638	23	5	a	a	DET
aiua-9638	23	6	computergenerated	computergenerate	VERB
aiua-9638	23	7	list	list	NOUN
aiua-9638	23	8	to	to	PART
aiua-9638	23	9	receive	receive	VERB
aiua-9638	23	10	either	either	CCONJ
aiua-9638	23	11	tadalafil	tadalafil	PROPN
aiua-9638	23	12	5	5	NUM
aiua-9638	23	13	mg	mg	NOUN
aiua-9638	23	14	once	once	ADV
aiua-9638	23	15	daily	daily	ADJ
aiua-9638	23	16	plus	plus	CCONJ
aiua-9638	23	17	nutritional	nutritional	ADJ
aiua-9638	23	18	supplement	supplement	NOUN
aiua-9638	23	19	once	once	ADV
aiua-9638	23	20	daily	daily	ADV
aiua-9638	23	21	(	(	PUNCT
aiua-9638	23	22	group	group	NOUN
aiua-9638	23	23	a	a	NOUN
aiua-9638	23	24	)	)	PUNCT
aiua-9638	23	25	or	or	CCONJ
aiua-9638	23	26	tadalafil	tadalafil	NUM
aiua-9638	23	27	5	5	NUM
aiua-9638	23	28	mg	mg	NOUN
aiua-9638	23	29	plus	plus	CCONJ
aiua-9638	23	30	placebo	placebo	NOUN
aiua-9638	23	31	with	with	ADP
aiua-9638	23	32	the	the	DET
aiua-9638	23	33	same	same	ADJ
aiua-9638	23	34	administration	administration	NOUN
aiua-9638	23	35	schedule	schedule	NOUN
aiua-9638	23	36	(	(	PUNCT
aiua-9638	23	37	group	group	NOUN
aiua-9638	23	38	b	b	NOUN
aiua-9638	23	39	)	)	PUNCT
aiua-9638	23	40	for	for	ADP
aiua-9638	23	41	3	3	NUM
aiua-9638	23	42	months	month	NOUN
aiua-9638	23	43	.	.	PUNCT
aiua-9638	24	1	blood	blood	NOUN
aiua-9638	24	2	samples	sample	NOUN
aiua-9638	24	3	,	,	PUNCT
aiua-9638	24	4	iief-5	iief-5	NUM
aiua-9638	24	5	,	,	PUNCT
aiua-9638	24	6	sep-2	sep-2	X
aiua-9638	24	7	and	and	CCONJ
aiua-9638	24	8	sep-3	sep-3	PUNCT
aiua-9638	24	9	have	have	AUX
aiua-9638	24	10	been	be	AUX
aiua-9638	24	11	collected	collect	VERB
aiua-9638	24	12	again	again	ADV
aiua-9638	24	13	after	after	ADP
aiua-9638	24	14	3	3	NUM
aiua-9638	24	15	months	month	NOUN
aiua-9638	24	16	.	.	PUNCT
aiua-9638	25	1	cgmp	cgmp	PROPN
aiua-9638	25	2	was	be	AUX
aiua-9638	25	3	measured	measure	VERB
aiua-9638	25	4	in	in	ADP
aiua-9638	25	5	platelets	platelet	NOUN
aiua-9638	25	6	of	of	ADP
aiua-9638	25	7	38	38	NUM
aiua-9638	25	8	patients	patient	NOUN
aiua-9638	25	9	at	at	ADP
aiua-9638	25	10	baseline	baseline	NOUN
aiua-9638	25	11	and	and	CCONJ
aiua-9638	25	12	after	after	ADP
aiua-9638	25	13	one	one	NUM
aiua-9638	25	14	months	month	NOUN
aiua-9638	25	15	.	.	PUNCT
aiua-9638	26	1	results	result	NOUN
aiua-9638	26	2	:	:	PUNCT
aiua-9638	26	3	mean	mean	VERB
aiua-9638	26	4	age	age	NOUN
aiua-9638	26	5	was	be	AUX
aiua-9638	26	6	59.98	59.98	NUM
aiua-9638	26	7	±	±	NUM
aiua-9638	26	8	6.90	6.90	NUM
aiua-9638	26	9	(	(	PUNCT
aiua-9638	26	10	range	range	NOUN
aiua-9638	26	11	38	38	NUM
aiua-9638	26	12	-	-	SYM
aiua-9638	26	13	69	69	NUM
aiua-9638	26	14	)	)	PUNCT
aiua-9638	26	15	,	,	PUNCT
aiua-9638	26	16	mean	mean	VERB
aiua-9638	26	17	iief-5	iief-5	NUM
aiua-9638	26	18	score	score	NOUN
aiua-9638	26	19	at	at	ADP
aiua-9638	26	20	baseline	baseline	NOUN
aiua-9638	26	21	was	be	AUX
aiua-9638	26	22	13.59	13.59	NUM
aiua-9638	26	23	±	±	NUM
aiua-9638	26	24	3.90	3.90	NUM
aiua-9638	26	25	.	.	PUNCT
aiua-9638	27	1	after	after	ADP
aiua-9638	27	2	three	three	NUM
aiua-9638	27	3	months	month	NOUN
aiua-9638	27	4	of	of	ADP
aiua-9638	27	5	treatment	treatment	NOUN
aiua-9638	27	6	,	,	PUNCT
aiua-9638	27	7	iief-5	iief-5	NUM
aiua-9638	27	8	score	score	NOUN
aiua-9638	27	9	significantly	significantly	ADV
aiua-9638	27	10	improved	improve	VERB
aiua-9638	27	11	in	in	ADP
aiua-9638	27	12	both	both	DET
aiua-9638	27	13	groups	group	NOUN
aiua-9638	27	14	compared	compare	VERB
aiua-9638	27	15	to	to	PART
aiua-9638	27	16	baseline	baseline	VERB
aiua-9638	27	17	(	(	PUNCT
aiua-9638	27	18	13.18	13.18	NUM
aiua-9638	27	19	±	±	NUM
aiua-9638	27	20	3.75	3.75	NUM
aiua-9638	27	21	vs	vs	ADP
aiua-9638	27	22	20.48	20.48	NUM
aiua-9638	27	23	±	±	NUM
aiua-9638	27	24	2.24	2.24	NUM
aiua-9638	27	25	,	,	PUNCT
aiua-9638	27	26	p	p	X
aiua-9638	27	27	<	<	X
aiua-9638	27	28	0.0001	0.0001	NUM
aiua-9638	27	29	;	;	PUNCT
aiua-9638	27	30	14.15	14.15	NUM
aiua-9638	27	31	±	±	NUM
aiua-9638	27	32	4.09	4.09	NUM
aiua-9638	27	33	vs	vs	ADP
aiua-9638	27	34	19.06	19.06	NUM
aiua-9638	27	35	±	±	NUM
aiua-9638	27	36	4.36	4.36	NUM
aiua-9638	27	37	,	,	PUNCT
aiua-9638	27	38	p	p	X
aiua-9638	27	39	<	<	X
aiua-9638	27	40	0.0001	0.0001	NUM
aiua-9638	27	41	,	,	PUNCT
aiua-9638	27	42	in	in	ADP
aiua-9638	27	43	group	group	NOUN
aiua-9638	27	44	a	a	PROPN
aiua-9638	27	45	and	and	CCONJ
aiua-9638	27	46	group	group	NOUN
aiua-9638	27	47	b	b	PROPN
aiua-9638	27	48	respectively	respectively	ADV
aiua-9638	27	49	)	)	PUNCT
aiua-9638	27	50	.	.	PUNCT
aiua-9638	28	1	patients	patient	NOUN
aiua-9638	28	2	treated	treat	VERB
aiua-9638	28	3	with	with	ADP
aiua-9638	28	4	tadalafil	tadalafil	PROPN
aiua-9638	28	5	plus	plus	CCONJ
aiua-9638	28	6	nutritional	nutritional	ADJ
aiua-9638	28	7	supplement	supplement	NOUN
aiua-9638	28	8	showed	show	VERB
aiua-9638	28	9	a	a	DET
aiua-9638	28	10	significantly	significantly	ADV
aiua-9638	28	11	higher	high	ADJ
aiua-9638	28	12	increase	increase	NOUN
aiua-9638	28	13	in	in	ADP
aiua-9638	28	14	iief-5	iief-5	NUM
aiua-9638	28	15	score	score	NOUN
aiua-9638	28	16	compared	compare	VERB
aiua-9638	28	17	to	to	ADP
aiua-9638	28	18	those	those	PRON
aiua-9638	28	19	who	who	PRON
aiua-9638	28	20	received	receive	VERB
aiua-9638	28	21	placebo	placebo	NOUN
aiua-9638	28	22	(	(	PUNCT
aiua-9638	28	23	7.27	7.27	NUM
aiua-9638	28	24	±	±	NUM
aiua-9638	28	25	2.20	2.20	NUM
aiua-9638	28	26	and	and	CCONJ
aiua-9638	28	27	4.9	4.9	NUM
aiua-9638	28	28	±	±	NUM
aiua-9638	28	29	2.79	2.79	NUM
aiua-9638	28	30	,	,	PUNCT
aiua-9638	28	31	respectively	respectively	ADV
aiua-9638	28	32	;	;	PUNCT
aiua-9638	28	33	p	p	X
aiua-9638	28	34	<	<	X
aiua-9638	28	35	0.0001	0.0001	NUM
aiua-9638	28	36	;)	;)	NOUN
aiua-9638	28	37	.	.	PUNCT
aiua-9638	29	1	no	no	DET
aiua-9638	29	2	hormonal	hormonal	ADJ
aiua-9638	29	3	differences	difference	NOUN
aiua-9638	29	4	and	and	CCONJ
aiua-9638	29	5	metabolic	metabolic	NOUN
aiua-9638	29	6	effects	effect	NOUN
aiua-9638	29	7	were	be	AUX
aiua-9638	29	8	found	find	VERB
aiua-9638	29	9	.	.	PUNCT
aiua-9638	30	1	according	accord	VERB
aiua-9638	30	2	cgmp	cgmp	PROPN
aiua-9638	30	3	result	result	PROPN
aiua-9638	30	4	,	,	PUNCT
aiua-9638	30	5	nutritional	nutritional	ADJ
aiua-9638	30	6	supplements	supplement	NOUN
aiua-9638	30	7	ameliorates	ameliorate	VERB
aiua-9638	30	8	and	and	CCONJ
aiua-9638	30	9	extends	extend	VERB
aiua-9638	30	10	the	the	DET
aiua-9638	30	11	activity	activity	NOUN
aiua-9638	30	12	of	of	ADP
aiua-9638	30	13	the	the	DET
aiua-9638	30	14	chronic	chronic	ADJ
aiua-9638	30	15	treatment	treatment	NOUN
aiua-9638	30	16	.	.	PUNCT
aiua-9638	31	1	conclusions	conclusion	NOUN
aiua-9638	31	2	:	:	PUNCT
aiua-9638	31	3	iief-5	iief-5	NUM
aiua-9638	31	4	significant	significant	ADJ
aiua-9638	31	5	increase	increase	NOUN
aiua-9638	31	6	in	in	ADP
aiua-9638	31	7	group	group	PROPN
aiua-9638	31	8	b	b	PROPN
aiua-9638	31	9	,	,	PUNCT
aiua-9638	31	10	can	can	AUX
aiua-9638	31	11	be	be	AUX
aiua-9638	31	12	ascribed	ascribe	VERB
aiua-9638	31	13	to	to	ADP
aiua-9638	31	14	the	the	DET
aiua-9638	31	15	nutritional	nutritional	ADJ
aiua-9638	31	16	supplement	supplement	NOUN
aiua-9638	31	17	properties	property	NOUN
aiua-9638	31	18	and	and	CCONJ
aiua-9638	31	19	antioxidant	antioxidant	ADJ
aiua-9638	31	20	effects	effect	NOUN
aiua-9638	31	21	of	of	ADP
aiua-9638	31	22	moringa	moringa	NOUN
aiua-9638	31	23	oleifera	oleifera	ADV
aiua-9638	31	24	,	,	PUNCT
aiua-9638	31	25	ginseng	ginseng	NOUN
aiua-9638	31	26	and	and	CCONJ
aiua-9638	31	27	rutin	rutin	NOUN
aiua-9638	31	28	and	and	CCONJ
aiua-9638	31	29	this	this	PRON
aiua-9638	31	30	can	can	AUX
aiua-9638	31	31	enhance	enhance	VERB
aiua-9638	31	32	the	the	DET
aiua-9638	31	33	endothelial	endothelial	NOUN
aiua-9638	31	34	no	no	PRON
aiua-9638	31	35	and	and	CCONJ
aiua-9638	31	36	cgmp	cgmp	PROPN
aiua-9638	31	37	production	production	NOUN
aiua-9638	31	38	.	.	PUNCT
aiua-9638	32	1	key	key	ADJ
aiua-9638	32	2	words	word	NOUN
aiua-9638	32	3	:	:	PUNCT
aiua-9638	32	4	erectile	erectile	ADJ
aiua-9638	32	5	dysfunction	dysfunction	NOUN
aiua-9638	32	6	;	;	PUNCT
aiua-9638	32	7	pde5	pde5	NOUN
aiua-9638	32	8	;	;	PUNCT
aiua-9638	32	9	dietary	dietary	ADJ
aiua-9638	32	10	supplement	supplement	NOUN
aiua-9638	32	11	;	;	PUNCT
aiua-9638	32	12	phosphodiesterase	phosphodiesterase	NOUN
aiua-9638	32	13	:	:	PUNCT
aiua-9638	32	14	natural	natural	ADJ
aiua-9638	32	15	health	health	NOUN
aiua-9638	32	16	product	product	NOUN
aiua-9638	32	17	.	.	PUNCT
aiua-9638	32	18	submitted	submit	VERB
aiua-9638	32	19	25	25	NUM
aiua-9638	32	20	january	january	PROPN
aiua-9638	32	21	2021	2021	NUM
aiua-9638	32	22	;	;	PUNCT
aiua-9638	32	23	accepted	accept	VERB
aiua-9638	32	24	5	5	NUM
aiua-9638	32	25	march	march	NOUN
aiua-9638	32	26	2021	2021	NUM
aiua-9638	32	27	introduction	introduction	NOUN
aiua-9638	32	28	erectile	erectile	NOUN
aiua-9638	32	29	dysfunction	dysfunction	NOUN
aiua-9638	32	30	(	(	PUNCT
aiua-9638	32	31	ed	ed	NOUN
aiua-9638	32	32	)	)	PUNCT
aiua-9638	32	33	has	have	AUX
aiua-9638	32	34	been	be	AUX
aiua-9638	32	35	identified	identify	VERB
aiua-9638	32	36	as	as	ADP
aiua-9638	32	37	the	the	DET
aiua-9638	32	38	most	most	ADV
aiua-9638	32	39	common	common	ADJ
aiua-9638	32	40	sexual	sexual	ADJ
aiua-9638	32	41	problem	problem	NOUN
aiua-9638	32	42	,	,	PUNCT
aiua-9638	32	43	with	with	SCONJ
aiua-9638	32	44	high	high	ADJ
aiua-9638	32	45	prevalence	prevalence	NOUN
aiua-9638	32	46	and	and	CCONJ
aiua-9638	32	47	incia	incia	NOUN
aiua-9638	32	48	new	new	ADJ
aiua-9638	32	49	original	original	ADJ
aiua-9638	32	50	nutraceutical	nutraceutical	ADJ
aiua-9638	32	51	formulation	formulation	NOUN
aiua-9638	32	52	ameliorates	ameliorate	VERB
aiua-9638	32	53	the	the	DET
aiua-9638	32	54	effect	effect	NOUN
aiua-9638	32	55	of	of	ADP
aiua-9638	32	56	tadalafil	tadalafil	NOUN
aiua-9638	32	57	on	on	ADP
aiua-9638	32	58	clinical	clinical	ADJ
aiua-9638	32	59	score	score	NOUN
aiua-9638	32	60	and	and	CCONJ
aiua-9638	32	61	cgmp	cgmp	PROPN
aiua-9638	32	62	accumulation	accumulation	NOUN
aiua-9638	32	63	vincenzo	vincenzo	NOUN
aiua-9638	32	64	mirone	mirone	NOUN
aiua-9638	32	65	1	1	NUM
aiua-9638	32	66	,	,	PUNCT
aiua-9638	32	67	luigi	luigi	PROPN
aiua-9638	32	68	napolitano	napolitano	PROPN
aiua-9638	32	69	1	1	NUM
aiua-9638	32	70	,	,	PUNCT
aiua-9638	32	71	roberta	roberta	PROPN
aiua-9638	32	72	d’emmanuele	d’emmanuele	PROPN
aiua-9638	32	73	di	di	PROPN
aiua-9638	32	74	villa	villa	PROPN
aiua-9638	32	75	bianca	bianca	PROPN
aiua-9638	33	1	2	2	NUM
aiua-9638	33	2	,	,	PUNCT
aiua-9638	33	3	emma	emma	PROPN
aiua-9638	33	4	mitidieri	mitidieri	PROPN
aiua-9638	33	5	2	2	NUM
aiua-9638	33	6	,	,	PUNCT
aiua-9638	33	7	raffaella	raffaella	PROPN
aiua-9638	33	8	sorrentino	sorrentino	PROPN
aiua-9638	33	9	2	2	NUM
aiua-9638	33	10	,	,	PUNCT
aiua-9638	33	11	arianna	arianna	PROPN
aiua-9638	33	12	vanelli	vanelli	PROPN
aiua-9638	33	13	3	3	NUM
aiua-9638	33	14	,	,	PUNCT
aiua-9638	33	15	domenico	domenico	PROPN
aiua-9638	33	16	vanacore	vanacore	ADV
aiua-9638	33	17	2	2	NUM
aiua-9638	33	18	,	,	PUNCT
aiua-9638	33	19	carlotta	carlotta	PROPN
aiua-9638	33	20	turnaturi	turnaturi	PROPN
aiua-9638	33	21	2	2	NUM
aiua-9638	33	22	,	,	PUNCT
aiua-9638	33	23	roberto	roberto	PROPN
aiua-9638	33	24	la	la	PROPN
aiua-9638	33	25	rocca	rocca	PROPN
aiua-9638	33	26	1	1	NUM
aiua-9638	33	27	,	,	PUNCT
aiua-9638	33	28	giuseppe	giuseppe	PROPN
aiua-9638	33	29	celentano	celentano	PROPN
aiua-9638	33	30	1	1	NUM
aiua-9638	33	31	,	,	PUNCT
aiua-9638	33	32	davide	davide	NOUN
aiua-9638	33	33	arcaniolo	arcaniolo	NOUN
aiua-9638	33	34	4	4	NUM
aiua-9638	33	35	,	,	PUNCT
aiua-9638	33	36	giuseppe	giuseppe	PROPN
aiua-9638	33	37	cirino	cirino	PROPN
aiua-9638	33	38	2	2	NUM
aiua-9638	33	39	1	1	NUM
aiua-9638	33	40	department	department	NOUN
aiua-9638	33	41	of	of	ADP
aiua-9638	33	42	neurosciences	neuroscience	NOUN
aiua-9638	33	43	,	,	PUNCT
aiua-9638	33	44	sciences	science	NOUN
aiua-9638	33	45	of	of	ADP
aiua-9638	33	46	reproduction	reproduction	NOUN
aiua-9638	33	47	,	,	PUNCT
aiua-9638	33	48	and	and	CCONJ
aiua-9638	33	49	odontostomatology	odontostomatology	NOUN
aiua-9638	33	50	,	,	PUNCT
aiua-9638	33	51	university	university	PROPN
aiua-9638	33	52	of	of	ADP
aiua-9638	33	53	naples	naples	PROPN
aiua-9638	33	54	federico	federico	PROPN
aiua-9638	33	55	ii	ii	PROPN
aiua-9638	33	56	,	,	PUNCT
aiua-9638	33	57	naples	naples	PROPN
aiua-9638	33	58	,	,	PUNCT
aiua-9638	33	59	italy	italy	PROPN
aiua-9638	33	60	;	;	PUNCT
aiua-9638	33	61	2	2	NUM
aiua-9638	33	62	department	department	NOUN
aiua-9638	33	63	of	of	ADP
aiua-9638	33	64	pharmacy	pharmacy	NOUN
aiua-9638	33	65	,	,	PUNCT
aiua-9638	33	66	school	school	NOUN
aiua-9638	33	67	of	of	ADP
aiua-9638	33	68	medicine	medicine	NOUN
aiua-9638	33	69	and	and	CCONJ
aiua-9638	33	70	surgery	surgery	NOUN
aiua-9638	33	71	,	,	PUNCT
aiua-9638	33	72	university	university	NOUN
aiua-9638	33	73	of	of	ADP
aiua-9638	33	74	naples	naples	PROPN
aiua-9638	33	75	,	,	PUNCT
aiua-9638	33	76	federico	federico	PROPN
aiua-9638	33	77	ii	ii	PROPN
aiua-9638	33	78	,	,	PUNCT
aiua-9638	33	79	naples	naples	PROPN
aiua-9638	33	80	,	,	PUNCT
aiua-9638	33	81	italy	italy	PROPN
aiua-9638	33	82	;	;	PUNCT
aiua-9638	33	83	3	3	NUM
aiua-9638	33	84	responsabile	responsabile	NOUN
aiua-9638	33	85	ricerca	ricerca	NOUN
aiua-9638	33	86	e	e	NOUN
aiua-9638	33	87	sviluppo	sviluppo	PROPN
aiua-9638	33	88	nutrilinea	nutrilinea	PROPN
aiua-9638	33	89	srl	srl	PROPN
aiua-9638	33	90	,	,	PUNCT
aiua-9638	33	91	varese	varese	PROPN
aiua-9638	33	92	,	,	PUNCT
aiua-9638	33	93	italy	italy	PROPN
aiua-9638	33	94	;	;	PUNCT
aiua-9638	33	95	4	4	NUM
aiua-9638	33	96	urology	urology	NOUN
aiua-9638	33	97	unit	unit	NOUN
aiua-9638	33	98	,	,	PUNCT
aiua-9638	33	99	department	department	NOUN
aiua-9638	33	100	of	of	ADP
aiua-9638	33	101	woman	woman	NOUN
aiua-9638	33	102	child	child	NOUN
aiua-9638	33	103	and	and	CCONJ
aiua-9638	33	104	of	of	ADP
aiua-9638	33	105	general	general	ADJ
aiua-9638	33	106	and	and	CCONJ
aiua-9638	33	107	specialist	specialist	ADJ
aiua-9638	33	108	surgery	surgery	NOUN
aiua-9638	33	109	,	,	PUNCT
aiua-9638	33	110	university	university	NOUN
aiua-9638	33	111	of	of	ADP
aiua-9638	33	112	campania	campania	PROPN
aiua-9638	33	113	"	"	PUNCT
aiua-9638	33	114	luigi	luigi	PROPN
aiua-9638	33	115	vanvitelli	vanvitelli	PROPN
aiua-9638	33	116	"	"	PUNCT
aiua-9638	33	117	,	,	PUNCT
aiua-9638	33	118	naples	naples	PROPN
aiua-9638	33	119	,	,	PUNCT
aiua-9638	33	120	italy	italy	PROPN
aiua-9638	33	121	.	.	PUNCT
aiua-9638	34	1	doi	doi	PROPN
aiua-9638	34	2	:	:	PUNCT
aiua-9638	34	3	10.4081	10.4081	NUM
aiua-9638	34	4	/	/	SYM
aiua-9638	34	5	aiua.2021.2.221	aiua.2021.2.221	NOUN
aiua-9638	34	6	summary	summary	NOUN
aiua-9638	34	7	archivio	archivio	NOUN
aiua-9638	34	8	italiano	italiano	X
aiua-9638	34	9	di	di	X
aiua-9638	34	10	urologia	urologia	PROPN
aiua-9638	34	11	e	e	PROPN
aiua-9638	34	12	andrologia	andrologia	NOUN
aiua-9638	34	13	2021	2021	NUM
aiua-9638	34	14	;	;	PUNCT
aiua-9638	34	15	93	93	NUM
aiua-9638	34	16	,	,	PUNCT
aiua-9638	34	17	2	2	NUM
aiua-9638	34	18	v.	v.	ADP
aiua-9638	34	19	mirone	mirone	PROPN
aiua-9638	34	20	,	,	PUNCT
aiua-9638	34	21	l.	l.	PROPN
aiua-9638	34	22	napolitano	napolitano	PROPN
aiua-9638	34	23	,	,	PUNCT
aiua-9638	34	24	r.	r.	PROPN
aiua-9638	34	25	d’emmanuele	d’emmanuele	PROPN
aiua-9638	34	26	di	di	PROPN
aiua-9638	34	27	villa	villa	PROPN
aiua-9638	34	28	bianca	bianca	PROPN
aiua-9638	34	29	,	,	PUNCT
aiua-9638	34	30	et	et	PROPN
aiua-9638	34	31	al	al	PROPN
aiua-9638	34	32	.	.	PROPN
aiua-9638	34	33	222	222	NUM
aiua-9638	34	34	the	the	DET
aiua-9638	34	35	study	study	NOUN
aiua-9638	34	36	aims	aim	VERB
aiua-9638	34	37	to	to	PART
aiua-9638	34	38	evaluate	evaluate	VERB
aiua-9638	34	39	the	the	DET
aiua-9638	34	40	efficacy	efficacy	NOUN
aiua-9638	34	41	of	of	ADP
aiua-9638	34	42	the	the	DET
aiua-9638	34	43	combination	combination	NOUN
aiua-9638	34	44	of	of	ADP
aiua-9638	34	45	tadalafil	tadalafil	PROPN
aiua-9638	34	46	5	5	NUM
aiua-9638	34	47	mg	mg	NOUN
aiua-9638	34	48	and	and	CCONJ
aiua-9638	34	49	nutritional	nutritional	ADJ
aiua-9638	34	50	supplements	supplement	NOUN
aiua-9638	34	51	composed	compose	VERB
aiua-9638	34	52	by	by	ADP
aiua-9638	34	53	panax	panax	PROPN
aiua-9638	34	54	ginseng	ginseng	PROPN
aiua-9638	34	55	,	,	PUNCT
aiua-9638	34	56	moringa	moringa	PROPN
aiua-9638	34	57	oleifera	oleifera	NOUN
aiua-9638	34	58	and	and	CCONJ
aiua-9638	34	59	rutin	rutin	NOUN
aiua-9638	34	60	on	on	ADP
aiua-9638	34	61	erectile	erectile	ADJ
aiua-9638	34	62	function	function	NOUN
aiua-9638	34	63	in	in	ADP
aiua-9638	34	64	men	man	NOUN
aiua-9638	34	65	with	with	ADP
aiua-9638	34	66	mild	mild	ADJ
aiua-9638	34	67	and	and	CCONJ
aiua-9638	34	68	moderate	moderate	ADJ
aiua-9638	34	69	vasculogenic	vasculogenic	ADJ
aiua-9638	34	70	ed	ed	NOUN
aiua-9638	34	71	.	.	PUNCT
aiua-9638	35	1	in	in	ADP
aiua-9638	35	2	order	order	NOUN
aiua-9638	35	3	to	to	PART
aiua-9638	35	4	address	address	VERB
aiua-9638	35	5	this	this	DET
aiua-9638	35	6	issue	issue	NOUN
aiua-9638	35	7	,	,	PUNCT
aiua-9638	35	8	we	we	PRON
aiua-9638	35	9	applied	apply	VERB
aiua-9638	35	10	two	two	NUM
aiua-9638	35	11	different	different	ADJ
aiua-9638	35	12	approaches	approach	NOUN
aiua-9638	35	13	:	:	PUNCT
aiua-9638	35	14	i	i	X
aiua-9638	35	15	)	)	PUNCT
aiua-9638	35	16	the	the	DET
aiua-9638	35	17	assessment	assessment	NOUN
aiua-9638	35	18	of	of	ADP
aiua-9638	35	19	index	index	NOUN
aiua-9638	35	20	of	of	ADP
aiua-9638	35	21	erectile	erectile	NOUN
aiua-9638	35	22	function	function	NOUN
aiua-9638	35	23	(	(	PUNCT
aiua-9638	35	24	iief	iief	ADJ
aiua-9638	35	25	)	)	PUNCT
aiua-9638	35	26	and	and	CCONJ
aiua-9638	35	27	sexual	sexual	ADJ
aiua-9638	35	28	encounter	encounter	NOUN
aiua-9638	35	29	profile	profile	NOUN
aiua-9638	35	30	(	(	PUNCT
aiua-9638	35	31	sep	sep	PROPN
aiua-9638	35	32	)	)	PUNCT
aiua-9638	35	33	that	that	PRON
aiua-9638	35	34	represent	represent	VERB
aiua-9638	35	35	primary	primary	ADJ
aiua-9638	35	36	endpoints	endpoint	NOUN
aiua-9638	35	37	in	in	ADP
aiua-9638	35	38	clinical	clinical	ADJ
aiua-9638	35	39	studies	study	NOUN
aiua-9638	35	40	on	on	ADP
aiua-9638	35	41	ed	ed	PROPN
aiua-9638	35	42	(	(	PUNCT
aiua-9638	35	43	17	17	NUM
aiua-9638	35	44	)	)	PUNCT
aiua-9638	35	45	;	;	PUNCT
aiua-9638	35	46	ii	ii	X
aiua-9638	35	47	)	)	PUNCT
aiua-9638	35	48	the	the	DET
aiua-9638	35	49	measurement	measurement	NOUN
aiua-9638	35	50	of	of	ADP
aiua-9638	35	51	platelet	platelet	NOUN
aiua-9638	35	52	cgmp	cgmp	PROPN
aiua-9638	35	53	content	content	PROPN
aiua-9638	35	54	that	that	PRON
aiua-9638	35	55	represents	represent	VERB
aiua-9638	35	56	biomarker	biomarker	NOUN
aiua-9638	35	57	of	of	ADP
aiua-9638	35	58	pde5	pde5	NOUN
aiua-9638	35	59	activity	activity	NOUN
aiua-9638	35	60	(	(	PUNCT
aiua-9638	35	61	18	18	NUM
aiua-9638	35	62	-	-	SYM
aiua-9638	35	63	19	19	NUM
aiua-9638	35	64	)	)	PUNCT
aiua-9638	35	65	.	.	PUNCT
aiua-9638	36	1	methods	method	NOUN
aiua-9638	36	2	the	the	DET
aiua-9638	36	3	study	study	NOUN
aiua-9638	36	4	consisted	consist	VERB
aiua-9638	36	5	of	of	ADP
aiua-9638	36	6	two	two	NUM
aiua-9638	36	7	different	different	ADJ
aiua-9638	36	8	phases	phase	NOUN
aiua-9638	36	9	:	:	PUNCT
aiua-9638	36	10	a	a	DET
aiua-9638	36	11	clinical	clinical	ADJ
aiua-9638	36	12	one	one	NOUN
aiua-9638	36	13	and	and	CCONJ
aiua-9638	36	14	an	an	DET
aiua-9638	36	15	experimental	experimental	ADJ
aiua-9638	36	16	ex	ex	X
aiua-9638	36	17	vivo	vivo	NOUN
aiua-9638	36	18	one	one	NUM
aiua-9638	36	19	.	.	PUNCT
aiua-9638	37	1	in	in	ADP
aiua-9638	37	2	a	a	DET
aiua-9638	37	3	multicenter	multicenter	NOUN
aiua-9638	37	4	randomized	randomize	VERB
aiua-9638	37	5	,	,	PUNCT
aiua-9638	37	6	double	double	ADJ
aiua-9638	37	7	-	-	PUNCT
aiua-9638	37	8	blind	blind	ADJ
aiua-9638	37	9	,	,	PUNCT
aiua-9638	37	10	placebocontrolled	placebocontrolle	VERB
aiua-9638	37	11	trial	trial	NOUN
aiua-9638	37	12	we	we	PRON
aiua-9638	37	13	enrolled	enrol	VERB
aiua-9638	37	14	consecutive	consecutive	ADJ
aiua-9638	37	15	patients	patient	NOUN
aiua-9638	37	16	with	with	ADP
aiua-9638	37	17	vasculogenic	vasculogenic	ADJ
aiua-9638	37	18	ed	ed	NOUN
aiua-9638	37	19	attending	attend	VERB
aiua-9638	37	20	urology	urology	NOUN
aiua-9638	37	21	clinic	clinic	NOUN
aiua-9638	37	22	of	of	ADP
aiua-9638	37	23	university	university	PROPN
aiua-9638	37	24	of	of	ADP
aiua-9638	37	25	naples	naples	PROPN
aiua-9638	37	26	“	"	PUNCT
aiua-9638	37	27	federico	federico	PROPN
aiua-9638	37	28	ii	ii	PROPN
aiua-9638	37	29	”	"	PUNCT
aiua-9638	37	30	,	,	PUNCT
aiua-9638	37	31	university	university	PROPN
aiua-9638	37	32	of	of	ADP
aiua-9638	37	33	campania	campania	PROPN
aiua-9638	37	34	“	"	PUNCT
aiua-9638	37	35	luigi	luigi	PROPN
aiua-9638	37	36	vanvitelli	vanvitelli	PROPN
aiua-9638	37	37	”	"	PUNCT
aiua-9638	37	38	and	and	CCONJ
aiua-9638	37	39	interdepartmental	interdepartmental	ADJ
aiua-9638	37	40	research	research	NOUN
aiua-9638	37	41	center	center	NOUN
aiua-9638	37	42	for	for	ADP
aiua-9638	37	43	sexual	sexual	ADJ
aiua-9638	37	44	medicine	medicine	NOUN
aiua-9638	37	45	(	(	PUNCT
aiua-9638	37	46	cirms	cirm	NOUN
aiua-9638	37	47	)	)	PUNCT
aiua-9638	37	48	,	,	PUNCT
aiua-9638	37	49	university	university	NOUN
aiua-9638	37	50	of	of	ADP
aiua-9638	37	51	naples	naples	PROPN
aiua-9638	37	52	federico	federico	PROPN
aiua-9638	37	53	ii	ii	PROPN
aiua-9638	37	54	.	.	PUNCT
aiua-9638	38	1	inclusion	inclusion	NOUN
aiua-9638	38	2	criteria	criterion	NOUN
aiua-9638	38	3	were	be	AUX
aiua-9638	38	4	:	:	PUNCT
aiua-9638	38	5	patient	patient	ADJ
aiua-9638	38	6	age	age	NOUN
aiua-9638	38	7	between	between	ADP
aiua-9638	38	8	18	18	NUM
aiua-9638	38	9	and	and	CCONJ
aiua-9638	38	10	69	69	NUM
aiua-9638	38	11	years	year	NOUN
aiua-9638	38	12	;	;	PUNCT
aiua-9638	38	13	mild	mild	ADJ
aiua-9638	38	14	to	to	ADP
aiua-9638	38	15	moderate	moderate	ADJ
aiua-9638	38	16	ed	ed	NOUN
aiua-9638	38	17	for	for	ADP
aiua-9638	38	18	at	at	ADV
aiua-9638	38	19	least	least	ADV
aiua-9638	38	20	6	6	NUM
aiua-9638	38	21	months	month	NOUN
aiua-9638	38	22	with	with	ADP
aiua-9638	38	23	a	a	DET
aiua-9638	38	24	short	short	ADJ
aiua-9638	38	25	form	form	NOUN
aiua-9638	38	26	of	of	ADP
aiua-9638	38	27	international	international	ADJ
aiua-9638	38	28	index	index	NOUN
aiua-9638	38	29	of	of	ADP
aiua-9638	38	30	erectile	erectile	NOUN
aiua-9638	38	31	function	function	NOUN
aiua-9638	38	32	score	score	NOUN
aiua-9638	38	33	(	(	PUNCT
aiua-9638	38	34	iief-5	iief-5	NUM
aiua-9638	38	35	)	)	PUNCT
aiua-9638	38	36	>	>	X
aiua-9638	38	37	7	7	NUM
aiua-9638	38	38	and	and	CCONJ
aiua-9638	38	39	<	<	X
aiua-9638	38	40	22	22	NUM
aiua-9638	38	41	;	;	PUNCT
aiua-9638	38	42	hypertension	hypertension	NOUN
aiua-9638	38	43	treated	treat	VERB
aiua-9638	38	44	with	with	ADP
aiua-9638	38	45	ace	ace	NOUN
aiua-9638	38	46	inhibitors	inhibitor	NOUN
aiua-9638	38	47	,	,	PUNCT
aiua-9638	38	48	beta	beta	NOUN
aiua-9638	38	49	-	-	PUNCT
aiua-9638	38	50	blockers	blocker	NOUN
aiua-9638	38	51	or	or	CCONJ
aiua-9638	38	52	calcium	calcium	NOUN
aiua-9638	38	53	antagonists	antagonist	NOUN
aiua-9638	38	54	and/or	and/or	CCONJ
aiua-9638	38	55	type	type	VERB
aiua-9638	38	56	2	2	NUM
aiua-9638	38	57	diabetes	diabetes	NOUN
aiua-9638	38	58	treated	treat	VERB
aiua-9638	38	59	with	with	ADP
aiua-9638	38	60	oral	oral	ADJ
aiua-9638	38	61	hypoglycemic	hypoglycemic	ADJ
aiua-9638	38	62	agents	agent	NOUN
aiua-9638	38	63	;	;	PUNCT
aiua-9638	38	64	the	the	DET
aiua-9638	38	65	patient	patient	NOUN
aiua-9638	38	66	has	have	AUX
aiua-9638	38	67	been	be	AUX
aiua-9638	38	68	in	in	ADP
aiua-9638	38	69	a	a	DET
aiua-9638	38	70	stable	stable	ADJ
aiua-9638	38	71	sexual	sexual	ADJ
aiua-9638	38	72	relationship	relationship	NOUN
aiua-9638	38	73	for	for	ADP
aiua-9638	38	74	>	>	X
aiua-9638	38	75	3	3	NUM
aiua-9638	38	76	months	month	NOUN
aiua-9638	38	77	.	.	PUNCT
aiua-9638	39	1	patients	patient	NOUN
aiua-9638	39	2	have	have	AUX
aiua-9638	39	3	had	have	VERB
aiua-9638	39	4	to	to	PART
aiua-9638	39	5	be	be	AUX
aiua-9638	39	6	naïve	naïve	ADJ
aiua-9638	39	7	for	for	ADP
aiua-9638	39	8	pde5inhibitors	pde5inhibitors	PROPN
aiua-9638	39	9	treatment	treatment	NOUN
aiua-9638	39	10	.	.	PUNCT
aiua-9638	40	1	exclusion	exclusion	NOUN
aiua-9638	40	2	criteria	criterion	NOUN
aiua-9638	40	3	were	be	AUX
aiua-9638	40	4	:	:	PUNCT
aiua-9638	40	5	patients	patient	NOUN
aiua-9638	40	6	who	who	PRON
aiua-9638	40	7	had	have	VERB
aiua-9638	40	8	severe	severe	ADJ
aiua-9638	40	9	ed	ed	NOUN
aiua-9638	40	10	(	(	PUNCT
aiua-9638	40	11	iief-5	iief-5	NUM
aiua-9638	40	12	score	score	VERB
aiua-9638	40	13	<	<	X
aiua-9638	40	14	8)	8)	NUM
aiua-9638	40	15	,	,	PUNCT
aiua-9638	40	16	ed	ed	NOUN
aiua-9638	40	17	due	due	ADP
aiua-9638	40	18	to	to	ADP
aiua-9638	40	19	endocrine	endocrine	NOUN
aiua-9638	40	20	disorders	disorder	NOUN
aiua-9638	40	21	,	,	PUNCT
aiua-9638	40	22	premature	premature	ADJ
aiua-9638	40	23	ejaculation	ejaculation	NOUN
aiua-9638	40	24	,	,	PUNCT
aiua-9638	40	25	previous	previous	ADJ
aiua-9638	40	26	pelvic	pelvic	ADJ
aiua-9638	40	27	surgery	surgery	NOUN
aiua-9638	40	28	,	,	PUNCT
aiua-9638	40	29	peyronie	peyronie	NOUN
aiua-9638	40	30	’s	’s	PART
aiua-9638	40	31	disease	disease	NOUN
aiua-9638	40	32	,	,	PUNCT
aiua-9638	40	33	liver	liver	NOUN
aiua-9638	40	34	or	or	CCONJ
aiua-9638	40	35	renal	renal	ADJ
aiua-9638	40	36	failure	failure	NOUN
aiua-9638	40	37	,	,	PUNCT
aiua-9638	40	38	history	history	NOUN
aiua-9638	40	39	of	of	ADP
aiua-9638	40	40	myocardial	myocardial	ADJ
aiua-9638	40	41	infarction	infarction	NOUN
aiua-9638	40	42	,	,	PUNCT
aiua-9638	40	43	cardiovascular	cardiovascular	ADJ
aiua-9638	40	44	disease	disease	NOUN
aiua-9638	40	45	,	,	PUNCT
aiua-9638	40	46	stroke	stroke	NOUN
aiua-9638	40	47	,	,	PUNCT
aiua-9638	40	48	unstable	unstable	ADJ
aiua-9638	40	49	angina	angina	NOUN
aiua-9638	40	50	and	and	CCONJ
aiua-9638	40	51	heart	heart	NOUN
aiua-9638	40	52	failure	failure	NOUN
aiua-9638	40	53	within	within	ADP
aiua-9638	40	54	the	the	DET
aiua-9638	40	55	previous	previous	ADJ
aiua-9638	40	56	6	6	NUM
aiua-9638	40	57	months	month	NOUN
aiua-9638	40	58	,	,	PUNCT
aiua-9638	40	59	intake	intake	NOUN
aiua-9638	40	60	of	of	ADP
aiua-9638	40	61	nitrates	nitrate	NOUN
aiua-9638	40	62	,	,	PUNCT
aiua-9638	40	63	diabetes	diabetes	NOUN
aiua-9638	40	64	mellitus	mellitus	NOUN
aiua-9638	40	65	on	on	ADP
aiua-9638	40	66	insulin	insulin	NOUN
aiua-9638	40	67	therapy	therapy	NOUN
aiua-9638	40	68	,	,	PUNCT
aiua-9638	40	69	dyslipidemia	dyslipidemia	VERB
aiua-9638	40	70	under	under	ADP
aiua-9638	40	71	drug	drug	NOUN
aiua-9638	40	72	treatment	treatment	NOUN
aiua-9638	40	73	,	,	PUNCT
aiua-9638	40	74	spinal	spinal	ADJ
aiua-9638	40	75	cord	cord	NOUN
aiua-9638	40	76	injuries	injury	NOUN
aiua-9638	40	77	.	.	PUNCT
aiua-9638	41	1	at	at	ADP
aiua-9638	41	2	screening	screen	VERB
aiua-9638	41	3	visit	visit	NOUN
aiua-9638	41	4	patients	patient	NOUN
aiua-9638	41	5	underwent	undergo	VERB
aiua-9638	41	6	clinical	clinical	ADJ
aiua-9638	41	7	examination	examination	NOUN
aiua-9638	41	8	,	,	PUNCT
aiua-9638	41	9	blood	blood	NOUN
aiua-9638	41	10	test	test	NOUN
aiua-9638	41	11	(	(	PUNCT
aiua-9638	41	12	hormonal	hormonal	ADJ
aiua-9638	41	13	and	and	CCONJ
aiua-9638	41	14	metabolic	metabolic	NOUN
aiua-9638	41	15	profile	profile	NOUN
aiua-9638	41	16	)	)	PUNCT
aiua-9638	41	17	and	and	CCONJ
aiua-9638	41	18	filled	fill	VERB
aiua-9638	41	19	out	out	ADP
aiua-9638	41	20	the	the	DET
aiua-9638	41	21	iief-5	iief-5	NUM
aiua-9638	41	22	questionnaire	questionnaire	NOUN
aiua-9638	41	23	and	and	CCONJ
aiua-9638	41	24	the	the	DET
aiua-9638	41	25	sep	sep	NOUN
aiua-9638	41	26	(	(	PUNCT
aiua-9638	41	27	sep-2	sep-2	ADV
aiua-9638	41	28	:	:	PUNCT
aiua-9638	41	29	«	«	PUNCT
aiua-9638	41	30	were	be	AUX
aiua-9638	41	31	you	you	PRON
aiua-9638	41	32	able	able	ADJ
aiua-9638	41	33	to	to	PART
aiua-9638	41	34	insert	insert	VERB
aiua-9638	41	35	your	your	PRON
aiua-9638	41	36	penis	penis	NOUN
aiua-9638	41	37	into	into	ADP
aiua-9638	41	38	your	your	PRON
aiua-9638	41	39	partner	partner	NOUN
aiua-9638	41	40	's	's	PART
aiua-9638	41	41	vagina	vagina	NOUN
aiua-9638	41	42	?	?	PUNCT
aiua-9638	41	43	»	»	PUNCT
aiua-9638	41	44	and	and	CCONJ
aiua-9638	41	45	sep3	sep3	PROPN
aiua-9638	41	46	«	«	PUNCT
aiua-9638	41	47	did	do	VERB
aiua-9638	41	48	your	your	PRON
aiua-9638	41	49	erection	erection	NOUN
aiua-9638	41	50	last	last	ADJ
aiua-9638	41	51	long	long	ADV
aiua-9638	41	52	enough	enough	ADV
aiua-9638	41	53	for	for	SCONJ
aiua-9638	41	54	you	you	PRON
aiua-9638	41	55	to	to	PART
aiua-9638	41	56	have	have	VERB
aiua-9638	41	57	sexual	sexual	ADJ
aiua-9638	41	58	intercourse	intercourse	NOUN
aiua-9638	41	59	?	?	PUNCT
aiua-9638	41	60	»	»	PUNCT
aiua-9638	41	61	)	)	PUNCT
aiua-9638	41	62	.	.	PUNCT
aiua-9638	42	1	patients	patient	NOUN
aiua-9638	42	2	who	who	PRON
aiua-9638	42	3	met	meet	VERB
aiua-9638	42	4	inclusion	inclusion	NOUN
aiua-9638	42	5	criteria	criterion	NOUN
aiua-9638	42	6	were	be	AUX
aiua-9638	42	7	randomized	randomize	VERB
aiua-9638	42	8	by	by	ADP
aiua-9638	42	9	a	a	DET
aiua-9638	42	10	computer	computer	NOUN
aiua-9638	42	11	-	-	PUNCT
aiua-9638	42	12	generated	generate	VERB
aiua-9638	42	13	list	list	NOUN
aiua-9638	42	14	to	to	PART
aiua-9638	42	15	receive	receive	VERB
aiua-9638	42	16	either	either	CCONJ
aiua-9638	42	17	tadalafil	tadalafil	PROPN
aiua-9638	42	18	5	5	NUM
aiua-9638	42	19	mg	mg	NOUN
aiua-9638	42	20	once	once	ADV
aiua-9638	42	21	daily	daily	ADJ
aiua-9638	42	22	plus	plus	CCONJ
aiua-9638	42	23	nutritional	nutritional	ADJ
aiua-9638	42	24	supplement	supplement	NOUN
aiua-9638	42	25	once	once	ADV
aiua-9638	42	26	daily	daily	ADV
aiua-9638	42	27	(	(	PUNCT
aiua-9638	42	28	group	group	NOUN
aiua-9638	42	29	a	a	NOUN
aiua-9638	42	30	)	)	PUNCT
aiua-9638	42	31	or	or	CCONJ
aiua-9638	42	32	tadalafil	tadalafil	NUM
aiua-9638	42	33	5	5	NUM
aiua-9638	42	34	mg	mg	NOUN
aiua-9638	42	35	plus	plus	CCONJ
aiua-9638	42	36	placebo	placebo	NOUN
aiua-9638	42	37	with	with	ADP
aiua-9638	42	38	the	the	DET
aiua-9638	42	39	same	same	ADJ
aiua-9638	42	40	administration	administration	NOUN
aiua-9638	42	41	schedule	schedule	NOUN
aiua-9638	42	42	(	(	PUNCT
aiua-9638	42	43	group	group	NOUN
aiua-9638	42	44	b	b	NOUN
aiua-9638	42	45	)	)	PUNCT
aiua-9638	42	46	for	for	ADP
aiua-9638	42	47	3	3	NUM
aiua-9638	42	48	months	month	NOUN
aiua-9638	42	49	.	.	PUNCT
aiua-9638	43	1	blood	blood	NOUN
aiua-9638	43	2	samples	sample	NOUN
aiua-9638	43	3	,	,	PUNCT
aiua-9638	43	4	iief-5	iief-5	NUM
aiua-9638	43	5	,	,	PUNCT
aiua-9638	43	6	sep-2	sep-2	X
aiua-9638	43	7	and	and	CCONJ
aiua-9638	43	8	sep-3	sep-3	PUNCT
aiua-9638	43	9	have	have	AUX
aiua-9638	43	10	been	be	AUX
aiua-9638	43	11	collected	collect	VERB
aiua-9638	43	12	again	again	ADV
aiua-9638	43	13	after	after	ADP
aiua-9638	43	14	3	3	NUM
aiua-9638	43	15	months	month	NOUN
aiua-9638	43	16	.	.	PUNCT
aiua-9638	44	1	all	all	DET
aiua-9638	44	2	adverse	adverse	ADJ
aiua-9638	44	3	events	event	NOUN
aiua-9638	44	4	(	(	PUNCT
aiua-9638	44	5	aes	aes	NOUN
aiua-9638	44	6	)	)	PUNCT
aiua-9638	44	7	occurred	occur	VERB
aiua-9638	44	8	during	during	ADP
aiua-9638	44	9	the	the	DET
aiua-9638	44	10	study	study	NOUN
aiua-9638	44	11	period	period	NOUN
aiua-9638	44	12	were	be	AUX
aiua-9638	44	13	recorded	record	VERB
aiua-9638	44	14	.	.	PUNCT
aiua-9638	45	1	the	the	DET
aiua-9638	45	2	study	study	NOUN
aiua-9638	45	3	was	be	AUX
aiua-9638	45	4	carried	carry	VERB
aiua-9638	45	5	out	out	ADP
aiua-9638	45	6	in	in	ADP
aiua-9638	45	7	accordance	accordance	NOUN
aiua-9638	45	8	with	with	ADP
aiua-9638	45	9	the	the	DET
aiua-9638	45	10	declaration	declaration	NOUN
aiua-9638	45	11	of	of	ADP
aiua-9638	45	12	helsinki	helsinki	PROPN
aiua-9638	45	13	and	and	CCONJ
aiua-9638	45	14	gcp	gcp	PROPN
aiua-9638	45	15	.	.	PUNCT
aiua-9638	46	1	all	all	DET
aiua-9638	46	2	patients	patient	NOUN
aiua-9638	46	3	provided	provide	VERB
aiua-9638	46	4	written	write	VERB
aiua-9638	46	5	informed	inform	VERB
aiua-9638	46	6	consent	consent	NOUN
aiua-9638	46	7	.	.	PUNCT
aiua-9638	47	1	the	the	DET
aiua-9638	47	2	protocol	protocol	NOUN
aiua-9638	47	3	was	be	AUX
aiua-9638	47	4	approved	approve	VERB
aiua-9638	47	5	by	by	ADP
aiua-9638	47	6	the	the	DET
aiua-9638	47	7	ethical	ethical	PROPN
aiua-9638	47	8	committee	committee	NOUN
aiua-9638	47	9	of	of	ADP
aiua-9638	47	10	federico	federico	PROPN
aiua-9638	47	11	ii	ii	PROPN
aiua-9638	47	12	university	university	PROPN
aiua-9638	47	13	of	of	ADP
aiua-9638	47	14	napoli	napoli	PROPN
aiua-9638	47	15	.	.	PUNCT
aiua-9638	48	1	nutritional	nutritional	ADJ
aiua-9638	48	2	supplement	supplement	NOUN
aiua-9638	48	3	composition	composition	NOUN
aiua-9638	48	4	the	the	DET
aiua-9638	48	5	nutritional	nutritional	ADJ
aiua-9638	48	6	supplement	supplement	NOUN
aiua-9638	48	7	used	use	VERB
aiua-9638	48	8	for	for	ADP
aiua-9638	48	9	the	the	DET
aiua-9638	48	10	study	study	NOUN
aiua-9638	48	11	resulted	result	VERB
aiua-9638	48	12	from	from	ADP
aiua-9638	48	13	a	a	DET
aiua-9638	48	14	combination	combination	NOUN
aiua-9638	48	15	of	of	ADP
aiua-9638	48	16	panax	panax	PROPN
aiua-9638	48	17	ginseng	ginseng	PROPN
aiua-9638	48	18	(	(	PUNCT
aiua-9638	48	19	500	500	NUM
aiua-9638	48	20	mg	mg	NUM
aiua-9638	48	21	)	)	PUNCT
aiua-9638	48	22	,	,	PUNCT
aiua-9638	48	23	moringa	moringa	PROPN
aiua-9638	48	24	oleifera	oleifera	NOUN
aiua-9638	48	25	(	(	PUNCT
aiua-9638	48	26	200	200	NUM
aiua-9638	48	27	mg	mg	NOUN
aiua-9638	48	28	)	)	PUNCT
aiua-9638	48	29	and	and	CCONJ
aiua-9638	48	30	rutin	rutin	NOUN
aiua-9638	48	31	(	(	PUNCT
aiua-9638	48	32	50	50	NUM
aiua-9638	48	33	mg	mg	NUM
aiua-9638	48	34	)	)	PUNCT
aiua-9638	48	35	.	.	PUNCT
aiua-9638	49	1	the	the	DET
aiua-9638	49	2	three	three	NUM
aiua-9638	49	3	components	component	NOUN
aiua-9638	49	4	were	be	AUX
aiua-9638	49	5	assembled	assemble	VERB
aiua-9638	49	6	in	in	ADP
aiua-9638	49	7	a	a	DET
aiua-9638	49	8	three	three	NUM
aiua-9638	49	9	-	-	PUNCT
aiua-9638	49	10	layer	layer	NOUN
aiua-9638	49	11	tablet	tablet	NOUN
aiua-9638	49	12	that	that	PRON
aiua-9638	49	13	allows	allow	VERB
aiua-9638	49	14	different	different	ADJ
aiua-9638	49	15	timing	timing	NOUN
aiua-9638	49	16	for	for	ADP
aiua-9638	49	17	the	the	DET
aiua-9638	49	18	release	release	NOUN
aiua-9638	49	19	of	of	ADP
aiua-9638	49	20	active	active	ADJ
aiua-9638	49	21	ingredients	ingredient	NOUN
aiua-9638	49	22	.	.	PUNCT
aiua-9638	50	1	human	human	ADJ
aiua-9638	50	2	washed	washed	NOUN
aiua-9638	50	3	platelets	platelet	VERB
aiua-9638	50	4	blood	blood	NOUN
aiua-9638	50	5	samples	sample	NOUN
aiua-9638	50	6	were	be	AUX
aiua-9638	50	7	collected	collect	VERB
aiua-9638	50	8	from	from	ADP
aiua-9638	50	9	additional	additional	ADJ
aiua-9638	50	10	patients	patient	NOUN
aiua-9638	50	11	who	who	PRON
aiua-9638	50	12	met	meet	VERB
aiua-9638	50	13	inclusion	inclusion	NOUN
aiua-9638	50	14	and	and	CCONJ
aiua-9638	50	15	exclusion	exclusion	NOUN
aiua-9638	50	16	criteria	criterion	NOUN
aiua-9638	50	17	described	describe	VERB
aiua-9638	50	18	above	above	ADV
aiua-9638	50	19	.	.	PUNCT
aiua-9638	51	1	these	these	DET
aiua-9638	51	2	subjects	subject	NOUN
aiua-9638	51	3	received	receive	VERB
aiua-9638	51	4	tadalafil	tadalafil	PROPN
aiua-9638	51	5	5	5	NUM
aiua-9638	51	6	mg	mg	PROPN
aiua-9638	51	7	/	/	SYM
aiua-9638	51	8	daily	daily	ADJ
aiua-9638	51	9	plus	plus	CCONJ
aiua-9638	51	10	nutritional	nutritional	ADJ
aiua-9638	51	11	supplement	supplement	NOUN
aiua-9638	51	12	1	1	NUM
aiua-9638	51	13	cpr	cpr	NOUN
aiua-9638	51	14	/	/	SYM
aiua-9638	51	15	daily	daily	ADV
aiua-9638	51	16	for	for	ADP
aiua-9638	51	17	one	one	NUM
aiua-9638	51	18	month	month	NOUN
aiua-9638	51	19	.	.	PUNCT
aiua-9638	52	1	the	the	DET
aiua-9638	52	2	blood	blood	NOUN
aiua-9638	52	3	samples	sample	NOUN
aiua-9638	52	4	were	be	AUX
aiua-9638	52	5	collected	collect	VERB
aiua-9638	52	6	before	before	ADV
aiua-9638	52	7	(	(	PUNCT
aiua-9638	52	8	baseline	baseline	NOUN
aiua-9638	52	9	)	)	PUNCT
aiua-9638	52	10	and	and	CCONJ
aiua-9638	52	11	after	after	ADP
aiua-9638	52	12	treatment	treatment	NOUN
aiua-9638	52	13	.	.	PUNCT
aiua-9638	53	1	human	human	ADJ
aiua-9638	53	2	washed	wash	VERB
aiua-9638	53	3	platelets	platelet	NOUN
aiua-9638	53	4	were	be	AUX
aiua-9638	53	5	obtained	obtain	VERB
aiua-9638	53	6	by	by	ADP
aiua-9638	53	7	blood	blood	NOUN
aiua-9638	53	8	(	(	PUNCT
aiua-9638	53	9	20	20	NUM
aiua-9638	53	10	ml	ml	NOUN
aiua-9638	53	11	)	)	PUNCT
aiua-9638	53	12	samples	sample	NOUN
aiua-9638	53	13	collected	collect	VERB
aiua-9638	53	14	by	by	ADP
aiua-9638	53	15	venipuncture	venipuncture	NOUN
aiua-9638	53	16	.	.	PUNCT
aiua-9638	54	1	each	each	DET
aiua-9638	54	2	sample	sample	NOUN
aiua-9638	54	3	was	be	AUX
aiua-9638	54	4	mixed	mix	VERB
aiua-9638	54	5	with	with	ADP
aiua-9638	54	6	trisodium	trisodium	ADJ
aiua-9638	54	7	citrate	citrate	NOUN
aiua-9638	54	8	(	(	PUNCT
aiua-9638	54	9	3.8	3.8	NUM
aiua-9638	54	10	%	%	NOUN
aiua-9638	54	11	w	w	PROPN
aiua-9638	54	12	/	/	SYM
aiua-9638	54	13	v	v	NUM
aiua-9638	54	14	1:10	1:10	NUM
aiua-9638	54	15	ratio	ratio	NOUN
aiua-9638	54	16	)	)	PUNCT
aiua-9638	54	17	and	and	CCONJ
aiua-9638	54	18	then	then	ADV
aiua-9638	54	19	centrifuged	centrifuge	VERB
aiua-9638	54	20	at	at	ADP
aiua-9638	54	21	150	150	NUM
aiua-9638	54	22	x	x	SYM
aiua-9638	54	23	g	g	NOUN
aiua-9638	54	24	for	for	ADP
aiua-9638	54	25	10	10	NUM
aiua-9638	54	26	min	min	NOUN
aiua-9638	54	27	to	to	PART
aiua-9638	54	28	obtain	obtain	VERB
aiua-9638	54	29	plateletrich	plateletrich	NOUN
aiua-9638	54	30	plasma	plasma	NOUN
aiua-9638	54	31	(	(	PUNCT
aiua-9638	54	32	prp	prp	PROPN
aiua-9638	54	33	)	)	PUNCT
aiua-9638	54	34	as	as	ADP
aiua-9638	54	35	a	a	DET
aiua-9638	54	36	supernatant	supernatant	NOUN
aiua-9638	54	37	.	.	PUNCT
aiua-9638	55	1	washed	wash	VERB
aiua-9638	55	2	platelets	platelet	NOUN
aiua-9638	55	3	were	be	AUX
aiua-9638	55	4	prepared	prepare	VERB
aiua-9638	55	5	as	as	ADP
aiua-9638	55	6	previously	previously	ADV
aiua-9638	55	7	described	describe	VERB
aiua-9638	55	8	(	(	PUNCT
aiua-9638	55	9	18	18	NUM
aiua-9638	55	10	,	,	PUNCT
aiua-9638	55	11	19	19	NUM
aiua-9638	55	12	)	)	PUNCT
aiua-9638	55	13	.	.	PUNCT
aiua-9638	56	1	prp	prp	PROPN
aiua-9638	56	2	was	be	AUX
aiua-9638	56	3	centrifuged	centrifuge	VERB
aiua-9638	56	4	at	at	ADP
aiua-9638	56	5	800	800	NUM
aiua-9638	56	6	×	×	NOUN
aiua-9638	56	7	g	g	NOUN
aiua-9638	56	8	for	for	ADP
aiua-9638	56	9	12	12	NUM
aiua-9638	56	10	min	min	NOUN
aiua-9638	56	11	after	after	ADP
aiua-9638	56	12	the	the	DET
aiua-9638	56	13	addition	addition	NOUN
aiua-9638	56	14	of	of	ADP
aiua-9638	56	15	1/10	1/10	NUM
aiua-9638	56	16	volume	volume	NOUN
aiua-9638	56	17	acd	acd	NOUN
aiua-9638	56	18	solution	solution	NOUN
aiua-9638	56	19	(	(	PUNCT
aiua-9638	56	20	85	85	NUM
aiua-9638	56	21	mm	mm	NUM
aiua-9638	56	22	na3	na3	NOUN
aiua-9638	56	23	-	-	NOUN
aiua-9638	56	24	citrate	citrate	NOUN
aiua-9638	56	25	,	,	PUNCT
aiua-9638	56	26	11	11	NUM
aiua-9638	56	27	mm	mm	NOUN
aiua-9638	56	28	d	d	NOUN
aiua-9638	56	29	-	-	NOUN
aiua-9638	56	30	glucose	glucose	NOUN
aiua-9638	56	31	,	,	PUNCT
aiua-9638	56	32	71	71	NUM
aiua-9638	56	33	mm	mm	NOUN
aiua-9638	56	34	citric	citric	ADJ
aiua-9638	56	35	acid	acid	NOUN
aiua-9638	56	36	,	,	PUNCT
aiua-9638	56	37	ph	ph	NOUN
aiua-9638	56	38	4.4	4.4	NUM
aiua-9638	56	39	)	)	PUNCT
aiua-9638	56	40	.	.	PUNCT
aiua-9638	57	1	the	the	DET
aiua-9638	57	2	pellet	pellet	NOUN
aiua-9638	57	3	was	be	AUX
aiua-9638	57	4	resuspended	resuspend	VERB
aiua-9638	57	5	in	in	ADP
aiua-9638	57	6	ca+	ca+	NOUN
aiua-9638	57	7	2	2	NUM
aiua-9638	57	8	/	/	SYM
aiua-9638	57	9	mg+	mg+	NOUN
aiua-9638	57	10	2	2	NUM
aiua-9638	57	11	-	-	PUNCT
aiua-9638	57	12	free	free	ADJ
aiua-9638	57	13	hepes	hepe	NOUN
aiua-9638	57	14	-	-	PUNCT
aiua-9638	57	15	tyrode	tyrode	NOUN
aiua-9638	57	16	buffer	buffer	NOUN
aiua-9638	57	17	(	(	PUNCT
aiua-9638	57	18	134	134	NUM
aiua-9638	57	19	mm	mm	NOUN
aiua-9638	57	20	nacl	nacl	NOUN
aiua-9638	57	21	,	,	PUNCT
aiua-9638	57	22	12	12	NUM
aiua-9638	57	23	mm	mm	NOUN
aiua-9638	57	24	nahco3	nahco3	NOUN
aiua-9638	57	25	,	,	PUNCT
aiua-9638	57	26	2.9	2.9	NUM
aiua-9638	57	27	mm	mm	NOUN
aiua-9638	57	28	kcl	kcl	PROPN
aiua-9638	57	29	,	,	PUNCT
aiua-9638	57	30	0.36	0.36	NUM
aiua-9638	57	31	mm	mm	NOUN
aiua-9638	57	32	na2hpo4	na2hpo4	PROPN
aiua-9638	57	33	,	,	PUNCT
aiua-9638	57	34	5	5	NUM
aiua-9638	57	35	mm	mm	NOUN
aiua-9638	57	36	hepes	hepe	NOUN
aiua-9638	57	37	,	,	PUNCT
aiua-9638	57	38	5	5	NUM
aiua-9638	57	39	mm	mm	NOUN
aiua-9638	57	40	glucose	glucose	NOUN
aiua-9638	57	41	,	,	PUNCT
aiua-9638	57	42	0.5	0.5	NUM
aiua-9638	57	43	%	%	NOUN
aiua-9638	57	44	(	(	PUNCT
aiua-9638	57	45	w	w	NOUN
aiua-9638	57	46	/	/	SYM
aiua-9638	57	47	v	v	NOUN
aiua-9638	57	48	)	)	PUNCT
aiua-9638	57	49	bovine	bovine	NOUN
aiua-9638	57	50	serum	serum	NOUN
aiua-9638	57	51	albumin	albumin	NOUN
aiua-9638	57	52	,	,	PUNCT
aiua-9638	57	53	ph	ph	NOUN
aiua-9638	57	54	7.4	7.4	NUM
aiua-9638	57	55	)	)	PUNCT
aiua-9638	57	56	and	and	CCONJ
aiua-9638	57	57	adjusted	adjust	VERB
aiua-9638	57	58	to	to	ADP
aiua-9638	57	59	5	5	NUM
aiua-9638	57	60	×	×	PROPN
aiua-9638	57	61	105	105	NUM
aiua-9638	57	62	platelets/µl	platelets/µl	NOUN
aiua-9638	57	63	.	.	PUNCT
aiua-9638	58	1	the	the	DET
aiua-9638	58	2	platelet	platelet	NOUN
aiua-9638	58	3	number	number	NOUN
aiua-9638	58	4	was	be	AUX
aiua-9638	58	5	determined	determine	VERB
aiua-9638	58	6	by	by	ADP
aiua-9638	58	7	using	use	VERB
aiua-9638	58	8	a	a	DET
aiua-9638	58	9	cell	cell	NOUN
aiua-9638	58	10	counter	counter	NOUN
aiua-9638	58	11	(	(	PUNCT
aiua-9638	58	12	act	act	PROPN
aiua-9638	58	13	diff	diff	PROPN
aiua-9638	58	14	2	2	NUM
aiua-9638	58	15	,	,	PUNCT
aiua-9638	58	16	instrument	instrument	NOUN
aiua-9638	58	17	laboratory	laboratory	NOUN
aiua-9638	58	18	,	,	PUNCT
aiua-9638	58	19	milan	milan	PROPN
aiua-9638	58	20	,	,	PUNCT
aiua-9638	58	21	italy	italy	PROPN
aiua-9638	58	22	)	)	PUNCT
aiua-9638	58	23	.	.	PUNCT
aiua-9638	59	1	cgmp	cgmp	PROPN
aiua-9638	59	2	measurement	measurement	PROPN
aiua-9638	59	3	human	human	ADJ
aiua-9638	59	4	washed	wash	VERB
aiua-9638	59	5	platelets	platelet	NOUN
aiua-9638	59	6	(	(	PUNCT
aiua-9638	59	7	5	5	NUM
aiua-9638	59	8	×	×	NOUN
aiua-9638	59	9	105	105	NUM
aiua-9638	59	10	platelets/µl	platelets/µl	NOUN
aiua-9638	59	11	)	)	PUNCT
aiua-9638	59	12	were	be	AUX
aiua-9638	59	13	incubated	incubate	VERB
aiua-9638	59	14	at	at	ADP
aiua-9638	59	15	37	37	NUM
aiua-9638	59	16	°	°	ADP
aiua-9638	59	17	c	c	NOUN
aiua-9638	59	18	with	with	ADP
aiua-9638	59	19	vehicle	vehicle	NOUN
aiua-9638	59	20	or	or	CCONJ
aiua-9638	59	21	diethylamine	diethylamine	ADJ
aiua-9638	59	22	nonoate	nonoate	NOUN
aiua-9638	59	23	(	(	PUNCT
aiua-9638	59	24	dea	dea	NOUN
aiua-9638	59	25	-	-	PUNCT
aiua-9638	59	26	nonoate	nonoate	NOUN
aiua-9638	59	27	,	,	PUNCT
aiua-9638	59	28	alexis	alexis	PROPN
aiua-9638	59	29	;	;	PUNCT
aiua-9638	59	30	vinci	vinci	PROPN
aiua-9638	59	31	biochem	biochem	PROPN
aiua-9638	59	32	,	,	PUNCT
aiua-9638	59	33	vinci	vinci	PROPN
aiua-9638	59	34	,	,	PUNCT
aiua-9638	59	35	italy	italy	PROPN
aiua-9638	59	36	)	)	PUNCT
aiua-9638	59	37	,	,	PUNCT
aiua-9638	59	38	a	a	DET
aiua-9638	59	39	stable	stable	ADJ
aiua-9638	59	40	donor	donor	NOUN
aiua-9638	59	41	of	of	ADP
aiua-9638	59	42	no	no	PRON
aiua-9638	59	43	at	at	ADP
aiua-9638	59	44	the	the	DET
aiua-9638	59	45	concentration	concentration	NOUN
aiua-9638	59	46	of	of	ADP
aiua-9638	59	47	10	10	NUM
aiua-9638	59	48	µm	µm	NOUN
aiua-9638	59	49	or	or	CCONJ
aiua-9638	59	50	100	100	NUM
aiua-9638	59	51	μm	μm	NUM
aiua-9638	59	52	.	.	PUNCT
aiua-9638	60	1	the	the	DET
aiua-9638	60	2	reaction	reaction	NOUN
aiua-9638	60	3	was	be	AUX
aiua-9638	60	4	stopped	stop	VERB
aiua-9638	60	5	after	after	ADP
aiua-9638	60	6	30	30	NUM
aiua-9638	60	7	minutes	minute	NOUN
aiua-9638	60	8	in	in	ADP
aiua-9638	60	9	liquid	liquid	ADJ
aiua-9638	60	10	nitrogen	nitrogen	NOUN
aiua-9638	60	11	.	.	PUNCT
aiua-9638	61	1	dea	dea	NOUN
aiua-9638	61	2	-	-	PUNCT
aiua-9638	61	3	nonoate	nonoate	NOUN
aiua-9638	61	4	spontaneously	spontaneously	ADV
aiua-9638	61	5	dissociates	dissociate	NOUN
aiua-9638	61	6	in	in	ADP
aiua-9638	61	7	a	a	DET
aiua-9638	61	8	ph	ph	NOUN
aiua-9638	61	9	-	-	PUNCT
aiua-9638	61	10	dependent	dependent	ADJ
aiua-9638	61	11	,	,	PUNCT
aiua-9638	61	12	first	first	ADJ
aiua-9638	61	13	-	-	PUNCT
aiua-9638	61	14	order	order	NOUN
aiua-9638	61	15	process	process	NOUN
aiua-9638	61	16	with	with	ADP
aiua-9638	61	17	a	a	DET
aiua-9638	61	18	half	half	ADJ
aiua-9638	61	19	-	-	PUNCT
aiua-9638	61	20	life	life	NOUN
aiua-9638	61	21	of	of	ADP
aiua-9638	61	22	2	2	NUM
aiua-9638	61	23	min	min	NOUN
aiua-9638	61	24	at	at	ADP
aiua-9638	61	25	37	37	NUM
aiua-9638	61	26	°	°	NOUN
aiua-9638	61	27	c	c	NOUN
aiua-9638	61	28	,	,	PUNCT
aiua-9638	61	29	ph	ph	NOUN
aiua-9638	61	30	7.4	7.4	NUM
aiua-9638	61	31	,	,	PUNCT
aiua-9638	61	32	to	to	PART
aiua-9638	61	33	liberate	liberate	VERB
aiua-9638	61	34	1.5	1.5	NUM
aiua-9638	61	35	mol	mol	NOUN
aiua-9638	61	36	of	of	ADP
aiua-9638	61	37	no	no	PRON
aiua-9638	61	38	per	per	ADP
aiua-9638	61	39	mole	mole	NOUN
aiua-9638	61	40	of	of	ADP
aiua-9638	61	41	parent	parent	NOUN
aiua-9638	61	42	compound	compound	NOUN
aiua-9638	61	43	(	(	PUNCT
aiua-9638	61	44	20	20	NUM
aiua-9638	61	45	)	)	PUNCT
aiua-9638	61	46	.	.	PUNCT
aiua-9638	62	1	platelet	platelet	NOUN
aiua-9638	62	2	suspensions	suspension	NOUN
aiua-9638	62	3	were	be	AUX
aiua-9638	62	4	hydrolyzed	hydrolyze	VERB
aiua-9638	62	5	with	with	ADP
aiua-9638	62	6	hcl	hcl	PROPN
aiua-9638	62	7	3.3	3.3	NUM
aiua-9638	62	8	m.	m.	NOUN
aiua-9638	62	9	the	the	DET
aiua-9638	62	10	lysates	lysate	NOUN
aiua-9638	62	11	were	be	AUX
aiua-9638	62	12	centrifuged	centrifuge	VERB
aiua-9638	62	13	(	(	PUNCT
aiua-9638	62	14	600	600	NUM
aiua-9638	62	15	×	×	NOUN
aiua-9638	62	16	g	g	NOUN
aiua-9638	62	17	for	for	ADP
aiua-9638	62	18	10	10	NUM
aiua-9638	62	19	min	min	NOUN
aiua-9638	62	20	)	)	PUNCT
aiua-9638	62	21	and	and	CCONJ
aiua-9638	62	22	cgmp	cgmp	PROPN
aiua-9638	62	23	measured	measure	VERB
aiua-9638	62	24	in	in	ADP
aiua-9638	62	25	supernatants	supernatant	NOUN
aiua-9638	62	26	as	as	SCONJ
aiua-9638	62	27	described	describe	VERB
aiua-9638	62	28	in	in	ADP
aiua-9638	62	29	the	the	DET
aiua-9638	62	30	manufacture	manufacture	NOUN
aiua-9638	62	31	’s	’s	PART
aiua-9638	62	32	protocol	protocol	NOUN
aiua-9638	62	33	of	of	ADP
aiua-9638	62	34	cgmp	cgmp	PROPN
aiua-9638	62	35	eia	eia	PROPN
aiua-9638	62	36	kit	kit	PROPN
aiua-9638	62	37	(	(	PUNCT
aiua-9638	62	38	cayman	cayman	PROPN
aiua-9638	62	39	,	,	PUNCT
aiua-9638	62	40	vinci	vinci	PROPN
aiua-9638	62	41	biochem	biochem	PROPN
aiua-9638	62	42	,	,	PUNCT
aiua-9638	62	43	vinci	vinci	PROPN
aiua-9638	62	44	,	,	PUNCT
aiua-9638	62	45	italy	italy	PROPN
aiua-9638	62	46	)	)	PUNCT
aiua-9638	62	47	(	(	PUNCT
aiua-9638	62	48	18	18	NUM
aiua-9638	62	49	)	)	PUNCT
aiua-9638	62	50	.	.	PUNCT
aiua-9638	63	1	results	result	VERB
aiua-9638	63	2	a	a	DET
aiua-9638	63	3	total	total	NOUN
aiua-9638	63	4	of	of	ADP
aiua-9638	63	5	86	86	NUM
aiua-9638	63	6	patients	patient	NOUN
aiua-9638	63	7	were	be	AUX
aiua-9638	63	8	enrolled	enrol	VERB
aiua-9638	63	9	in	in	ADP
aiua-9638	63	10	the	the	DET
aiua-9638	63	11	trial	trial	NOUN
aiua-9638	63	12	.	.	PUNCT
aiua-9638	64	1	45	45	NUM
aiua-9638	64	2	patients	patient	NOUN
aiua-9638	64	3	in	in	ADP
aiua-9638	64	4	group	group	PROPN
aiua-9638	64	5	a	a	PRON
aiua-9638	64	6	and	and	CCONJ
aiua-9638	64	7	33	33	NUM
aiua-9638	64	8	patients	patient	NOUN
aiua-9638	64	9	in	in	ADP
aiua-9638	64	10	group	group	PROPN
aiua-9638	64	11	b	b	PROPN
aiua-9638	64	12	completed	complete	VERB
aiua-9638	64	13	the	the	DET
aiua-9638	64	14	study	study	NOUN
aiua-9638	64	15	.	.	PUNCT
aiua-9638	65	1	mean	mean	ADJ
aiua-9638	65	2	age	age	NOUN
aiua-9638	65	3	was	be	AUX
aiua-9638	65	4	59.98	59.98	NUM
aiua-9638	65	5	±	±	NUM
aiua-9638	65	6	6.90	6.90	NUM
aiua-9638	65	7	(	(	PUNCT
aiua-9638	65	8	range	range	NOUN
aiua-9638	65	9	38	38	NUM
aiua-9638	65	10	-	-	SYM
aiua-9638	65	11	69	69	NUM
aiua-9638	65	12	)	)	PUNCT
aiua-9638	65	13	,	,	PUNCT
aiua-9638	65	14	mean	mean	VERB
aiua-9638	65	15	iief-5	iief-5	NUM
aiua-9638	65	16	score	score	NOUN
aiua-9638	65	17	was	be	AUX
aiua-9638	65	18	13.59	13.59	NUM
aiua-9638	65	19	±	±	NUM
aiua-9638	65	20	3.90	3.90	NUM
aiua-9638	65	21	.	.	PUNCT
aiua-9638	66	1	table	table	NOUN
aiua-9638	66	2	1	1	NUM
aiua-9638	66	3	showed	show	VERB
aiua-9638	66	4	the	the	DET
aiua-9638	66	5	baseline	baseline	NOUN
aiua-9638	66	6	characteristics	characteristic	NOUN
aiua-9638	66	7	of	of	ADP
aiua-9638	66	8	the	the	DET
aiua-9638	66	9	two	two	NUM
aiua-9638	66	10	groups	group	NOUN
aiua-9638	66	11	.	.	PUNCT
aiua-9638	67	1	no	no	DET
aiua-9638	67	2	differences	difference	NOUN
aiua-9638	67	3	were	be	AUX
aiua-9638	67	4	noticed	notice	VERB
aiua-9638	67	5	between	between	ADP
aiua-9638	67	6	groups	group	NOUN
aiua-9638	67	7	in	in	ADP
aiua-9638	67	8	terms	term	NOUN
aiua-9638	67	9	of	of	ADP
aiua-9638	67	10	age	age	NOUN
aiua-9638	67	11	,	,	PUNCT
aiua-9638	67	12	baseline	baseline	ADJ
aiua-9638	67	13	erectile	erectile	NOUN
aiua-9638	67	14	function	function	NOUN
aiua-9638	67	15	,	,	PUNCT
aiua-9638	67	16	comorbidities	comorbiditie	NOUN
aiua-9638	67	17	,	,	PUNCT
aiua-9638	67	18	blood	blood	NOUN
aiua-9638	67	19	tests	test	NOUN
aiua-9638	67	20	except	except	SCONJ
aiua-9638	67	21	for	for	ADP
aiua-9638	67	22	total	total	ADJ
aiua-9638	67	23	cholesterol	cholesterol	NOUN
aiua-9638	67	24	,	,	PUNCT
aiua-9638	67	25	significantly	significantly	ADV
aiua-9638	67	26	lower	low	ADJ
aiua-9638	67	27	in	in	ADP
aiua-9638	67	28	group	group	PROPN
aiua-9638	67	29	a	a	NOUN
aiua-9638	67	30	,	,	PUNCT
aiua-9638	67	31	and	and	CCONJ
aiua-9638	67	32	liver	liver	NOUN
aiua-9638	67	33	function	function	NOUN
aiua-9638	67	34	tests	test	NOUN
aiua-9638	67	35	,	,	PUNCT
aiua-9638	67	36	significantly	significantly	ADV
aiua-9638	67	37	higher	high	ADJ
aiua-9638	67	38	in	in	ADP
aiua-9638	67	39	group	group	NOUN
aiua-9638	67	40	a.	a.	NOUN
aiua-9638	67	41	after	after	ADP
aiua-9638	67	42	three	three	NUM
aiua-9638	67	43	months	month	NOUN
aiua-9638	67	44	of	of	ADP
aiua-9638	67	45	treatment	treatment	NOUN
aiua-9638	67	46	,	,	PUNCT
aiua-9638	67	47	iief-5	iief-5	NUM
aiua-9638	67	48	score	score	NOUN
aiua-9638	67	49	significantly	significantly	ADV
aiua-9638	67	50	improved	improve	VERB
aiua-9638	67	51	in	in	ADP
aiua-9638	67	52	both	both	DET
aiua-9638	67	53	groups	group	NOUN
aiua-9638	67	54	compared	compare	VERB
aiua-9638	67	55	to	to	PART
aiua-9638	67	56	baseline	baseline	VERB
aiua-9638	67	57	(	(	PUNCT
aiua-9638	67	58	13.18	13.18	NUM
aiua-9638	67	59	±	±	NUM
aiua-9638	67	60	3.75	3.75	NUM
aiua-9638	67	61	vs	vs	ADP
aiua-9638	67	62	20.48	20.48	NUM
aiua-9638	67	63	±	±	NUM
aiua-9638	67	64	2.24	2.24	NUM
aiua-9638	67	65	,	,	PUNCT
aiua-9638	67	66	p	p	X
aiua-9638	67	67	<	<	X
aiua-9638	67	68	0,0001	0,0001	PROPN
aiua-9638	67	69	;	;	PUNCT
aiua-9638	67	70	14.15	14.15	NUM
aiua-9638	67	71	±	±	NUM
aiua-9638	67	72	4.09	4.09	NUM
aiua-9638	67	73	vs	vs	ADP
aiua-9638	67	74	19.06	19.06	NUM
aiua-9638	67	75	±	±	NUM
aiua-9638	67	76	4.36	4.36	NUM
aiua-9638	67	77	,	,	PUNCT
aiua-9638	67	78	p	p	X
aiua-9638	67	79	<	<	X
aiua-9638	67	80	0.0001	0.0001	NUM
aiua-9638	67	81	,	,	PUNCT
aiua-9638	67	82	in	in	ADP
aiua-9638	67	83	group	group	NOUN
aiua-9638	67	84	a	a	PROPN
aiua-9638	67	85	and	and	CCONJ
aiua-9638	67	86	group	group	PROPN
aiua-9638	67	87	b	b	PROPN
aiua-9638	67	88	respectively	respectively	ADV
aiua-9638	67	89	,	,	PUNCT
aiua-9638	67	90	figure	figure	NOUN
aiua-9638	67	91	1	1	NUM
aiua-9638	67	92	)	)	PUNCT
aiua-9638	67	93	.	.	PUNCT
aiua-9638	68	1	patients	patient	NOUN
aiua-9638	68	2	treated	treat	VERB
aiua-9638	68	3	with	with	ADP
aiua-9638	68	4	tadalafil	tadalafil	PROPN
aiua-9638	68	5	plus	plus	CCONJ
aiua-9638	68	6	nutritional	nutritional	ADJ
aiua-9638	68	7	supplement	supplement	NOUN
aiua-9638	68	8	showed	show	VERB
aiua-9638	68	9	a	a	DET
aiua-9638	68	10	significantly	significantly	ADV
aiua-9638	68	11	higher	high	ADJ
aiua-9638	68	12	increase	increase	NOUN
aiua-9638	68	13	in	in	ADP
aiua-9638	68	14	iief-5	iief-5	NUM
aiua-9638	68	15	score	score	NOUN
aiua-9638	68	16	compared	compare	VERB
aiua-9638	68	17	to	to	ADP
aiua-9638	68	18	those	those	PRON
aiua-9638	68	19	who	who	PRON
aiua-9638	68	20	received	receive	VERB
aiua-9638	68	21	placebo	placebo	NOUN
aiua-9638	68	22	(	(	PUNCT
aiua-9638	68	23	7.27	7.27	NUM
aiua-9638	68	24	±	±	NUM
aiua-9638	68	25	2.20	2.20	NUM
aiua-9638	68	26	and	and	CCONJ
aiua-9638	68	27	4.9	4.9	NUM
aiua-9638	68	28	±	±	NUM
aiua-9638	68	29	2.79	2.79	NUM
aiua-9638	68	30	,	,	PUNCT
aiua-9638	68	31	respectively	respectively	ADV
aiua-9638	68	32	;	;	PUNCT
aiua-9638	68	33	p	p	X
aiua-9638	68	34	<	<	X
aiua-9638	68	35	0.0001	0.0001	NUM
aiua-9638	68	36	;	;	PUNCT
aiua-9638	68	37	figure	figure	NOUN
aiua-9638	68	38	1	1	NUM
aiua-9638	68	39	)	)	PUNCT
aiua-9638	68	40	.	.	PUNCT
aiua-9638	69	1	a	a	DET
aiua-9638	69	2	total	total	NOUN
aiua-9638	69	3	of	of	ADP
aiua-9638	69	4	28	28	NUM
aiua-9638	69	5	patients	patient	NOUN
aiua-9638	69	6	(	(	PUNCT
aiua-9638	69	7	36	36	NUM
aiua-9638	69	8	%	%	NOUN
aiua-9638	69	9	)	)	PUNCT
aiua-9638	69	10	completely	completely	ADV
aiua-9638	69	11	restored	restore	VERB
aiua-9638	69	12	their	their	PRON
aiua-9638	69	13	erectile	erectile	NOUN
aiua-9638	69	14	function	function	NOUN
aiua-9638	69	15	(	(	PUNCT
aiua-9638	69	16	iief-5	iief-5	NUM
aiua-9638	69	17	≥	≥	NOUN
aiua-9638	69	18	22	22	NUM
aiua-9638	69	19	)	)	PUNCT
aiua-9638	69	20	and	and	CCONJ
aiua-9638	69	21	no	no	DET
aiua-9638	69	22	differences	difference	NOUN
aiua-9638	69	23	were	be	AUX
aiua-9638	69	24	noticed	notice	VERB
aiua-9638	69	25	between	between	ADP
aiua-9638	69	26	the	the	DET
aiua-9638	69	27	two	two	NUM
aiua-9638	69	28	groups	group	NOUN
aiua-9638	69	29	(	(	PUNCT
aiua-9638	69	30	15/45	15/45	NUM
aiua-9638	69	31	in	in	ADP
aiua-9638	69	32	group	group	PROPN
aiua-9638	69	33	a	a	PRON
aiua-9638	69	34	vs	vs	ADP
aiua-9638	69	35	13/33	13/33	NUM
aiua-9638	69	36	in	in	ADP
aiua-9638	69	37	group	group	PROPN
aiua-9638	69	38	b	b	PROPN
aiua-9638	69	39	,	,	PUNCT
aiua-9638	69	40	p	p	X
aiua-9638	69	41	=	=	NOUN
aiua-9638	69	42	0.58	0.58	NUM
aiua-9638	69	43	)	)	PUNCT
aiua-9638	69	44	.	.	PUNCT
aiua-9638	70	1	regarding	regard	VERB
aiua-9638	70	2	sep-2	sep-2	X
aiua-9638	70	3	and	and	CCONJ
aiua-9638	70	4	sep-3	sep-3	NUM
aiua-9638	70	5	questions	question	NOUN
aiua-9638	70	6	,	,	PUNCT
aiua-9638	70	7	the	the	DET
aiua-9638	70	8	proportion	proportion	NOUN
aiua-9638	70	9	of	of	ADP
aiua-9638	70	10	"	"	PUNCT
aiua-9638	70	11	yes	yes	INTJ
aiua-9638	70	12	"	"	PUNCT
aiua-9638	70	13	responses	response	NOUN
aiua-9638	70	14	to	to	ADP
aiua-9638	70	15	sep-2	sep-2	X
aiua-9638	70	16	and	and	CCONJ
aiua-9638	70	17	proportion	proportion	NOUN
aiua-9638	70	18	of	of	ADP
aiua-9638	70	19	"	"	PUNCT
aiua-9638	70	20	yes	yes	INTJ
aiua-9638	70	21	"	"	PUNCT
aiua-9638	70	22	responses	response	NOUN
aiua-9638	70	23	to	to	ADP
aiua-9638	70	24	sep-3	sep-3	NUM
aiua-9638	70	25	significantly	significantly	ADV
aiua-9638	70	26	increased	increase	VERB
aiua-9638	70	27	in	in	ADP
aiua-9638	70	28	both	both	DET
aiua-9638	70	29	groups	group	NOUN
aiua-9638	70	30	(	(	PUNCT
aiua-9638	70	31	p	p	X
aiua-9638	70	32	<	<	X
aiua-9638	70	33	0.0001	0.0001	NUM
aiua-9638	70	34	,	,	PUNCT
aiua-9638	70	35	figure	figure	NOUN
aiua-9638	70	36	2	2	NUM
aiua-9638	70	37	)	)	PUNCT
aiua-9638	70	38	with	with	ADP
aiua-9638	70	39	no	no	DET
aiua-9638	70	40	differences	difference	NOUN
aiua-9638	70	41	between	between	ADP
aiua-9638	70	42	groups	group	NOUN
aiua-9638	70	43	(	(	PUNCT
aiua-9638	70	44	p	p	X
aiua-9638	70	45	=	=	NOUN
aiua-9638	70	46	0.73	0.73	NUM
aiua-9638	70	47	for	for	ADP
aiua-9638	70	48	sep-2	sep-2	PRON
aiua-9638	70	49	;	;	PUNCT
aiua-9638	70	50	p	p	X
aiua-9638	70	51	=	=	SYM
aiua-9638	70	52	0.83	0.83	NUM
aiua-9638	70	53	for	for	ADP
aiua-9638	70	54	sep-3	sep-3	NOUN
aiua-9638	70	55	)	)	PUNCT
aiua-9638	70	56	(	(	PUNCT
aiua-9638	70	57	figure	figure	NOUN
aiua-9638	70	58	2	2	NUM
aiua-9638	70	59	)	)	PUNCT
aiua-9638	70	60	.	.	PUNCT
aiua-9638	71	1	treatment	treatment	NOUN
aiua-9638	71	2	did	do	AUX
aiua-9638	71	3	not	not	PART
aiua-9638	71	4	affect	affect	VERB
aiua-9638	71	5	hormonal	hormonal	ADJ
aiua-9638	71	6	plasma	plasma	NOUN
aiua-9638	71	7	levels	level	NOUN
aiua-9638	71	8	(	(	PUNCT
aiua-9638	71	9	table	table	NOUN
aiua-9638	71	10	2	2	NUM
aiua-9638	71	11	)	)	PUNCT
aiua-9638	71	12	.	.	PUNCT
aiua-9638	72	1	no	no	DET
aiua-9638	72	2	differences	difference	NOUN
aiua-9638	72	3	were	be	AUX
aiua-9638	72	4	noticed	notice	VERB
aiua-9638	72	5	in	in	ADP
aiua-9638	72	6	metabolic	metabolic	NOUN
aiua-9638	72	7	profile	profile	NOUN
aiua-9638	72	8	before	before	ADV
aiua-9638	72	9	and	and	CCONJ
aiua-9638	72	10	after	after	ADP
aiua-9638	72	11	treatment	treatment	NOUN
aiua-9638	72	12	in	in	ADP
aiua-9638	72	13	both	both	DET
aiua-9638	72	14	groups	group	NOUN
aiua-9638	72	15	.	.	PUNCT
aiua-9638	73	1	table	table	NOUN
aiua-9638	73	2	3	3	NUM
aiua-9638	73	3	shows	show	VERB
aiua-9638	73	4	adverse	adverse	ADJ
aiua-9638	73	5	events	event	NOUN
aiua-9638	73	6	related	relate	VERB
aiua-9638	73	7	to	to	ADP
aiua-9638	73	8	treatment	treatment	NOUN
aiua-9638	73	9	.	.	PUNCT
aiua-9638	74	1	the	the	DET
aiua-9638	74	2	rate	rate	NOUN
aiua-9638	74	3	of	of	ADP
aiua-9638	74	4	aes	aes	PROPN
aiua-9638	74	5	is	be	AUX
aiua-9638	74	6	comparable	comparable	ADJ
aiua-9638	74	7	between	between	ADP
aiua-9638	74	8	the	the	DET
aiua-9638	74	9	two	two	NUM
aiua-9638	74	10	groups	group	NOUN
aiua-9638	74	11	.	.	PUNCT
aiua-9638	75	1	ex	ex	PRON
aiua-9638	75	2	vivo	vivo	ADJ
aiua-9638	75	3	study	study	NOUN
aiua-9638	75	4	the	the	DET
aiua-9638	75	5	cgmp	cgmp	PROPN
aiua-9638	75	6	content	content	NOUN
aiua-9638	75	7	was	be	AUX
aiua-9638	75	8	measured	measure	VERB
aiua-9638	75	9	in	in	ADP
aiua-9638	75	10	platelets	platelet	NOUN
aiua-9638	75	11	collected	collect	VERB
aiua-9638	75	12	from	from	ADP
aiua-9638	75	13	38	38	NUM
aiua-9638	75	14	patients	patient	NOUN
aiua-9638	75	15	at	at	ADP
aiua-9638	75	16	baseline	baseline	NOUN
aiua-9638	75	17	i.e.	i.e.	X
aiua-9638	75	18	before	before	ADP
aiua-9638	75	19	treatment	treatment	NOUN
aiua-9638	75	20	and	and	CCONJ
aiua-9638	75	21	after	after	ADP
aiua-9638	75	22	one	one	NUM
aiua-9638	75	23	month	month	NOUN
aiua-9638	75	24	of	of	ADP
aiua-9638	75	25	treatment	treatment	NOUN
aiua-9638	75	26	with	with	ADP
aiua-9638	75	27	tadalafil	tadalafil	PROPN
aiua-9638	75	28	5	5	NUM
aiua-9638	75	29	mg	mg	NOUN
aiua-9638	75	30	once	once	ADV
aiua-9638	75	31	daily	daily	ADJ
aiua-9638	75	32	plus	plus	CCONJ
aiua-9638	75	33	nutritional	nutritional	ADJ
aiua-9638	75	34	supplement	supplement	NOUN
aiua-9638	75	35	once	once	ADV
aiua-9638	75	36	daily	daily	ADV
aiua-9638	75	37	.	.	PUNCT
aiua-9638	76	1	the	the	DET
aiua-9638	76	2	uneven	uneven	ADJ
aiua-9638	76	3	number	number	NOUN
aiua-9638	76	4	between	between	ADP
aiua-9638	76	5	before	before	ADP
aiua-9638	76	6	and	and	CCONJ
aiua-9638	76	7	after	after	ADP
aiua-9638	76	8	treatment	treatment	NOUN
aiua-9638	76	9	is	be	AUX
aiua-9638	76	10	due	due	ADJ
aiua-9638	76	11	to	to	ADP
aiua-9638	76	12	the	the	DET
aiua-9638	76	13	patients	patient	NOUN
aiua-9638	76	14	that	that	PRON
aiua-9638	76	15	have	have	AUX
aiua-9638	76	16	not	not	PART
aiua-9638	76	17	returned	return	VERB
aiua-9638	76	18	because	because	SCONJ
aiua-9638	76	19	of	of	ADP
aiua-9638	76	20	covid-19	covid-19	PROPN
aiua-9638	76	21	pandemic	pandemic	NOUN
aiua-9638	76	22	.	.	PUNCT
aiua-9638	77	1	following	follow	VERB
aiua-9638	77	2	one	one	NUM
aiua-9638	77	3	month	month	NOUN
aiua-9638	77	4	treatment	treatment	NOUN
aiua-9638	77	5	with	with	ADP
aiua-9638	77	6	tadalfil	tadalfil	ADJ
aiua-9638	77	7	plus	plus	CCONJ
aiua-9638	77	8	nutritional	nutritional	ADJ
aiua-9638	77	9	supplement	supplement	NOUN
aiua-9638	77	10	significantly	significantly	ADV
aiua-9638	77	11	(	(	PUNCT
aiua-9638	77	12	panax	panax	PROPN
aiua-9638	77	13	ginseng	ginseng	PROPN
aiua-9638	77	14	,	,	PUNCT
aiua-9638	77	15	moringa	moringa	PROPN
aiua-9638	77	16	223archivio	223archivio	PROPN
aiua-9638	77	17	italiano	italiano	NOUN
aiua-9638	77	18	di	di	NOUN
aiua-9638	77	19	urologia	urologia	PROPN
aiua-9638	77	20	e	e	PROPN
aiua-9638	77	21	andrologia	andrologia	NOUN
aiua-9638	77	22	2021	2021	NUM
aiua-9638	77	23	;	;	PUNCT
aiua-9638	77	24	93	93	NUM
aiua-9638	77	25	,	,	PUNCT
aiua-9638	77	26	2	2	NUM
aiua-9638	77	27	a	a	DET
aiua-9638	77	28	new	new	ADJ
aiua-9638	77	29	original	original	ADJ
aiua-9638	77	30	nutraceutical	nutraceutical	ADJ
aiua-9638	77	31	formulation	formulation	NOUN
aiua-9638	77	32	ameliorates	ameliorate	VERB
aiua-9638	77	33	the	the	DET
aiua-9638	77	34	effect	effect	NOUN
aiua-9638	77	35	of	of	ADP
aiua-9638	77	36	tadalafil	tadalafil	NOUN
aiua-9638	77	37	on	on	ADP
aiua-9638	77	38	clinical	clinical	ADJ
aiua-9638	77	39	score	score	NOUN
aiua-9638	77	40	and	and	CCONJ
aiua-9638	77	41	cgmp	cgmp	ADJ
aiua-9638	77	42	accumulation	accumulation	NOUN
aiua-9638	77	43	table	table	NOUN
aiua-9638	77	44	1	1	NUM
aiua-9638	77	45	.	.	PUNCT
aiua-9638	77	46	baseline	baseline	PROPN
aiua-9638	77	47	characteristics	characteristic	NOUN
aiua-9638	77	48	of	of	ADP
aiua-9638	77	49	patients	patient	NOUN
aiua-9638	77	50	.	.	PUNCT
aiua-9638	78	1	group	group	PROPN
aiua-9638	78	2	a	a	DET
aiua-9638	78	3	group	group	NOUN
aiua-9638	78	4	b	b	PROPN
aiua-9638	78	5	p	p	NOUN
aiua-9638	78	6	value	value	NOUN
aiua-9638	78	7	patients	patient	NOUN
aiua-9638	78	8	.	.	PUNCT
aiua-9638	79	1	n	n	CCONJ
aiua-9638	79	2	45	45	NUM
aiua-9638	79	3	33	33	NUM
aiua-9638	79	4	mean	mean	NOUN
aiua-9638	79	5	age	age	NOUN
aiua-9638	79	6	(	(	PUNCT
aiua-9638	79	7	range	range	NOUN
aiua-9638	79	8	)	)	PUNCT
aiua-9638	79	9	59.93	59.93	NUM
aiua-9638	79	10	±	±	NUM
aiua-9638	79	11	6.75	6.75	NUM
aiua-9638	79	12	(	(	PUNCT
aiua-9638	79	13	38	38	NUM
aiua-9638	79	14	-	-	SYM
aiua-9638	79	15	69	69	NUM
aiua-9638	79	16	)	)	PUNCT
aiua-9638	79	17	60.06	60.06	NUM
aiua-9638	79	18	±	±	NUM
aiua-9638	79	19	7.31	7.31	NUM
aiua-9638	79	20	(	(	PUNCT
aiua-9638	79	21	43	43	NUM
aiua-9638	79	22	-	-	SYM
aiua-9638	79	23	69	69	NUM
aiua-9638	79	24	)	)	PUNCT
aiua-9638	79	25	0.93	0.93	NUM
aiua-9638	79	26	iief-5	iief-5	ADV
aiua-9638	79	27	mean	mean	ADJ
aiua-9638	79	28	(	(	PUNCT
aiua-9638	79	29	range	range	NOUN
aiua-9638	79	30	)	)	PUNCT
aiua-9638	79	31	13.18	13.18	NUM
aiua-9638	79	32	±	±	NUM
aiua-9638	79	33	3.75	3.75	NUM
aiua-9638	79	34	(	(	PUNCT
aiua-9638	79	35	8	8	NUM
aiua-9638	79	36	-	-	SYM
aiua-9638	79	37	20	20	NUM
aiua-9638	79	38	)	)	PUNCT
aiua-9638	79	39	14.15	14.15	NUM
aiua-9638	79	40	±	±	NUM
aiua-9638	79	41	4.09	4.09	NUM
aiua-9638	79	42	(	(	PUNCT
aiua-9638	79	43	8	8	NUM
aiua-9638	79	44	-	-	SYM
aiua-9638	79	45	21	21	NUM
aiua-9638	79	46	)	)	PUNCT
aiua-9638	79	47	0.28	0.28	NUM
aiua-9638	79	48	sep2	sep2	NOUN
aiua-9638	79	49	%	%	NOUN
aiua-9638	79	50	(	(	PUNCT
aiua-9638	79	51	n	n	CCONJ
aiua-9638	79	52	)	)	PUNCT
aiua-9638	79	53	%	%	NOUN
aiua-9638	79	54	(	(	PUNCT
aiua-9638	79	55	n	n	CCONJ
aiua-9638	79	56	)	)	PUNCT
aiua-9638	79	57	0.18	0.18	NUM
aiua-9638	80	1	yes	yes	NUM
aiua-9638	80	2	80	80	NUM
aiua-9638	80	3	%	%	NOUN
aiua-9638	80	4	(	(	PUNCT
aiua-9638	80	5	36	36	NUM
aiua-9638	80	6	)	)	PUNCT
aiua-9638	80	7	66.7	66.7	NUM
aiua-9638	80	8	%	%	NOUN
aiua-9638	80	9	(	(	PUNCT
aiua-9638	80	10	22	22	NUM
aiua-9638	80	11	)	)	PUNCT
aiua-9638	80	12	no	no	DET
aiua-9638	80	13	20	20	NUM
aiua-9638	80	14	%	%	NOUN
aiua-9638	80	15	(	(	PUNCT
aiua-9638	80	16	9	9	NUM
aiua-9638	80	17	)	)	PUNCT
aiua-9638	80	18	33.3	33.3	NUM
aiua-9638	80	19	%	%	NOUN
aiua-9638	80	20	(	(	PUNCT
aiua-9638	80	21	11	11	NUM
aiua-9638	80	22	)	)	PUNCT
aiua-9638	80	23	sep3	sep3	NOUN
aiua-9638	81	1	0.60	0.60	NUM
aiua-9638	81	2	yes	yes	NOUN
aiua-9638	81	3	22.2	22.2	NUM
aiua-9638	81	4	%	%	NOUN
aiua-9638	81	5	(	(	PUNCT
aiua-9638	81	6	10	10	NUM
aiua-9638	81	7	)	)	PUNCT
aiua-9638	81	8	27.3	27.3	NUM
aiua-9638	81	9	%	%	NOUN
aiua-9638	81	10	(	(	PUNCT
aiua-9638	81	11	9	9	NUM
aiua-9638	81	12	)	)	PUNCT
aiua-9638	81	13	no	no	DET
aiua-9638	81	14	77.8	77.8	NUM
aiua-9638	81	15	%	%	NOUN
aiua-9638	81	16	(	(	PUNCT
aiua-9638	81	17	35	35	NUM
aiua-9638	81	18	)	)	PUNCT
aiua-9638	81	19	72.7	72.7	NUM
aiua-9638	81	20	%	%	NOUN
aiua-9638	81	21	(	(	PUNCT
aiua-9638	81	22	24	24	NUM
aiua-9638	81	23	)	)	PUNCT
aiua-9638	81	24	comorbidities	comorbiditie	NOUN
aiua-9638	81	25	%	%	NOUN
aiua-9638	81	26	(	(	PUNCT
aiua-9638	81	27	n	n	CCONJ
aiua-9638	81	28	)	)	PUNCT
aiua-9638	81	29	%	%	NOUN
aiua-9638	81	30	(	(	PUNCT
aiua-9638	81	31	n	n	CCONJ
aiua-9638	81	32	)	)	PUNCT
aiua-9638	81	33	hypertension	hypertension	NOUN
aiua-9638	81	34	0.17	0.17	NUM
aiua-9638	81	35	yes	yes	NOUN
aiua-9638	81	36	97.8	97.8	NUM
aiua-9638	81	37	%	%	NOUN
aiua-9638	81	38	(	(	PUNCT
aiua-9638	81	39	44	44	NUM
aiua-9638	81	40	)	)	PUNCT
aiua-9638	81	41	90.9	90.9	NUM
aiua-9638	81	42	%	%	NOUN
aiua-9638	81	43	(	(	PUNCT
aiua-9638	81	44	30	30	NUM
aiua-9638	81	45	)	)	PUNCT
aiua-9638	81	46	no	no	DET
aiua-9638	81	47	2.2	2.2	NUM
aiua-9638	81	48	%	%	NOUN
aiua-9638	81	49	(	(	PUNCT
aiua-9638	81	50	1	1	NUM
aiua-9638	81	51	)	)	PUNCT
aiua-9638	81	52	9.1	9.1	NUM
aiua-9638	81	53	%	%	NOUN
aiua-9638	81	54	(	(	PUNCT
aiua-9638	81	55	3	3	NUM
aiua-9638	81	56	)	)	PUNCT
aiua-9638	81	57	diabetes	diabetes	NOUN
aiua-9638	81	58	yes	yes	INTJ
aiua-9638	81	59	35.6	35.6	NUM
aiua-9638	81	60	%	%	NOUN
aiua-9638	81	61	(	(	PUNCT
aiua-9638	81	62	16	16	NUM
aiua-9638	81	63	)	)	PUNCT
aiua-9638	81	64	27.3	27.3	NUM
aiua-9638	81	65	%	%	NOUN
aiua-9638	81	66	(	(	PUNCT
aiua-9638	81	67	24	24	NUM
aiua-9638	81	68	)	)	PUNCT
aiua-9638	81	69	no	no	DET
aiua-9638	81	70	64.4	64.4	NUM
aiua-9638	81	71	%	%	NOUN
aiua-9638	81	72	(	(	PUNCT
aiua-9638	81	73	29	29	NUM
aiua-9638	81	74	)	)	PUNCT
aiua-9638	81	75	72.7	72.7	NUM
aiua-9638	81	76	%	%	NOUN
aiua-9638	81	77	(	(	PUNCT
aiua-9638	81	78	9	9	NUM
aiua-9638	81	79	)	)	PUNCT
aiua-9638	81	80	0.44	0.44	NUM
aiua-9638	81	81	lab	lab	NOUN
aiua-9638	81	82	values	value	NOUN
aiua-9638	81	83	total	total	ADJ
aiua-9638	81	84	testosterone	testosterone	NOUN
aiua-9638	81	85	526.04	526.04	NUM
aiua-9638	81	86	±	±	NUM
aiua-9638	81	87	128.49	128.49	NUM
aiua-9638	81	88	481.97	481.97	NUM
aiua-9638	81	89	±	±	NUM
aiua-9638	81	90	139.11	139.11	NUM
aiua-9638	81	91	0.15	0.15	NUM
aiua-9638	81	92	fsh	fsh	NOUN
aiua-9638	81	93	6.48	6.48	NUM
aiua-9638	81	94	±	±	NUM
aiua-9638	81	95	1.96	1.96	NUM
aiua-9638	81	96	6.16	6.16	NUM
aiua-9638	81	97	±	±	NUM
aiua-9638	81	98	2.09	2.09	NUM
aiua-9638	81	99	0.49	0.49	NUM
aiua-9638	81	100	lh	lh	PROPN
aiua-9638	81	101	6.13	6.13	NUM
aiua-9638	81	102	±	±	NUM
aiua-9638	81	103	2.72	2.72	NUM
aiua-9638	81	104	4.93	4.93	NUM
aiua-9638	81	105	±	±	NUM
aiua-9638	81	106	2.72	2.72	NUM
aiua-9638	81	107	0.06	0.06	NUM
aiua-9638	81	108	prl	prl	PROPN
aiua-9638	81	109	11.43	11.43	NUM
aiua-9638	81	110	±	±	NUM
aiua-9638	81	111	8.32	8.32	NUM
aiua-9638	81	112	12.11	12.11	NUM
aiua-9638	81	113	±	±	NUM
aiua-9638	81	114	4.90	4.90	NUM
aiua-9638	81	115	0.67	0.67	NUM
aiua-9638	81	116	fasting	fast	VERB
aiua-9638	81	117	blood	blood	NOUN
aiua-9638	81	118	glucose	glucose	NOUN
aiua-9638	81	119	106.80	106.80	NUM
aiua-9638	81	120	±	±	NUM
aiua-9638	81	121	29.60	29.60	NUM
aiua-9638	81	122	104.72	104.72	NUM
aiua-9638	81	123	±	±	NUM
aiua-9638	81	124	27.00	27.00	NUM
aiua-9638	81	125	0.75	0.75	NUM
aiua-9638	81	126	total	total	ADJ
aiua-9638	81	127	cholesterol	cholesterol	NOUN
aiua-9638	81	128	186.26	186.26	NUM
aiua-9638	81	129	±	±	NUM
aiua-9638	81	130	28.61	28.61	NUM
aiua-9638	81	131	201.60	201.60	NUM
aiua-9638	81	132	±	±	NUM
aiua-9638	81	133	30.67	30.67	NUM
aiua-9638	81	134	0.02	0.02	NUM
aiua-9638	81	135	ldl	ldl	NOUN
aiua-9638	81	136	142.68	142.68	NUM
aiua-9638	81	137	±	±	NUM
aiua-9638	81	138	29.69	29.69	NUM
aiua-9638	81	139	140.51	140.51	NUM
aiua-9638	81	140	±	±	NUM
aiua-9638	81	141	25.76	25.76	NUM
aiua-9638	81	142	0.17	0.17	NUM
aiua-9638	81	143	ast	ast	PROPN
aiua-9638	81	144	33.35	33.35	NUM
aiua-9638	81	145	±	±	NUM
aiua-9638	81	146	8.28	8.28	NUM
aiua-9638	81	147	27.06	27.06	NUM
aiua-9638	81	148	±	±	NUM
aiua-9638	81	149	8.78	8.78	NUM
aiua-9638	81	150	0.002	0.002	NUM
aiua-9638	81	151	alt	alt	VERB
aiua-9638	81	152	36.82	36.82	NUM
aiua-9638	81	153	±	±	NUM
aiua-9638	81	154	9.17	9.17	NUM
aiua-9638	81	155	30.81	30.81	NUM
aiua-9638	81	156	±	±	NUM
aiua-9638	81	157	9.22	9.22	NUM
aiua-9638	81	158	0.006	0.006	NUM
aiua-9638	81	159	ggt	ggt	NOUN
aiua-9638	81	160	47.31	47.31	NUM
aiua-9638	81	161	±	±	NUM
aiua-9638	81	162	7.55	7.55	NUM
aiua-9638	81	163	38.03	38.03	NUM
aiua-9638	81	164	±	±	NUM
aiua-9638	81	165	10.94	10.94	NUM
aiua-9638	81	166	0.0001	0.0001	NUM
aiua-9638	81	167	figure	figure	NOUN
aiua-9638	81	168	1	1	NUM
aiua-9638	81	169	.	.	PUNCT
aiua-9638	82	1	iief-5	iief-5	NOUN
aiua-9638	82	2	score	score	VERB
aiua-9638	82	3	before	before	ADV
aiua-9638	82	4	and	and	CCONJ
aiua-9638	82	5	after	after	ADP
aiua-9638	82	6	three	three	NUM
aiua-9638	82	7	months	month	NOUN
aiua-9638	82	8	of	of	ADP
aiua-9638	82	9	treatment	treatment	NOUN
aiua-9638	82	10	with	with	ADP
aiua-9638	82	11	tadalafil	tadalafil	PROPN
aiua-9638	82	12	(	(	PUNCT
aiua-9638	82	13	5	5	NUM
aiua-9638	82	14	mg	mg	PROPN
aiua-9638	82	15	/	/	SYM
aiua-9638	82	16	daily	daily	NOUN
aiua-9638	82	17	)	)	PUNCT
aiua-9638	82	18	plus	plus	CCONJ
aiua-9638	82	19	nutritional	nutritional	ADJ
aiua-9638	82	20	supplement	supplement	NOUN
aiua-9638	82	21	(	(	PUNCT
aiua-9638	82	22	1	1	NUM
aiua-9638	82	23	cpr	cpr	PROPN
aiua-9638	82	24	/	/	SYM
aiua-9638	82	25	daily	daily	ADJ
aiua-9638	82	26	)	)	PUNCT
aiua-9638	82	27	,	,	PUNCT
aiua-9638	82	28	group	group	NOUN
aiua-9638	82	29	a	a	NOUN
aiua-9638	82	30	,	,	PUNCT
aiua-9638	82	31	or	or	CCONJ
aiua-9638	82	32	tadalafil	tadalafil	PROPN
aiua-9638	82	33	(	(	PUNCT
aiua-9638	82	34	5	5	NUM
aiua-9638	82	35	mg	mg	PROPN
aiua-9638	82	36	/	/	SYM
aiua-9638	82	37	daily	daily	ADJ
aiua-9638	82	38	)	)	PUNCT
aiua-9638	82	39	plus	plus	CCONJ
aiua-9638	82	40	placebo	placebo	NOUN
aiua-9638	82	41	,	,	PUNCT
aiua-9638	82	42	group	group	NOUN
aiua-9638	82	43	b.	b.	PROPN
aiua-9638	83	1	both	both	DET
aiua-9638	83	2	treatments	treatment	NOUN
aiua-9638	83	3	significantly	significantly	ADV
aiua-9638	83	4	increased	increase	VERB
aiua-9638	83	5	iief-5	iief-5	NUM
aiua-9638	83	6	score	score	NOUN
aiua-9638	83	7	in	in	ADP
aiua-9638	83	8	each	each	DET
aiua-9638	83	9	group	group	NOUN
aiua-9638	83	10	compared	compare	VERB
aiua-9638	83	11	to	to	AUX
aiua-9638	83	12	baseline	baseline	VERB
aiua-9638	83	13	(	(	PUNCT
aiua-9638	83	14	group	group	NOUN
aiua-9638	83	15	a	a	X
aiua-9638	83	16	:	:	PUNCT
aiua-9638	83	17	13.18	13.18	NUM
aiua-9638	83	18	±	±	NUM
aiua-9638	83	19	3.75	3.75	NUM
aiua-9638	83	20	vs	vs	ADP
aiua-9638	83	21	20.48	20.48	NUM
aiua-9638	83	22	±	±	NUM
aiua-9638	83	23	2.24	2.24	NUM
aiua-9638	83	24	,	,	PUNCT
aiua-9638	83	25	p	p	X
aiua-9638	83	26	<	<	X
aiua-9638	83	27	0.0001	0.0001	NUM
aiua-9638	83	28	;	;	PUNCT
aiua-9638	83	29	group	group	NOUN
aiua-9638	83	30	b	b	NOUN
aiua-9638	83	31	:	:	PUNCT
aiua-9638	83	32	14.15	14.15	NUM
aiua-9638	83	33	±	±	NUM
aiua-9638	83	34	4.09	4.09	NUM
aiua-9638	83	35	vs	vs	ADP
aiua-9638	83	36	19.06	19.06	NUM
aiua-9638	83	37	±	±	NUM
aiua-9638	83	38	4.36	4.36	NUM
aiua-9638	83	39	,	,	PUNCT
aiua-9638	83	40	p	p	X
aiua-9638	83	41	<	<	X
aiua-9638	83	42	0.0001	0.0001	NUM
aiua-9638	83	43	)	)	PUNCT
aiua-9638	83	44	.	.	PUNCT
aiua-9638	84	1	the	the	DET
aiua-9638	84	2	treatment	treatment	NOUN
aiua-9638	84	3	with	with	ADP
aiua-9638	84	4	tadalafil	tadalafil	PROPN
aiua-9638	84	5	plus	plus	CCONJ
aiua-9638	84	6	nutritional	nutritional	ADJ
aiua-9638	84	7	supplement	supplement	NOUN
aiua-9638	84	8	(	(	PUNCT
aiua-9638	84	9	group	group	NOUN
aiua-9638	84	10	a	a	NOUN
aiua-9638	84	11	)	)	PUNCT
aiua-9638	84	12	significantly	significantly	ADV
aiua-9638	84	13	increased	increase	VERB
aiua-9638	84	14	ieef-5	ieef-5	NUM
aiua-9638	84	15	score	score	NOUN
aiua-9638	84	16	compared	compare	VERB
aiua-9638	84	17	to	to	ADP
aiua-9638	84	18	tadalafil	tadalafil	PROPN
aiua-9638	84	19	plus	plus	CCONJ
aiua-9638	84	20	placebo	placebo	NOUN
aiua-9638	84	21	(	(	PUNCT
aiua-9638	84	22	group	group	NOUN
aiua-9638	84	23	b	b	PROPN
aiua-9638	84	24	)	)	PUNCT
aiua-9638	84	25	(	(	PUNCT
aiua-9638	84	26	p	p	X
aiua-9638	84	27	<	<	X
aiua-9638	84	28	0.0001	0.0001	NUM
aiua-9638	84	29	;	;	PUNCT
aiua-9638	84	30	+7.27	+7.27	PROPN
aiua-9638	84	31	±	±	NOUN
aiua-9638	84	32	2.2	2.2	NUM
aiua-9638	84	33	and	and	CCONJ
aiua-9638	84	34	4.9	4.9	NUM
aiua-9638	84	35	±	±	NUM
aiua-9638	84	36	2.79	2.79	NUM
aiua-9638	84	37	,	,	PUNCT
aiua-9638	84	38	respectively	respectively	ADV
aiua-9638	84	39	)	)	PUNCT
aiua-9638	84	40	.	.	PUNCT
aiua-9638	85	1	data	datum	NOUN
aiua-9638	85	2	expressed	express	VERB
aiua-9638	85	3	as	as	ADP
aiua-9638	85	4	mean	mean	PROPN
aiua-9638	85	5	±	±	NUM
aiua-9638	85	6	s.d	s.d	PROPN
aiua-9638	85	7	.	.	PROPN
aiua-9638	85	8	were	be	AUX
aiua-9638	85	9	analyzed	analyze	VERB
aiua-9638	85	10	by	by	ADP
aiua-9638	85	11	one	one	NUM
aiua-9638	85	12	-	-	PUNCT
aiua-9638	85	13	way	way	NOUN
aiua-9638	85	14	anova	anova	PROPN
aiua-9638	85	15	followed	follow	VERB
aiua-9638	85	16	by	by	ADP
aiua-9638	85	17	bonferroni	bonferroni	NOUN
aiua-9638	85	18	post	post	NOUN
aiua-9638	85	19	-	-	NOUN
aiua-9638	85	20	test	test	NOUN
aiua-9638	85	21	.	.	PUNCT
aiua-9638	86	1	figure	figure	NOUN
aiua-9638	86	2	2	2	NUM
aiua-9638	86	3	.	.	PUNCT
aiua-9638	86	4	sep-2	sep-2	X
aiua-9638	86	5	and	and	CCONJ
aiua-9638	86	6	sep-3	sep-3	NUM
aiua-9638	86	7	answers	answer	NOUN
aiua-9638	86	8	before	before	ADV
aiua-9638	86	9	and	and	CCONJ
aiua-9638	86	10	after	after	ADP
aiua-9638	86	11	three	three	NUM
aiua-9638	86	12	months	month	NOUN
aiua-9638	86	13	of	of	ADP
aiua-9638	86	14	treatment	treatment	NOUN
aiua-9638	86	15	with	with	ADP
aiua-9638	86	16	tadalafil	tadalafil	PROPN
aiua-9638	86	17	(	(	PUNCT
aiua-9638	86	18	5	5	NUM
aiua-9638	86	19	mg	mg	PROPN
aiua-9638	86	20	/	/	SYM
aiua-9638	86	21	daily	daily	NOUN
aiua-9638	86	22	)	)	PUNCT
aiua-9638	86	23	plus	plus	CCONJ
aiua-9638	86	24	nutritional	nutritional	ADJ
aiua-9638	86	25	supplement	supplement	NOUN
aiua-9638	86	26	(	(	PUNCT
aiua-9638	86	27	1	1	NUM
aiua-9638	86	28	cpr	cpr	PROPN
aiua-9638	86	29	/	/	SYM
aiua-9638	86	30	daily	daily	ADJ
aiua-9638	86	31	)	)	PUNCT
aiua-9638	86	32	,	,	PUNCT
aiua-9638	86	33	group	group	NOUN
aiua-9638	86	34	a	a	NOUN
aiua-9638	86	35	,	,	PUNCT
aiua-9638	86	36	or	or	CCONJ
aiua-9638	86	37	tadalafil	tadalafil	PROPN
aiua-9638	86	38	(	(	PUNCT
aiua-9638	86	39	5	5	NUM
aiua-9638	86	40	mg	mg	PROPN
aiua-9638	86	41	/	/	SYM
aiua-9638	86	42	daily	daily	ADJ
aiua-9638	86	43	)	)	PUNCT
aiua-9638	86	44	plus	plus	CCONJ
aiua-9638	86	45	placebo	placebo	NOUN
aiua-9638	86	46	,	,	PUNCT
aiua-9638	86	47	group	group	NOUN
aiua-9638	86	48	b.	b.	PROPN
aiua-9638	87	1	both	both	DET
aiua-9638	87	2	treatments	treatment	NOUN
aiua-9638	87	3	significantly	significantly	ADV
aiua-9638	87	4	increased	increase	VERB
aiua-9638	87	5	sep-2	sep-2	PUNCT
aiua-9638	87	6	and	and	CCONJ
aiua-9638	87	7	sep-3	sep-3	PUNCT
aiua-9638	87	8	in	in	ADP
aiua-9638	87	9	each	each	DET
aiua-9638	87	10	group	group	NOUN
aiua-9638	87	11	compared	compare	VERB
aiua-9638	87	12	to	to	PART
aiua-9638	87	13	baseline	baseline	VERB
aiua-9638	87	14	.	.	PUNCT
aiua-9638	88	1	data	datum	NOUN
aiua-9638	88	2	were	be	AUX
aiua-9638	88	3	analyzed	analyze	VERB
aiua-9638	88	4	by	by	ADP
aiua-9638	88	5	one	one	NUM
aiua-9638	88	6	-	-	PUNCT
aiua-9638	88	7	way	way	NOUN
aiua-9638	88	8	anova	anova	PROPN
aiua-9638	88	9	followed	follow	VERB
aiua-9638	88	10	by	by	ADP
aiua-9638	88	11	bonferroni	bonferroni	NOUN
aiua-9638	88	12	post	post	NOUN
aiua-9638	88	13	-	-	NOUN
aiua-9638	88	14	test	test	NOUN
aiua-9638	88	15	.	.	PUNCT
aiua-9638	89	1	there	there	PRON
aiua-9638	89	2	was	be	VERB
aiua-9638	89	3	no	no	DET
aiua-9638	89	4	significant	significant	ADJ
aiua-9638	89	5	difference	difference	NOUN
aiua-9638	89	6	between	between	ADP
aiua-9638	89	7	group	group	NOUN
aiua-9638	89	8	a	a	PROPN
aiua-9638	89	9	and	and	CCONJ
aiua-9638	89	10	group	group	PROPN
aiua-9638	89	11	b.	b.	PROPN
aiua-9638	89	12	table	table	PROPN
aiua-9638	89	13	2	2	NUM
aiua-9638	89	14	.	.	PUNCT
aiua-9638	89	15	hormonal	hormonal	ADJ
aiua-9638	89	16	levels	level	NOUN
aiua-9638	89	17	before	before	ADP
aiua-9638	89	18	and	and	CCONJ
aiua-9638	89	19	after	after	ADP
aiua-9638	89	20	treatment	treatment	NOUN
aiua-9638	89	21	.	.	PUNCT
aiua-9638	90	1	group	group	PROPN
aiua-9638	90	2	a	a	DET
aiua-9638	90	3	(	(	PUNCT
aiua-9638	90	4	before	before	ADP
aiua-9638	90	5	)	)	PUNCT
aiua-9638	90	6	group	group	NOUN
aiua-9638	90	7	a	a	X
aiua-9638	90	8	(	(	PUNCT
aiua-9638	90	9	after	after	ADP
aiua-9638	90	10	)	)	PUNCT
aiua-9638	90	11	p	p	NOUN
aiua-9638	90	12	value	value	NOUN
aiua-9638	90	13	group	group	NOUN
aiua-9638	90	14	b	b	PROPN
aiua-9638	90	15	(	(	PUNCT
aiua-9638	90	16	before	before	ADP
aiua-9638	90	17	)	)	PUNCT
aiua-9638	90	18	group	group	NOUN
aiua-9638	90	19	b	b	PROPN
aiua-9638	90	20	(	(	PUNCT
aiua-9638	90	21	after	after	ADP
aiua-9638	90	22	)	)	PUNCT
aiua-9638	90	23	p	p	NOUN
aiua-9638	90	24	value	value	NOUN
aiua-9638	90	25	total	total	NOUN
aiua-9638	90	26	testosterone	testosterone	NOUN
aiua-9638	90	27	526.04	526.04	NUM
aiua-9638	90	28	±	±	NUM
aiua-9638	90	29	128.49	128.49	NUM
aiua-9638	90	30	532.34	532.34	NUM
aiua-9638	90	31	±	±	NUM
aiua-9638	90	32	115.73	115.73	NUM
aiua-9638	90	33	0.82	0.82	NUM
aiua-9638	90	34	481.97	481.97	NUM
aiua-9638	90	35	±	±	NUM
aiua-9638	90	36	139.11	139.11	NUM
aiua-9638	90	37	485.57	485.57	NUM
aiua-9638	90	38	±	±	NOUN
aiua-9638	90	39	122.48	122.48	NUM
aiua-9638	90	40	0.89	0.89	NUM
aiua-9638	90	41	fsh	fsh	NOUN
aiua-9638	90	42	6.48	6.48	NUM
aiua-9638	90	43	±	±	NUM
aiua-9638	90	44	1.96	1.96	NUM
aiua-9638	90	45	6.50	6.50	NUM
aiua-9638	90	46	±	±	NUM
aiua-9638	90	47	1.77	1.77	NUM
aiua-9638	90	48	0.96	0.96	NUM
aiua-9638	90	49	6.16	6.16	NUM
aiua-9638	90	50	±	±	NUM
aiua-9638	90	51	2.09	2.09	NUM
aiua-9638	90	52	6.19	6.19	NUM
aiua-9638	90	53	±	±	NUM
aiua-9638	90	54	2.15	2.15	NUM
aiua-9638	90	55	0.95	0.95	NUM
aiua-9638	90	56	lh	lh	PROPN
aiua-9638	90	57	6.13	6.13	NUM
aiua-9638	90	58	±	±	NUM
aiua-9638	90	59	2.72	2.72	NUM
aiua-9638	90	60	6.38	6.38	NUM
aiua-9638	90	61	±	±	NUM
aiua-9638	90	62	2.62	2.62	NUM
aiua-9638	90	63	0.68	0.68	NUM
aiua-9638	90	64	4.93	4.93	NUM
aiua-9638	90	65	±	±	NUM
aiua-9638	90	66	2.72	2.72	NUM
aiua-9638	90	67	5.01	5.01	NUM
aiua-9638	90	68	±	±	NUM
aiua-9638	90	69	2.62	2.62	NUM
aiua-9638	90	70	0.89	0.89	NUM
aiua-9638	90	71	prl	prl	PROPN
aiua-9638	90	72	11.43	11.43	NUM
aiua-9638	90	73	±	±	NUM
aiua-9638	90	74	8.32	8.32	NUM
aiua-9638	90	75	12.61	12.61	NUM
aiua-9638	90	76	±	±	NUM
aiua-9638	90	77	4.71	4.71	NUM
aiua-9638	90	78	0.46	0.46	NUM
aiua-9638	90	79	12.11	12.11	NUM
aiua-9638	90	80	±	±	NUM
aiua-9638	90	81	4.90	4.90	NUM
aiua-9638	90	82	12.39	12.39	NUM
aiua-9638	90	83	±	±	NUM
aiua-9638	90	84	4.71	4.71	NUM
aiua-9638	90	85	0.80	0.80	NUM
aiua-9638	90	86	archivio	archivio	NOUN
aiua-9638	90	87	italiano	italiano	NOUN
aiua-9638	90	88	di	di	X
aiua-9638	90	89	urologia	urologia	PROPN
aiua-9638	90	90	e	e	PROPN
aiua-9638	90	91	andrologia	andrologia	NOUN
aiua-9638	90	92	2021	2021	NUM
aiua-9638	90	93	;	;	PUNCT
aiua-9638	90	94	93	93	NUM
aiua-9638	90	95	,	,	PUNCT
aiua-9638	90	96	2	2	NUM
aiua-9638	90	97	v.	v.	ADP
aiua-9638	90	98	mirone	mirone	PROPN
aiua-9638	90	99	,	,	PUNCT
aiua-9638	90	100	l.	l.	PROPN
aiua-9638	90	101	napolitano	napolitano	PROPN
aiua-9638	90	102	,	,	PUNCT
aiua-9638	90	103	r.	r.	PROPN
aiua-9638	90	104	d’emmanuele	d’emmanuele	PROPN
aiua-9638	90	105	di	di	PROPN
aiua-9638	90	106	villa	villa	PROPN
aiua-9638	90	107	bianca	bianca	PROPN
aiua-9638	90	108	,	,	PUNCT
aiua-9638	90	109	et	et	PROPN
aiua-9638	90	110	al	al	PROPN
aiua-9638	90	111	.	.	PROPN
aiua-9638	91	1	224	224	NUM
aiua-9638	91	2	oleifera	oleifera	NOUN
aiua-9638	91	3	and	and	CCONJ
aiua-9638	91	4	rutin	rutin	NOUN
aiua-9638	91	5	)	)	PUNCT
aiua-9638	91	6	(	(	PUNCT
aiua-9638	91	7	p	p	X
aiua-9638	91	8	<	<	X
aiua-9638	91	9	0.05	0.05	NUM
aiua-9638	91	10	)	)	PUNCT
aiua-9638	91	11	increased	increase	VERB
aiua-9638	91	12	the	the	DET
aiua-9638	91	13	cgmp	cgmp	PROPN
aiua-9638	91	14	content	content	NOUN
aiua-9638	91	15	in	in	ADP
aiua-9638	91	16	platelets	platelet	NOUN
aiua-9638	91	17	stimulated	stimulate	VERB
aiua-9638	91	18	with	with	ADP
aiua-9638	91	19	dea	dea	NOUN
aiua-9638	91	20	-	-	PUNCT
aiua-9638	91	21	nonoate	nonoate	NOUN
aiua-9638	91	22	100	100	NUM
aiua-9638	91	23	µm	µm	NOUN
aiua-9638	91	24	compared	compare	VERB
aiua-9638	91	25	with	with	ADP
aiua-9638	91	26	the	the	DET
aiua-9638	91	27	same	same	ADJ
aiua-9638	91	28	concentration	concentration	NOUN
aiua-9638	91	29	of	of	ADP
aiua-9638	91	30	deanonoate	deanonoate	NOUN
aiua-9638	91	31	before	before	ADP
aiua-9638	91	32	the	the	DET
aiua-9638	91	33	treatment	treatment	NOUN
aiua-9638	91	34	i.e.	i.e.	X
aiua-9638	91	35	at	at	ADP
aiua-9638	91	36	baseline	baseline	NOUN
aiua-9638	91	37	(	(	PUNCT
aiua-9638	91	38	figure	figure	NOUN
aiua-9638	91	39	3	3	NUM
aiua-9638	91	40	)	)	PUNCT
aiua-9638	91	41	.	.	PUNCT
aiua-9638	92	1	discussion	discussion	NOUN
aiua-9638	92	2	a	a	DET
aiua-9638	92	3	variety	variety	NOUN
aiua-9638	92	4	of	of	ADP
aiua-9638	92	5	natural	natural	ADJ
aiua-9638	92	6	products	product	NOUN
aiua-9638	92	7	,	,	PUNCT
aiua-9638	92	8	including	include	VERB
aiua-9638	92	9	isolated	isolate	VERB
aiua-9638	92	10	compounds	compound	NOUN
aiua-9638	92	11	from	from	ADP
aiua-9638	92	12	plants	plant	NOUN
aiua-9638	92	13	,	,	PUNCT
aiua-9638	92	14	have	have	AUX
aiua-9638	92	15	been	be	AUX
aiua-9638	92	16	tested	test	VERB
aiua-9638	92	17	for	for	ADP
aiua-9638	92	18	treatment	treatment	NOUN
aiua-9638	92	19	of	of	ADP
aiua-9638	92	20	male	male	ADJ
aiua-9638	92	21	sexual	sexual	ADJ
aiua-9638	92	22	dysfunction	dysfunction	NOUN
aiua-9638	92	23	(	(	PUNCT
aiua-9638	92	24	21	21	NUM
aiua-9638	92	25	)	)	PUNCT
aiua-9638	92	26	.	.	PUNCT
aiua-9638	93	1	although	although	SCONJ
aiua-9638	93	2	guidelines	guideline	NOUN
aiua-9638	93	3	do	do	AUX
aiua-9638	93	4	not	not	PART
aiua-9638	93	5	give	give	VERB
aiua-9638	93	6	any	any	DET
aiua-9638	93	7	specific	specific	ADJ
aiua-9638	93	8	recommendation	recommendation	NOUN
aiua-9638	93	9	for	for	ADP
aiua-9638	93	10	their	their	PRON
aiua-9638	93	11	use	use	NOUN
aiua-9638	93	12	,	,	PUNCT
aiua-9638	93	13	natural	natural	ADJ
aiua-9638	93	14	extracts	extract	NOUN
aiua-9638	93	15	are	be	AUX
aiua-9638	93	16	potentially	potentially	ADV
aiua-9638	93	17	useful	useful	ADJ
aiua-9638	93	18	in	in	ADP
aiua-9638	93	19	the	the	DET
aiua-9638	93	20	management	management	NOUN
aiua-9638	93	21	and	and	CCONJ
aiua-9638	93	22	treatment	treatment	NOUN
aiua-9638	93	23	of	of	ADP
aiua-9638	93	24	male	male	ADJ
aiua-9638	93	25	sexual	sexual	ADJ
aiua-9638	93	26	dysfunction	dysfunction	NOUN
aiua-9638	93	27	(	(	PUNCT
aiua-9638	93	28	16	16	NUM
aiua-9638	93	29	)	)	PUNCT
aiua-9638	93	30	.	.	PUNCT
aiua-9638	94	1	ginseng	ginseng	NOUN
aiua-9638	94	2	has	have	AUX
aiua-9638	94	3	been	be	AUX
aiua-9638	94	4	tested	test	VERB
aiua-9638	94	5	for	for	ADP
aiua-9638	94	6	its	its	PRON
aiua-9638	94	7	therapeutic	therapeutic	ADJ
aiua-9638	94	8	properties	property	NOUN
aiua-9638	94	9	,	,	PUNCT
aiua-9638	94	10	which	which	PRON
aiua-9638	94	11	include	include	VERB
aiua-9638	94	12	improving	improve	VERB
aiua-9638	94	13	sexual	sexual	ADJ
aiua-9638	94	14	function	function	NOUN
aiua-9638	94	15	(	(	PUNCT
aiua-9638	94	16	22	22	NUM
aiua-9638	94	17	)	)	PUNCT
aiua-9638	94	18	,	,	PUNCT
aiua-9638	94	19	physical	physical	ADJ
aiua-9638	94	20	performance	performance	NOUN
aiua-9638	94	21	(	(	PUNCT
aiua-9638	94	22	23	23	NUM
aiua-9638	94	23	)	)	PUNCT
aiua-9638	94	24	,	,	PUNCT
aiua-9638	94	25	treating	treat	VERB
aiua-9638	94	26	cancer	cancer	NOUN
aiua-9638	94	27	(	(	PUNCT
aiua-9638	94	28	24	24	NUM
aiua-9638	94	29	)	)	PUNCT
aiua-9638	94	30	,	,	PUNCT
aiua-9638	94	31	diabetes	diabetes	NOUN
aiua-9638	94	32	(	(	PUNCT
aiua-9638	94	33	25	25	NUM
aiua-9638	94	34	)	)	PUNCT
aiua-9638	94	35	and	and	CCONJ
aiua-9638	94	36	hypertension	hypertension	NOUN
aiua-9638	94	37	(	(	PUNCT
aiua-9638	94	38	26	26	NUM
aiua-9638	94	39	)	)	PUNCT
aiua-9638	94	40	.	.	PUNCT
aiua-9638	95	1	data	datum	NOUN
aiua-9638	95	2	available	available	ADJ
aiua-9638	95	3	suggest	suggest	VERB
aiua-9638	95	4	that	that	SCONJ
aiua-9638	95	5	ginseng	ginseng	NOUN
aiua-9638	95	6	has	have	VERB
aiua-9638	95	7	some	some	DET
aiua-9638	95	8	testosterone	testosterone	NOUN
aiua-9638	95	9	-	-	PUNCT
aiua-9638	95	10	like	like	ADJ
aiua-9638	95	11	effects	effect	NOUN
aiua-9638	95	12	and	and	CCONJ
aiua-9638	95	13	it	it	PRON
aiua-9638	95	14	could	could	AUX
aiua-9638	95	15	contribute	contribute	VERB
aiua-9638	95	16	to	to	ADP
aiua-9638	95	17	smooth	smooth	ADJ
aiua-9638	95	18	muscle	muscle	NOUN
aiua-9638	95	19	relaxation	relaxation	NOUN
aiua-9638	95	20	of	of	ADP
aiua-9638	95	21	the	the	DET
aiua-9638	95	22	corpus	corpus	NOUN
aiua-9638	95	23	cavernosum	cavernosum	NOUN
aiua-9638	95	24	via	via	ADP
aiua-9638	95	25	no	no	DET
aiua-9638	95	26	pathway	pathway	NOUN
aiua-9638	95	27	(	(	PUNCT
aiua-9638	95	28	27	27	NUM
aiua-9638	95	29	)	)	PUNCT
aiua-9638	95	30	.	.	PUNCT
aiua-9638	96	1	moringa	moringa	PROPN
aiua-9638	96	2	oleifera	oleifera	NOUN
aiua-9638	96	3	has	have	AUX
aiua-9638	96	4	been	be	AUX
aiua-9638	96	5	long	long	ADV
aiua-9638	96	6	used	use	VERB
aiua-9638	96	7	in	in	ADP
aiua-9638	96	8	traditional	traditional	ADJ
aiua-9638	96	9	medicine	medicine	NOUN
aiua-9638	96	10	.	.	PUNCT
aiua-9638	97	1	many	many	ADJ
aiua-9638	97	2	studies	study	NOUN
aiua-9638	97	3	have	have	AUX
aiua-9638	97	4	reported	report	VERB
aiua-9638	97	5	its	its	PRON
aiua-9638	97	6	antioxidant	antioxidant	ADJ
aiua-9638	97	7	,	,	PUNCT
aiua-9638	97	8	hypoglycaemic	hypoglycaemic	ADJ
aiua-9638	97	9	,	,	PUNCT
aiua-9638	97	10	anti	anti	ADJ
aiua-9638	97	11	-	-	ADJ
aiua-9638	97	12	dyslipidaemia	dyslipidaemia	ADJ
aiua-9638	97	13	activities	activity	NOUN
aiua-9638	97	14	,	,	PUNCT
aiua-9638	97	15	tissue	tissue	NOUN
aiua-9638	97	16	-	-	PUNCT
aiua-9638	97	17	protective	protective	ADJ
aiua-9638	97	18	(	(	PUNCT
aiua-9638	97	19	liver	liver	NOUN
aiua-9638	97	20	,	,	PUNCT
aiua-9638	97	21	kidneys	kidney	NOUN
aiua-9638	97	22	,	,	PUNCT
aiua-9638	97	23	heart	heart	NOUN
aiua-9638	97	24	,	,	PUNCT
aiua-9638	97	25	testes	testis	NOUN
aiua-9638	97	26	,	,	PUNCT
aiua-9638	97	27	and	and	CCONJ
aiua-9638	97	28	lungs	lung	NOUN
aiua-9638	97	29	)	)	PUNCT
aiua-9638	97	30	,	,	PUNCT
aiua-9638	97	31	analgesic	analgesic	ADJ
aiua-9638	97	32	,	,	PUNCT
aiua-9638	97	33	antihypertensive	antihypertensive	ADJ
aiua-9638	97	34	and	and	CCONJ
aiua-9638	97	35	immunomodulatory	immunomodulatory	ADJ
aiua-9638	97	36	actions	action	NOUN
aiua-9638	97	37	(	(	PUNCT
aiua-9638	97	38	28	28	NUM
aiua-9638	97	39	-	-	SYM
aiua-9638	97	40	30	30	NUM
aiua-9638	97	41	)	)	PUNCT
aiua-9638	97	42	.	.	PUNCT
aiua-9638	98	1	rutin	rutin	NOUN
aiua-9638	98	2	is	be	AUX
aiua-9638	98	3	a	a	DET
aiua-9638	98	4	flavonoid	flavonoid	NOUN
aiua-9638	98	5	glycoside	glycoside	NOUN
aiua-9638	98	6	characterized	characterize	VERB
aiua-9638	98	7	by	by	ADP
aiua-9638	98	8	antioxidant	antioxidant	ADJ
aiua-9638	98	9	,	,	PUNCT
aiua-9638	98	10	antidiabetic	antidiabetic	ADJ
aiua-9638	98	11	,	,	PUNCT
aiua-9638	98	12	anti	anti	ADJ
aiua-9638	98	13	-	-	ADJ
aiua-9638	98	14	lipid	lipid	ADJ
aiua-9638	98	15	peroxidation	peroxidation	NOUN
aiua-9638	98	16	actions	action	NOUN
aiua-9638	98	17	.	.	PUNCT
aiua-9638	99	1	in	in	ADP
aiua-9638	99	2	particular	particular	ADJ
aiua-9638	99	3	,	,	PUNCT
aiua-9638	99	4	data	datum	NOUN
aiua-9638	99	5	suggest	suggest	VERB
aiua-9638	99	6	that	that	SCONJ
aiua-9638	99	7	rutin	rutin	NOUN
aiua-9638	99	8	has	have	VERB
aiua-9638	99	9	antioxidant	antioxidant	ADJ
aiua-9638	99	10	activity	activity	NOUN
aiua-9638	99	11	and	and	CCONJ
aiua-9638	99	12	increases	increase	VERB
aiua-9638	99	13	testosterone	testosterone	NOUN
aiua-9638	99	14	levels	level	NOUN
aiua-9638	99	15	in	in	ADP
aiua-9638	99	16	diabetic	diabetic	ADJ
aiua-9638	99	17	condition	condition	NOUN
aiua-9638	99	18	in	in	ADP
aiua-9638	99	19	preclinical	preclinical	ADJ
aiua-9638	99	20	studies	study	NOUN
aiua-9638	99	21	.	.	PUNCT
aiua-9638	100	1	furthermore	furthermore	ADV
aiua-9638	100	2	,	,	PUNCT
aiua-9638	100	3	it	it	PRON
aiua-9638	100	4	has	have	AUX
aiua-9638	100	5	been	be	AUX
aiua-9638	100	6	shown	show	VERB
aiua-9638	100	7	that	that	SCONJ
aiua-9638	100	8	in	in	ADP
aiua-9638	100	9	vitro	vitro	X
aiua-9638	100	10	rutin	rutin	NOUN
aiua-9638	100	11	can	can	AUX
aiua-9638	100	12	inhibit	inhibit	VERB
aiua-9638	100	13	pde5	pde5	NOUN
aiua-9638	100	14	and	and	CCONJ
aiua-9638	100	15	arginase	arginase	NOUN
aiua-9638	100	16	increasing	increase	VERB
aiua-9638	100	17	the	the	DET
aiua-9638	100	18	availability	availability	NOUN
aiua-9638	100	19	of	of	ADP
aiua-9638	100	20	no	no	PRON
aiua-9638	100	21	and	and	CCONJ
aiua-9638	100	22	cgmp	cgmp	PROPN
aiua-9638	100	23	(	(	PUNCT
aiua-9638	100	24	31	31	NUM
aiua-9638	100	25	-	-	SYM
aiua-9638	100	26	33	33	NUM
aiua-9638	100	27	)	)	PUNCT
aiua-9638	100	28	.	.	PUNCT
aiua-9638	101	1	this	this	DET
aiua-9638	101	2	nutritional	nutritional	ADJ
aiua-9638	101	3	supplement	supplement	NOUN
aiua-9638	101	4	formulation	formulation	NOUN
aiua-9638	101	5	,	,	PUNCT
aiua-9638	101	6	containing	contain	VERB
aiua-9638	101	7	a	a	DET
aiua-9638	101	8	balanced	balanced	ADJ
aiua-9638	101	9	content	content	NOUN
aiua-9638	101	10	of	of	ADP
aiua-9638	101	11	moringa	moringa	PROPN
aiua-9638	101	12	oleifera	oleifera	ADV
aiua-9638	101	13	,	,	PUNCT
aiua-9638	101	14	rutin	rutin	NOUN
aiua-9638	101	15	and	and	CCONJ
aiua-9638	101	16	ginseng	ginseng	NOUN
aiua-9638	101	17	,	,	PUNCT
aiua-9638	101	18	has	have	AUX
aiua-9638	101	19	designed	design	VERB
aiua-9638	101	20	to	to	PART
aiua-9638	101	21	act	act	VERB
aiua-9638	101	22	as	as	ADP
aiua-9638	101	23	an	an	DET
aiua-9638	101	24	endothelial	endothelial	ADJ
aiua-9638	101	25	protector	protector	NOUN
aiua-9638	101	26	to	to	PART
aiua-9638	101	27	be	be	AUX
aiua-9638	101	28	used	use	VERB
aiua-9638	101	29	as	as	ADP
aiua-9638	101	30	an	an	DET
aiua-9638	101	31	adjuvant	adjuvant	NOUN
aiua-9638	101	32	in	in	ADP
aiua-9638	101	33	the	the	DET
aiua-9638	101	34	treatment	treatment	NOUN
aiua-9638	101	35	of	of	ADP
aiua-9638	101	36	ed	ed	NOUN
aiua-9638	101	37	.	.	PUNCT
aiua-9638	102	1	the	the	DET
aiua-9638	102	2	efficacy	efficacy	NOUN
aiua-9638	102	3	of	of	ADP
aiua-9638	102	4	the	the	DET
aiua-9638	102	5	nutritional	nutritional	ADJ
aiua-9638	102	6	supplement	supplement	NOUN
aiua-9638	102	7	has	have	AUX
aiua-9638	102	8	been	be	AUX
aiua-9638	102	9	tested	test	VERB
aiua-9638	102	10	in	in	ADP
aiua-9638	102	11	a	a	DET
aiua-9638	102	12	clinical	clinical	ADJ
aiua-9638	102	13	study	study	NOUN
aiua-9638	102	14	by	by	ADP
aiua-9638	102	15	performing	perform	VERB
aiua-9638	102	16	a	a	DET
aiua-9638	102	17	combination	combination	NOUN
aiua-9638	102	18	therapy	therapy	NOUN
aiua-9638	102	19	with	with	ADP
aiua-9638	102	20	a	a	DET
aiua-9638	102	21	low	low	ADJ
aiua-9638	102	22	dose	dose	NOUN
aiua-9638	102	23	of	of	ADP
aiua-9638	102	24	chronic	chronic	ADJ
aiua-9638	102	25	tadalafil	tadalafil	NOUN
aiua-9638	102	26	regimen	regiman	NOUN
aiua-9638	102	27	that	that	PRON
aiua-9638	102	28	has	have	AUX
aiua-9638	102	29	shown	show	VERB
aiua-9638	102	30	to	to	PART
aiua-9638	102	31	improve	improve	VERB
aiua-9638	102	32	the	the	DET
aiua-9638	102	33	erectile	erectile	ADJ
aiua-9638	102	34	function	function	NOUN
aiua-9638	102	35	in	in	ADP
aiua-9638	102	36	vasculogenic	vasculogenic	ADJ
aiua-9638	102	37	patients	patient	NOUN
aiua-9638	102	38	.	.	PUNCT
aiua-9638	103	1	there	there	PRON
aiua-9638	103	2	were	be	VERB
aiua-9638	103	3	no	no	DET
aiua-9638	103	4	significant	significant	ADJ
aiua-9638	103	5	differences	difference	NOUN
aiua-9638	103	6	between	between	ADP
aiua-9638	103	7	the	the	DET
aiua-9638	103	8	groups	group	NOUN
aiua-9638	103	9	in	in	ADP
aiua-9638	103	10	terms	term	NOUN
aiua-9638	103	11	of	of	ADP
aiua-9638	103	12	baseline	baseline	ADJ
aiua-9638	103	13	erectile	erectile	NOUN
aiua-9638	103	14	function	function	NOUN
aiua-9638	103	15	and	and	CCONJ
aiua-9638	103	16	presence	presence	NOUN
aiua-9638	103	17	of	of	ADP
aiua-9638	103	18	comorbidities	comorbiditie	NOUN
aiua-9638	103	19	.	.	PUNCT
aiua-9638	104	1	the	the	DET
aiua-9638	104	2	addition	addition	NOUN
aiua-9638	104	3	of	of	ADP
aiua-9638	104	4	a	a	DET
aiua-9638	104	5	daily	daily	ADJ
aiua-9638	104	6	capsule	capsule	NOUN
aiua-9638	104	7	of	of	ADP
aiua-9638	104	8	the	the	DET
aiua-9638	104	9	nutritional	nutritional	ADJ
aiua-9638	104	10	supplement	supplement	NOUN
aiua-9638	104	11	to	to	ADP
aiua-9638	104	12	tadalafil	tadalafil	PROPN
aiua-9638	104	13	5	5	NUM
aiua-9638	104	14	mg	mg	NOUN
aiua-9638	104	15	daily	daily	ADV
aiua-9638	104	16	did	do	AUX
aiua-9638	104	17	not	not	PART
aiua-9638	104	18	affect	affect	VERB
aiua-9638	104	19	total	total	ADJ
aiua-9638	104	20	testosterone	testosterone	NOUN
aiua-9638	104	21	,	,	PUNCT
aiua-9638	104	22	fsh	fsh	NOUN
aiua-9638	104	23	,	,	PUNCT
aiua-9638	104	24	lh	lh	PROPN
aiua-9638	104	25	and	and	CCONJ
aiua-9638	104	26	prl	prl	PROPN
aiua-9638	104	27	values	value	NOUN
aiua-9638	104	28	.	.	PUNCT
aiua-9638	105	1	although	although	SCONJ
aiua-9638	105	2	several	several	ADJ
aiua-9638	105	3	animal	animal	NOUN
aiua-9638	105	4	and	and	CCONJ
aiua-9638	105	5	human	human	ADJ
aiua-9638	105	6	studies	study	NOUN
aiua-9638	105	7	suggested	suggest	VERB
aiua-9638	105	8	metabolic	metabolic	NOUN
aiua-9638	105	9	effects	effect	NOUN
aiua-9638	105	10	of	of	ADP
aiua-9638	105	11	moringa	moringa	NOUN
aiua-9638	105	12	oleifera	oleifera	NOUN
aiua-9638	105	13	and	and	CCONJ
aiua-9638	105	14	rutin	rutin	NOUN
aiua-9638	105	15	,	,	PUNCT
aiua-9638	105	16	in	in	ADP
aiua-9638	105	17	our	our	PRON
aiua-9638	105	18	study	study	NOUN
aiua-9638	105	19	,	,	PUNCT
aiua-9638	105	20	we	we	PRON
aiua-9638	105	21	did	do	AUX
aiua-9638	105	22	not	not	PART
aiua-9638	105	23	found	find	VERB
aiua-9638	105	24	anti	anti	ADJ
aiua-9638	105	25	-	-	ADJ
aiua-9638	105	26	dyslipidemic	dyslipidemic	ADJ
aiua-9638	105	27	and	and	CCONJ
aiua-9638	105	28	hypoglycemic	hypoglycemic	ADJ
aiua-9638	105	29	activity	activity	NOUN
aiua-9638	105	30	,	,	PUNCT
aiua-9638	105	31	probably	probably	ADV
aiua-9638	105	32	because	because	SCONJ
aiua-9638	105	33	this	this	PRON
aiua-9638	105	34	was	be	AUX
aiua-9638	105	35	a	a	DET
aiua-9638	105	36	chronic	chronic	ADJ
aiua-9638	105	37	effects	effect	NOUN
aiua-9638	105	38	and	and	CCONJ
aiua-9638	105	39	3	3	NUM
aiua-9638	105	40	months	month	NOUN
aiua-9638	105	41	could	could	AUX
aiua-9638	105	42	be	be	AUX
aiua-9638	105	43	a	a	DET
aiua-9638	105	44	limited	limited	ADJ
aiua-9638	105	45	time	time	NOUN
aiua-9638	105	46	to	to	PART
aiua-9638	105	47	observe	observe	VERB
aiua-9638	105	48	the	the	DET
aiua-9638	105	49	effect	effect	NOUN
aiua-9638	105	50	.	.	PUNCT
aiua-9638	106	1	in	in	ADP
aiua-9638	106	2	addition	addition	NOUN
aiua-9638	106	3	,	,	PUNCT
aiua-9638	106	4	human	human	ADJ
aiua-9638	106	5	studies	study	NOUN
aiua-9638	106	6	showed	show	VERB
aiua-9638	106	7	that	that	SCONJ
aiua-9638	106	8	moringa	moringa	NOUN
aiua-9638	106	9	oleifera	oleifera	ADV
aiua-9638	106	10	mainly	mainly	ADV
aiua-9638	106	11	determines	determine	VERB
aiua-9638	106	12	a	a	DET
aiua-9638	106	13	reduced	reduced	ADJ
aiua-9638	106	14	post	post	ADJ
aiua-9638	106	15	-	-	ADJ
aiua-9638	106	16	prandial	prandial	ADJ
aiua-9638	106	17	blood	blood	NOUN
aiua-9638	106	18	glucose	glucose	NOUN
aiua-9638	106	19	levels	level	NOUN
aiua-9638	106	20	and	and	CCONJ
aiua-9638	106	21	a	a	DET
aiua-9638	106	22	long	long	ADJ
aiua-9638	106	23	term	term	NOUN
aiua-9638	106	24	reduction	reduction	NOUN
aiua-9638	106	25	of	of	ADP
aiua-9638	106	26	hba1c	hba1c	PROPN
aiua-9638	106	27	,	,	PUNCT
aiua-9638	106	28	rather	rather	ADV
aiua-9638	106	29	than	than	ADP
aiua-9638	106	30	fasting	fast	VERB
aiua-9638	106	31	blood	blood	NOUN
aiua-9638	106	32	glucose	glucose	NOUN
aiua-9638	106	33	and	and	CCONJ
aiua-9638	106	34	we	we	PRON
aiua-9638	106	35	did	do	AUX
aiua-9638	106	36	not	not	PART
aiua-9638	106	37	assess	assess	VERB
aiua-9638	106	38	these	these	DET
aiua-9638	106	39	parameters	parameter	NOUN
aiua-9638	106	40	as	as	SCONJ
aiua-9638	106	41	it	it	PRON
aiua-9638	106	42	was	be	AUX
aiua-9638	106	43	not	not	PART
aiua-9638	106	44	the	the	DET
aiua-9638	106	45	purpose	purpose	NOUN
aiua-9638	106	46	of	of	ADP
aiua-9638	106	47	our	our	PRON
aiua-9638	106	48	study	study	NOUN
aiua-9638	106	49	(	(	PUNCT
aiua-9638	106	50	34	34	NUM
aiua-9638	106	51	)	)	PUNCT
aiua-9638	106	52	.	.	PUNCT
aiua-9638	107	1	the	the	DET
aiua-9638	107	2	clinic	clinic	PROPN
aiua-9638	107	3	al	al	PROPN
aiua-9638	107	4	evaluation	evaluation	NOUN
aiua-9638	107	5	indicates	indicate	VERB
aiua-9638	107	6	a	a	DET
aiua-9638	107	7	statistically	statistically	ADV
aiua-9638	107	8	significant	significant	ADJ
aiua-9638	107	9	effect	effect	NOUN
aiua-9638	107	10	on	on	ADP
aiua-9638	107	11	sexual	sexual	ADJ
aiua-9638	107	12	function	function	NOUN
aiua-9638	107	13	.	.	PUNCT
aiua-9638	108	1	the	the	DET
aiua-9638	108	2	iief-5	iief-5	NUM
aiua-9638	108	3	score	score	NOUN
aiua-9638	108	4	increased	increase	VERB
aiua-9638	108	5	in	in	ADP
aiua-9638	108	6	group	group	NOUN
aiua-9638	108	7	a	a	PRON
aiua-9638	108	8	of	of	ADP
aiua-9638	108	9	7.27	7.27	NUM
aiua-9638	108	10	points	point	NOUN
aiua-9638	108	11	vs	vs	ADP
aiua-9638	108	12	4.90	4.90	NUM
aiua-9638	108	13	in	in	ADP
aiua-9638	108	14	group	group	PROPN
aiua-9638	108	15	b	b	PROPN
aiua-9638	108	16	with	with	ADP
aiua-9638	108	17	a	a	DET
aiua-9638	108	18	significant	significant	ADJ
aiua-9638	108	19	difference	difference	NOUN
aiua-9638	108	20	of	of	ADP
aiua-9638	108	21	2.37	2.37	NUM
aiua-9638	108	22	points	point	NOUN
aiua-9638	108	23	that	that	PRON
aiua-9638	108	24	represents	represent	VERB
aiua-9638	108	25	a	a	DET
aiua-9638	108	26	20	20	NUM
aiua-9638	108	27	%	%	NOUN
aiua-9638	108	28	increase	increase	NOUN
aiua-9638	108	29	over	over	ADP
aiua-9638	108	30	the	the	DET
aiua-9638	108	31	placebo	placebo	NOUN
aiua-9638	108	32	treatment	treatment	NOUN
aiua-9638	108	33	.	.	PUNCT
aiua-9638	109	1	there	there	PRON
aiua-9638	109	2	was	be	VERB
aiua-9638	109	3	no	no	DET
aiua-9638	109	4	significant	significant	ADJ
aiua-9638	109	5	difference	difference	NOUN
aiua-9638	109	6	in	in	ADP
aiua-9638	109	7	sep2	sep2	PROPN
aiua-9638	109	8	and	and	CCONJ
aiua-9638	109	9	sep3	sep3	PROPN
aiua-9638	109	10	values	value	NOUN
aiua-9638	109	11	between	between	ADP
aiua-9638	109	12	tadalafil	tadalafil	PROPN
aiua-9638	109	13	plus	plus	CCONJ
aiua-9638	109	14	nutritional	nutritional	ADJ
aiua-9638	109	15	supplement	supplement	NOUN
aiua-9638	109	16	and	and	CCONJ
aiua-9638	109	17	tadalafil	tadalafil	ADJ
aiua-9638	109	18	plus	plus	CCONJ
aiua-9638	109	19	placebo	placebo	NOUN
aiua-9638	109	20	.	.	PUNCT
aiua-9638	110	1	thus	thus	ADV
aiua-9638	110	2	,	,	PUNCT
aiua-9638	110	3	the	the	DET
aiua-9638	110	4	treatment	treatment	NOUN
aiua-9638	110	5	with	with	ADP
aiua-9638	110	6	the	the	DET
aiua-9638	110	7	formulation	formulation	NOUN
aiua-9638	110	8	(	(	PUNCT
aiua-9638	110	9	panax	panax	PROPN
aiua-9638	110	10	ginseng	ginseng	PROPN
aiua-9638	110	11	,	,	PUNCT
aiua-9638	110	12	moringa	moringa	NOUN
aiua-9638	110	13	oleifera	oleifera	NOUN
aiua-9638	110	14	and	and	CCONJ
aiua-9638	110	15	rutin	rutin	NOUN
aiua-9638	110	16	)	)	PUNCT
aiua-9638	110	17	improves	improve	VERB
aiua-9638	110	18	the	the	DET
aiua-9638	110	19	ieef-5	ieef-5	NUM
aiua-9638	110	20	score	score	NOUN
aiua-9638	110	21	.	.	PUNCT
aiua-9638	111	1	the	the	DET
aiua-9638	111	2	second	second	ADJ
aiua-9638	111	3	part	part	NOUN
aiua-9638	111	4	of	of	ADP
aiua-9638	111	5	the	the	DET
aiua-9638	111	6	study	study	NOUN
aiua-9638	111	7	was	be	AUX
aiua-9638	111	8	performed	perform	VERB
aiua-9638	111	9	to	to	PART
aiua-9638	111	10	validate	validate	VERB
aiua-9638	111	11	the	the	DET
aiua-9638	111	12	data	datum	NOUN
aiua-9638	111	13	obtained	obtain	VERB
aiua-9638	111	14	by	by	ADP
aiua-9638	111	15	using	use	VERB
aiua-9638	111	16	the	the	DET
aiua-9638	111	17	questionnaires	questionnaire	NOUN
aiua-9638	111	18	.	.	PUNCT
aiua-9638	112	1	indeed	indeed	ADV
aiua-9638	112	2	,	,	PUNCT
aiua-9638	112	3	as	as	ADP
aiua-9638	112	4	in	in	ADP
aiua-9638	112	5	this	this	DET
aiua-9638	112	6	case	case	NOUN
aiua-9638	112	7	,	,	PUNCT
aiua-9638	112	8	questionnaires	questionnaire	NOUN
aiua-9638	112	9	are	be	AUX
aiua-9638	112	10	strongly	strongly	ADV
aiua-9638	112	11	biased	bias	VERB
aiua-9638	112	12	by	by	ADP
aiua-9638	112	13	the	the	DET
aiua-9638	112	14	placebo	placebo	NOUN
aiua-9638	112	15	treatment	treatment	NOUN
aiua-9638	112	16	.	.	PUNCT
aiua-9638	113	1	we	we	PRON
aiua-9638	113	2	have	have	AUX
aiua-9638	113	3	previously	previously	ADV
aiua-9638	113	4	shown	show	VERB
aiua-9638	113	5	that	that	SCONJ
aiua-9638	113	6	platelet	platelet	NOUN
aiua-9638	113	7	cgmp	cgmp	NOUN
aiua-9638	113	8	represents	represent	VERB
aiua-9638	113	9	a	a	DET
aiua-9638	113	10	suitable	suitable	ADJ
aiua-9638	113	11	and	and	CCONJ
aiua-9638	113	12	objective	objective	ADJ
aiua-9638	113	13	biomarker	biomarker	NOUN
aiua-9638	113	14	of	of	ADP
aiua-9638	113	15	pde5	pde5	NOUN
aiua-9638	113	16	-	-	PUNCT
aiua-9638	113	17	inhibitors	inhibitor	NOUN
aiua-9638	113	18	efficacy	efficacy	NOUN
aiua-9638	113	19	in	in	ADP
aiua-9638	113	20	ed	ed	PROPN
aiua-9638	113	21	clinical	clinical	ADJ
aiua-9638	113	22	studies	study	NOUN
aiua-9638	113	23	.	.	PUNCT
aiua-9638	114	1	this	this	DET
aiua-9638	114	2	evidence	evidence	NOUN
aiua-9638	114	3	relies	rely	VERB
aiua-9638	114	4	on	on	ADP
aiua-9638	114	5	the	the	DET
aiua-9638	114	6	fact	fact	NOUN
aiua-9638	114	7	that	that	SCONJ
aiua-9638	114	8	i	i	PRON
aiua-9638	114	9	)	)	PUNCT
aiua-9638	114	10	pde5	pde5	NOUN
aiua-9638	114	11	-	-	PUNCT
aiua-9638	114	12	inhibitors	inhibitor	NOUN
aiua-9638	114	13	act	act	VERB
aiua-9638	114	14	by	by	ADP
aiua-9638	114	15	enhancing	enhance	VERB
aiua-9638	114	16	the	the	DET
aiua-9638	114	17	no	no	NOUN
aiua-9638	114	18	/	/	SYM
aiua-9638	114	19	cgmp	cgmp	PROPN
aiua-9638	114	20	signaling	signaling	PROPN
aiua-9638	114	21	ii	ii	PROPN
aiua-9638	114	22	)	)	PUNCT
aiua-9638	114	23	pde5	pde5	PROPN
aiua-9638	114	24	is	be	AUX
aiua-9638	114	25	present	present	ADJ
aiua-9638	114	26	in	in	ADP
aiua-9638	114	27	human	human	ADJ
aiua-9638	114	28	platelets	platelet	NOUN
aiua-9638	114	29	(	(	PUNCT
aiua-9638	114	30	35	35	NUM
aiua-9638	114	31	,	,	PUNCT
aiua-9638	114	32	36	36	NUM
aiua-9638	114	33	)	)	PUNCT
aiua-9638	114	34	iii	iii	NOUN
aiua-9638	114	35	)	)	PUNCT
aiua-9638	114	36	treatment	treatment	NOUN
aiua-9638	114	37	with	with	ADP
aiua-9638	114	38	pde5inhibitors	pde5inhibitor	NOUN
aiua-9638	114	39	increases	increase	NOUN
aiua-9638	114	40	platelet	platelet	NOUN
aiua-9638	114	41	cgmp	cgmp	PROPN
aiua-9638	114	42	levels	level	NOUN
aiua-9638	114	43	(	(	PUNCT
aiua-9638	114	44	18	18	NUM
aiua-9638	114	45	,	,	PUNCT
aiua-9638	114	46	37	37	NUM
aiua-9638	114	47	)	)	PUNCT
aiua-9638	114	48	.	.	PUNCT
aiua-9638	115	1	in	in	ADP
aiua-9638	115	2	particular	particular	ADJ
aiua-9638	115	3	,	,	PUNCT
aiua-9638	115	4	we	we	PRON
aiua-9638	115	5	have	have	AUX
aiua-9638	115	6	demonstrated	demonstrate	VERB
aiua-9638	115	7	that	that	SCONJ
aiua-9638	115	8	,	,	PUNCT
aiua-9638	115	9	following	follow	VERB
aiua-9638	115	10	chronic	chronic	ADJ
aiua-9638	115	11	treatment	treatment	NOUN
aiua-9638	115	12	with	with	ADP
aiua-9638	115	13	vardenafil	vardenafil	NOUN
aiua-9638	115	14	5	5	NUM
aiua-9638	115	15	mg	mg	PROPN
aiua-9638	115	16	/	/	SYM
aiua-9638	115	17	daily	daily	NOUN
aiua-9638	115	18	of	of	ADP
aiua-9638	115	19	ed	ed	PROPN
aiua-9638	115	20	patients	patient	NOUN
aiua-9638	115	21	,	,	PUNCT
aiua-9638	115	22	the	the	DET
aiua-9638	115	23	platelet	platelet	NOUN
aiua-9638	115	24	cgmp	cgmp	PROPN
aiua-9638	115	25	levels	level	NOUN
aiua-9638	115	26	were	be	AUX
aiua-9638	115	27	significantly	significantly	ADV
aiua-9638	115	28	increased	increase	VERB
aiua-9638	115	29	and	and	CCONJ
aiua-9638	115	30	well	well	ADV
aiua-9638	115	31	correlated	correlate	VERB
aiua-9638	115	32	(	(	PUNCT
aiua-9638	115	33	significantly	significantly	ADV
aiua-9638	115	34	)	)	PUNCT
aiua-9638	115	35	with	with	ADP
aiua-9638	115	36	the	the	DET
aiua-9638	115	37	vss	vss	NOUN
aiua-9638	115	38	-	-	PUNCT
aiua-9638	115	39	rigiscan	rigiscan	NOUN
aiua-9638	115	40	measuretable	measuretable	NOUN
aiua-9638	115	41	3	3	NUM
aiua-9638	115	42	.	.	PUNCT
aiua-9638	115	43	adverse	adverse	ADJ
aiua-9638	115	44	events	event	NOUN
aiua-9638	115	45	.	.	PUNCT
aiua-9638	116	1	adverse	adverse	ADJ
aiua-9638	116	2	event	event	NOUN
aiua-9638	116	3	group	group	NOUN
aiua-9638	116	4	a	a	DET
aiua-9638	116	5	group	group	NOUN
aiua-9638	116	6	b	b	PROPN
aiua-9638	116	7	p	p	NOUN
aiua-9638	116	8	value	value	NOUN
aiua-9638	116	9	headache	headache	NOUN
aiua-9638	116	10	6	6	NUM
aiua-9638	116	11	4	4	NUM
aiua-9638	116	12	nasal	nasal	NOUN
aiua-9638	116	13	congestion	congestion	NOUN
aiua-9638	116	14	1	1	NUM
aiua-9638	116	15	3	3	NUM
aiua-9638	116	16	back	back	NOUN
aiua-9638	116	17	pain	pain	NOUN
aiua-9638	116	18	3	3	NUM
aiua-9638	116	19	1	1	NUM
aiua-9638	116	20	dyspepsia	dyspepsia	NOUN
aiua-9638	116	21	0	0	NUM
aiua-9638	116	22	1	1	NUM
aiua-9638	116	23	myalgia	myalgia	NOUN
aiua-9638	116	24	1	1	NUM
aiua-9638	116	25	1	1	NUM
aiua-9638	116	26	cough	cough	NOUN
aiua-9638	116	27	0	0	NUM
aiua-9638	116	28	1	1	NUM
aiua-9638	116	29	insomnia	insomnia	NOUN
aiua-9638	116	30	1	1	NUM
aiua-9638	116	31	0	0	NUM
aiua-9638	116	32	flushing	flush	VERB
aiua-9638	116	33	6	6	NUM
aiua-9638	116	34	5	5	NUM
aiua-9638	116	35	dizziness	dizziness	NOUN
aiua-9638	116	36	2	2	NUM
aiua-9638	116	37	2	2	NUM
aiua-9638	116	38	total	total	NOUN
aiua-9638	116	39	of	of	ADP
aiua-9638	116	40	adverse	adverse	ADJ
aiua-9638	116	41	events	event	NOUN
aiua-9638	116	42	reported	report	VERB
aiua-9638	116	43	20	20	NUM
aiua-9638	116	44	18	18	NUM
aiua-9638	116	45	0.38	0.38	NUM
aiua-9638	116	46	figure	figure	NOUN
aiua-9638	116	47	3	3	NUM
aiua-9638	116	48	.	.	PUNCT
aiua-9638	116	49	effect	effect	NOUN
aiua-9638	116	50	of	of	ADP
aiua-9638	116	51	tadalafil	tadalafil	PROPN
aiua-9638	116	52	(	(	PUNCT
aiua-9638	116	53	5	5	NUM
aiua-9638	116	54	mg	mg	PROPN
aiua-9638	116	55	/	/	SYM
aiua-9638	116	56	daily	daily	NOUN
aiua-9638	116	57	)	)	PUNCT
aiua-9638	116	58	plus	plus	CCONJ
aiua-9638	116	59	nutritional	nutritional	ADJ
aiua-9638	116	60	supplement	supplement	NOUN
aiua-9638	116	61	(	(	PUNCT
aiua-9638	116	62	1	1	NUM
aiua-9638	116	63	cpr	cpr	PROPN
aiua-9638	116	64	/	/	SYM
aiua-9638	116	65	daily	daily	ADV
aiua-9638	116	66	)	)	PUNCT
aiua-9638	116	67	on	on	ADP
aiua-9638	116	68	platelet	platelet	NOUN
aiua-9638	116	69	cgmp	cgmp	NOUN
aiua-9638	116	70	of	of	ADP
aiua-9638	116	71	ed	ed	NOUN
aiua-9638	116	72	patients	patient	NOUN
aiua-9638	116	73	.	.	PUNCT
aiua-9638	117	1	the	the	DET
aiua-9638	117	2	levels	level	NOUN
aiua-9638	117	3	of	of	ADP
aiua-9638	117	4	cgmp	cgmp	PROPN
aiua-9638	117	5	,	,	PUNCT
aiua-9638	117	6	expressed	express	VERB
aiua-9638	117	7	as	as	ADP
aiua-9638	117	8	pmoles	pmole	NOUN
aiua-9638	117	9	/	/	SYM
aiua-9638	117	10	ml	ml	NOUN
aiua-9638	117	11	,	,	PUNCT
aiua-9638	117	12	were	be	AUX
aiua-9638	117	13	measured	measure	VERB
aiua-9638	117	14	in	in	ADP
aiua-9638	117	15	5×105	5×105	PROPN
aiua-9638	117	16	/	/	SYM
aiua-9638	117	17	μl	μl	NUM
aiua-9638	117	18	platelet	platelet	NOUN
aiua-9638	117	19	following	follow	VERB
aiua-9638	117	20	stimulation	stimulation	NOUN
aiua-9638	117	21	with	with	ADP
aiua-9638	117	22	vehicle	vehicle	NOUN
aiua-9638	117	23	(	(	PUNCT
aiua-9638	117	24	v	v	NOUN
aiua-9638	117	25	)	)	PUNCT
aiua-9638	117	26	or	or	CCONJ
aiua-9638	117	27	diethylamine	diethylamine	NOUN
aiua-9638	117	28	(	(	PUNCT
aiua-9638	117	29	dea)-nonoate	dea)-nonoate	NOUN
aiua-9638	117	30	(	(	PUNCT
aiua-9638	117	31	10	10	NUM
aiua-9638	117	32	,	,	PUNCT
aiua-9638	117	33	and	and	CCONJ
aiua-9638	117	34	100	100	NUM
aiua-9638	117	35	μm	μm	NUM
aiua-9638	117	36	)	)	PUNCT
aiua-9638	117	37	.	.	PUNCT
aiua-9638	118	1	the	the	DET
aiua-9638	118	2	cgmp	cgmp	PROPN
aiua-9638	118	3	content	content	PROPN
aiua-9638	118	4	was	be	AUX
aiua-9638	118	5	evaluated	evaluate	VERB
aiua-9638	118	6	before	before	ADP
aiua-9638	118	7	(	(	PUNCT
aiua-9638	118	8	•	•	NOUN
aiua-9638	118	9	)	)	PUNCT
aiua-9638	118	10	or	or	CCONJ
aiua-9638	118	11	after	after	ADP
aiua-9638	118	12	one	one	NUM
aiua-9638	118	13	month	month	NOUN
aiua-9638	118	14	of	of	ADP
aiua-9638	118	15	treatment	treatment	NOUN
aiua-9638	118	16	(	(	PUNCT
aiua-9638	118	17	o	o	NOUN
aiua-9638	118	18	)	)	PUNCT
aiua-9638	118	19	.	.	PUNCT
aiua-9638	119	1	cgmp	cgmp	PROPN
aiua-9638	119	2	accumulation	accumulation	PROPN
aiua-9638	119	3	after	after	SCONJ
aiua-9638	119	4	treatment	treatment	NOUN
aiua-9638	119	5	was	be	AUX
aiua-9638	119	6	significantly	significantly	ADV
aiua-9638	119	7	higher	high	ADJ
aiua-9638	119	8	in	in	ADP
aiua-9638	119	9	platelets	platelet	NOUN
aiua-9638	119	10	stimulated	stimulate	VERB
aiua-9638	119	11	with	with	ADP
aiua-9638	119	12	deanonoate	deanonoate	NOUN
aiua-9638	119	13	100	100	NUM
aiua-9638	119	14	µm	µm	NOUN
aiua-9638	119	15	compared	compare	VERB
aiua-9638	119	16	to	to	ADP
aiua-9638	119	17	the	the	DET
aiua-9638	119	18	same	same	ADJ
aiua-9638	119	19	concentration	concentration	NOUN
aiua-9638	119	20	of	of	ADP
aiua-9638	119	21	dea	dea	NOUN
aiua-9638	119	22	-	-	NOUN
aiua-9638	119	23	nonoate	nonoate	NOUN
aiua-9638	119	24	before	before	ADP
aiua-9638	119	25	the	the	DET
aiua-9638	119	26	treatment	treatment	NOUN
aiua-9638	119	27	(	(	PUNCT
aiua-9638	119	28	*	*	PUNCT
aiua-9638	119	29	p	p	X
aiua-9638	119	30	<	<	X
aiua-9638	119	31	0.05	0.05	NUM
aiua-9638	119	32	)	)	PUNCT
aiua-9638	119	33	.	.	PUNCT
aiua-9638	120	1	data	datum	NOUN
aiua-9638	120	2	expressed	express	VERB
aiua-9638	120	3	as	as	ADP
aiua-9638	120	4	mean	mean	NOUN
aiua-9638	120	5	±	±	NUM
aiua-9638	120	6	s.e.m	s.e.m	NOUN
aiua-9638	120	7	.	.	PROPN
aiua-9638	120	8	were	be	AUX
aiua-9638	120	9	analyzed	analyze	VERB
aiua-9638	120	10	by	by	ADP
aiua-9638	120	11	one	one	NUM
aiua-9638	120	12	-	-	PUNCT
aiua-9638	120	13	way	way	NOUN
aiua-9638	120	14	anova	anova	PROPN
aiua-9638	120	15	followed	follow	VERB
aiua-9638	120	16	by	by	ADP
aiua-9638	120	17	bonferroni	bonferroni	NOUN
aiua-9638	120	18	post	post	NOUN
aiua-9638	120	19	-	-	NOUN
aiua-9638	120	20	test	test	NOUN
aiua-9638	120	21	.	.	PUNCT
aiua-9638	121	1	225archivio	225archivio	NOUN
aiua-9638	121	2	italiano	italiano	NOUN
aiua-9638	121	3	di	di	X
aiua-9638	121	4	urologia	urologia	PROPN
aiua-9638	121	5	e	e	PROPN
aiua-9638	121	6	andrologia	andrologia	NOUN
aiua-9638	121	7	2021	2021	NUM
aiua-9638	121	8	;	;	PUNCT
aiua-9638	121	9	93	93	NUM
aiua-9638	121	10	,	,	PUNCT
aiua-9638	121	11	2	2	NUM
aiua-9638	121	12	a	a	DET
aiua-9638	121	13	new	new	ADJ
aiua-9638	121	14	original	original	ADJ
aiua-9638	121	15	nutraceutical	nutraceutical	ADJ
aiua-9638	121	16	formulation	formulation	NOUN
aiua-9638	121	17	ameliorates	ameliorate	VERB
aiua-9638	121	18	the	the	DET
aiua-9638	121	19	effect	effect	NOUN
aiua-9638	121	20	of	of	ADP
aiua-9638	121	21	tadalafil	tadalafil	NOUN
aiua-9638	121	22	on	on	ADP
aiua-9638	121	23	clinical	clinical	ADJ
aiua-9638	121	24	score	score	NOUN
aiua-9638	121	25	and	and	CCONJ
aiua-9638	121	26	cgmp	cgmp	PROPN
aiua-9638	121	27	accumulation	accumulation	NOUN
aiua-9638	121	28	ment	ment	NOUN
aiua-9638	121	29	(	(	PUNCT
aiua-9638	121	30	18	18	NUM
aiua-9638	121	31	)	)	PUNCT
aiua-9638	121	32	.	.	PUNCT
aiua-9638	122	1	thus	thus	ADV
aiua-9638	122	2	,	,	PUNCT
aiua-9638	122	3	the	the	DET
aiua-9638	122	4	measurement	measurement	NOUN
aiua-9638	122	5	of	of	ADP
aiua-9638	122	6	platelet	platelet	NOUN
aiua-9638	122	7	cgmp	cgmp	ADV
aiua-9638	122	8	from	from	ADP
aiua-9638	122	9	blood	blood	NOUN
aiua-9638	122	10	samples	sample	NOUN
aiua-9638	122	11	of	of	ADP
aiua-9638	122	12	patients	patient	NOUN
aiua-9638	122	13	represents	represent	VERB
aiua-9638	122	14	an	an	DET
aiua-9638	122	15	unbiased	unbiased	ADJ
aiua-9638	122	16	marker	marker	NOUN
aiua-9638	122	17	of	of	ADP
aiua-9638	122	18	activity	activity	NOUN
aiua-9638	122	19	.	.	PUNCT
aiua-9638	123	1	the	the	DET
aiua-9638	123	2	analysis	analysis	NOUN
aiua-9638	123	3	of	of	ADP
aiua-9638	123	4	platelets	platelet	NOUN
aiua-9638	123	5	harvested	harvest	VERB
aiua-9638	123	6	from	from	ADP
aiua-9638	123	7	patients	patient	NOUN
aiua-9638	123	8	treated	treat	VERB
aiua-9638	123	9	with	with	ADP
aiua-9638	123	10	the	the	DET
aiua-9638	123	11	nutritional	nutritional	ADJ
aiua-9638	123	12	supplement	supplement	NOUN
aiua-9638	123	13	plus	plus	CCONJ
aiua-9638	123	14	tadalafil	tadalafil	PROPN
aiua-9638	123	15	showed	show	VERB
aiua-9638	123	16	a	a	DET
aiua-9638	123	17	significant	significant	ADJ
aiua-9638	123	18	increase	increase	NOUN
aiua-9638	123	19	in	in	ADP
aiua-9638	123	20	the	the	DET
aiua-9638	123	21	cgmp	cgmp	PROPN
aiua-9638	123	22	levels	level	NOUN
aiua-9638	123	23	when	when	SCONJ
aiua-9638	123	24	stimulated	stimulate	VERB
aiua-9638	123	25	with	with	ADP
aiua-9638	123	26	dea	dea	NOUN
aiua-9638	123	27	-	-	PUNCT
aiua-9638	123	28	nonoate	nonoate	NOUN
aiua-9638	123	29	100	100	NUM
aiua-9638	123	30	µm	µm	NOUN
aiua-9638	123	31	.	.	PUNCT
aiua-9638	124	1	this	this	DET
aiua-9638	124	2	result	result	NOUN
aiua-9638	124	3	suggests	suggest	VERB
aiua-9638	124	4	that	that	SCONJ
aiua-9638	124	5	the	the	DET
aiua-9638	124	6	treatment	treatment	NOUN
aiua-9638	124	7	with	with	ADP
aiua-9638	124	8	the	the	DET
aiua-9638	124	9	nutritional	nutritional	ADJ
aiua-9638	124	10	supplement	supplement	NOUN
aiua-9638	124	11	ameliorates	ameliorate	NOUN
aiua-9638	124	12	and	and	CCONJ
aiua-9638	124	13	extends	extend	VERB
aiua-9638	124	14	the	the	DET
aiua-9638	124	15	activity	activity	NOUN
aiua-9638	124	16	of	of	ADP
aiua-9638	124	17	the	the	DET
aiua-9638	124	18	chronic	chronic	ADJ
aiua-9638	124	19	treatment	treatment	NOUN
aiua-9638	124	20	with	with	ADP
aiua-9638	124	21	tadalafil	tadalafil	NOUN
aiua-9638	124	22	maintaining	maintain	VERB
aiua-9638	124	23	a	a	DET
aiua-9638	124	24	significant	significant	ADJ
aiua-9638	124	25	more	more	ADV
aiua-9638	124	26	elevated	elevated	ADJ
aiua-9638	124	27	levels	level	NOUN
aiua-9638	124	28	of	of	ADP
aiua-9638	124	29	inhibition	inhibition	NOUN
aiua-9638	124	30	of	of	ADP
aiua-9638	124	31	pde5	pde5	NOUN
aiua-9638	124	32	.	.	PUNCT
aiua-9638	125	1	in	in	ADP
aiua-9638	125	2	this	this	DET
aiua-9638	125	3	context	context	NOUN
aiua-9638	125	4	,	,	PUNCT
aiua-9638	125	5	it	it	PRON
aiua-9638	125	6	is	be	AUX
aiua-9638	125	7	important	important	ADJ
aiua-9638	125	8	to	to	PART
aiua-9638	125	9	stress	stress	VERB
aiua-9638	125	10	that	that	SCONJ
aiua-9638	125	11	there	there	PRON
aiua-9638	125	12	are	be	VERB
aiua-9638	125	13	several	several	ADJ
aiua-9638	125	14	clinical	clinical	ADJ
aiua-9638	125	15	pieces	piece	NOUN
aiua-9638	125	16	of	of	ADP
aiua-9638	125	17	evidence	evidence	NOUN
aiua-9638	125	18	that	that	SCONJ
aiua-9638	125	19	pde5	pde5	NOUN
aiua-9638	125	20	-	-	PUNCT
aiua-9638	125	21	inhibitors	inhibitor	NOUN
aiua-9638	125	22	effect	effect	NOUN
aiua-9638	125	23	can	can	AUX
aiua-9638	125	24	go	go	VERB
aiua-9638	125	25	beyond	beyond	ADP
aiua-9638	125	26	their	their	PRON
aiua-9638	125	27	half	half	ADJ
aiua-9638	125	28	-	-	PUNCT
aiua-9638	125	29	life	life	NOUN
aiua-9638	125	30	(	(	PUNCT
aiua-9638	125	31	18	18	NUM
aiua-9638	125	32	,	,	PUNCT
aiua-9638	125	33	38	38	NUM
aiua-9638	125	34	)	)	PUNCT
aiua-9638	125	35	.	.	PUNCT
aiua-9638	126	1	indeed	indeed	ADV
aiua-9638	126	2	,	,	PUNCT
aiua-9638	126	3	clinical	clinical	ADJ
aiua-9638	126	4	data	datum	NOUN
aiua-9638	126	5	reported	report	VERB
aiua-9638	126	6	that	that	SCONJ
aiua-9638	126	7	men	man	NOUN
aiua-9638	126	8	still	still	ADV
aiua-9638	126	9	have	have	AUX
aiua-9638	126	10	facilitated	facilitate	VERB
aiua-9638	126	11	erections	erection	NOUN
aiua-9638	126	12	when	when	SCONJ
aiua-9638	126	13	the	the	DET
aiua-9638	126	14	levels	level	NOUN
aiua-9638	126	15	of	of	ADP
aiua-9638	126	16	pde5	pde5	NOUN
aiua-9638	126	17	-	-	PUNCT
aiua-9638	126	18	inhibitors	inhibitor	NOUN
aiua-9638	126	19	are	be	AUX
aiua-9638	126	20	below	below	ADP
aiua-9638	126	21	of	of	ADP
aiua-9638	126	22	the	the	DET
aiua-9638	126	23	therapeutic	therapeutic	ADJ
aiua-9638	126	24	plasmatic	plasmatic	ADJ
aiua-9638	126	25	concentration	concentration	NOUN
aiua-9638	126	26	(	(	PUNCT
aiua-9638	126	27	39	39	NUM
aiua-9638	126	28	-	-	SYM
aiua-9638	126	29	41	41	NUM
aiua-9638	126	30	)	)	PUNCT
aiua-9638	126	31	.	.	PUNCT
aiua-9638	127	1	conclusions	conclusion	NOUN
aiua-9638	127	2	in	in	ADP
aiua-9638	127	3	conclusion	conclusion	NOUN
aiua-9638	127	4	,	,	PUNCT
aiua-9638	127	5	the	the	DET
aiua-9638	127	6	significant	significant	ADJ
aiua-9638	127	7	increase	increase	NOUN
aiua-9638	127	8	of	of	ADP
aiua-9638	127	9	the	the	DET
aiua-9638	127	10	iief-5	iief-5	NUM
aiua-9638	127	11	can	can	AUX
aiua-9638	127	12	be	be	AUX
aiua-9638	127	13	ascribed	ascribe	VERB
aiua-9638	127	14	to	to	ADP
aiua-9638	127	15	the	the	DET
aiua-9638	127	16	nutritional	nutritional	ADJ
aiua-9638	127	17	supplement	supplement	NOUN
aiua-9638	127	18	properties	property	NOUN
aiua-9638	127	19	.	.	PUNCT
aiua-9638	128	1	indeed	indeed	ADV
aiua-9638	128	2	,	,	PUNCT
aiua-9638	128	3	beyond	beyond	ADP
aiua-9638	128	4	the	the	DET
aiua-9638	128	5	well	well	ADV
aiua-9638	128	6	-	-	PUNCT
aiua-9638	128	7	known	know	VERB
aiua-9638	128	8	antioxidant	antioxidant	NOUN
aiua-9638	128	9	effects	effect	NOUN
aiua-9638	128	10	,	,	PUNCT
aiua-9638	128	11	moringa	moringa	PROPN
aiua-9638	128	12	oleifera	oleifera	NOUN
aiua-9638	128	13	,	,	PUNCT
aiua-9638	128	14	ginseng	ginseng	NOUN
aiua-9638	128	15	and	and	CCONJ
aiua-9638	128	16	rutin	rutin	NOUN
aiua-9638	128	17	,	,	PUNCT
aiua-9638	128	18	it	it	PRON
aiua-9638	128	19	has	have	AUX
aiua-9638	128	20	been	be	AUX
aiua-9638	128	21	reported	report	VERB
aiua-9638	128	22	that	that	PRON
aiua-9638	128	23	can	can	AUX
aiua-9638	128	24	enhance	enhance	VERB
aiua-9638	128	25	the	the	DET
aiua-9638	128	26	endothelial	endothelial	NOUN
aiua-9638	128	27	no	no	PRON
aiua-9638	128	28	and	and	CCONJ
aiua-9638	128	29	cgmp	cgmp	PROPN
aiua-9638	128	30	production	production	NOUN
aiua-9638	128	31	(	(	PUNCT
aiua-9638	128	32	41	41	NUM
aiua-9638	128	33	-	-	SYM
aiua-9638	128	34	43	43	NUM
aiua-9638	128	35	)	)	PUNCT
aiua-9638	128	36	.	.	PUNCT
aiua-9638	129	1	references	reference	NOUN
aiua-9638	129	2	1	1	NUM
aiua-9638	129	3	.	.	PUNCT
aiua-9638	129	4	shamloul	shamloul	PROPN
aiua-9638	129	5	r	r	PROPN
aiua-9638	129	6	,	,	PUNCT
aiua-9638	129	7	ghanem	ghanem	PROPN
aiua-9638	129	8	h.	h.	PROPN
aiua-9638	129	9	erectile	erectile	NOUN
aiua-9638	129	10	dysfunction	dysfunction	NOUN
aiua-9638	129	11	.	.	PUNCT
aiua-9638	130	1	lancet	lancet	PROPN
aiua-9638	130	2	.	.	PUNCT
aiua-9638	131	1	2013	2013	NUM
aiua-9638	131	2	;	;	PUNCT
aiua-9638	131	3	381;153	381;153	NUM
aiua-9638	131	4	-	-	PUNCT
aiua-9638	131	5	165	165	NUM
aiua-9638	131	6	.	.	NOUN
aiua-9638	131	7	2	2	X
aiua-9638	131	8	.	.	X
aiua-9638	131	9	gareri	gareri	NOUN
aiua-9638	131	10	p	p	NOUN
aiua-9638	131	11	,	,	PUNCT
aiua-9638	131	12	castagna	castagna	PROPN
aiua-9638	131	13	a	a	PROPN
aiua-9638	131	14	,	,	PUNCT
aiua-9638	131	15	francomano	francomano	PROPN
aiua-9638	132	1	d	d	NOUN
aiua-9638	132	2	,	,	PUNCT
aiua-9638	132	3	et	et	PROPN
aiua-9638	132	4	al	al	PROPN
aiua-9638	132	5	.	.	PROPN
aiua-9638	132	6	erectile	erectile	ADJ
aiua-9638	132	7	dysfunction	dysfunction	NOUN
aiua-9638	132	8	in	in	ADP
aiua-9638	132	9	the	the	DET
aiua-9638	132	10	elderly	elderly	ADJ
aiua-9638	132	11	:	:	PUNCT
aiua-9638	132	12	an	an	DET
aiua-9638	132	13	old	old	ADJ
aiua-9638	132	14	widespread	widespread	ADJ
aiua-9638	132	15	issue	issue	NOUN
aiua-9638	132	16	with	with	ADP
aiua-9638	132	17	novel	novel	ADJ
aiua-9638	132	18	treatment	treatment	NOUN
aiua-9638	132	19	perspectives	perspective	NOUN
aiua-9638	132	20	.	.	PUNCT
aiua-9638	133	1	int	int	NOUN
aiua-9638	133	2	j	j	PROPN
aiua-9638	133	3	endocrinol	endocrinol	NOUN
aiua-9638	133	4	.	.	PUNCT
aiua-9638	133	5	2014	2014	NUM
aiua-9638	133	6	;	;	PUNCT
aiua-9638	133	7	2014:878670	2014:878670	X
aiua-9638	133	8	.	.	NOUN
aiua-9638	134	1	3	3	X
aiua-9638	134	2	.	.	X
aiua-9638	134	3	yafi	yafi	PROPN
aiua-9638	134	4	fa	fa	PROPN
aiua-9638	134	5	,	,	PUNCT
aiua-9638	134	6	jenkins	jenkins	PROPN
aiua-9638	134	7	l	l	PROPN
aiua-9638	134	8	,	,	PUNCT
aiua-9638	134	9	albersen	albersen	PROPN
aiua-9638	134	10	m	m	PROPN
aiua-9638	134	11	,	,	PUNCT
aiua-9638	134	12	et	et	PROPN
aiua-9638	134	13	al	al	PROPN
aiua-9638	134	14	.	.	PROPN
aiua-9638	134	15	erectile	erectile	ADJ
aiua-9638	134	16	dysfunction	dysfunction	NOUN
aiua-9638	134	17	.	.	PUNCT
aiua-9638	135	1	nat	nat	PROPN
aiua-9638	135	2	rev	rev	VERB
aiua-9638	135	3	dis	dis	PROPN
aiua-9638	135	4	primers	primer	NOUN
aiua-9638	135	5	.	.	PUNCT
aiua-9638	136	1	2016	2016	NUM
aiua-9638	136	2	;	;	PUNCT
aiua-9638	136	3	2:16003	2:16003	NUM
aiua-9638	136	4	.	.	NOUN
aiua-9638	136	5	4	4	NUM
aiua-9638	136	6	.	.	PUNCT
aiua-9638	137	1	baumann	baumann	PROPN
aiua-9638	137	2	f	f	PROPN
aiua-9638	137	3	,	,	PUNCT
aiua-9638	137	4	hehli	hehli	NOUN
aiua-9638	137	5	d	d	NOUN
aiua-9638	137	6	,	,	PUNCT
aiua-9638	137	7	makaloski	makaloski	ADJ
aiua-9638	137	8	v	v	NOUN
aiua-9638	137	9	,	,	PUNCT
aiua-9638	137	10	et	et	PROPN
aiua-9638	137	11	al	al	PROPN
aiua-9638	137	12	.	.	PROPN
aiua-9638	137	13	erectile	erectile	ADJ
aiua-9638	137	14	dysfunction	dysfunction	NOUN
aiua-9638	137	15	—	—	PUNCT
aiua-9638	137	16	overview	overview	NOUN
aiua-9638	137	17	from	from	ADP
aiua-9638	137	18	a	a	DET
aiua-9638	137	19	cardiovascular	cardiovascular	ADJ
aiua-9638	137	20	perspective	perspective	NOUN
aiua-9638	137	21	.	.	PUNCT
aiua-9638	138	1	vasa	vasa	NOUN
aiua-9638	138	2	.	.	PUNCT
aiua-9638	139	1	2017	2017	NUM
aiua-9638	140	1	;	;	PUNCT
aiua-9638	140	2	10:1	10:1	NUM
aiua-9638	140	3	-	-	SYM
aiua-9638	140	4	7	7	NUM
aiua-9638	140	5	.	.	NOUN
aiua-9638	140	6	5	5	NUM
aiua-9638	140	7	.	.	X
aiua-9638	140	8	eisenberg	eisenberg	PROPN
aiua-9638	140	9	ml	ml	PROPN
aiua-9638	140	10	,	,	PUNCT
aiua-9638	140	11	meldrum	meldrum	PROPN
aiua-9638	140	12	d.	d.	PROPN
aiua-9638	140	13	effects	effect	NOUN
aiua-9638	140	14	of	of	ADP
aiua-9638	140	15	age	age	NOUN
aiua-9638	140	16	on	on	ADP
aiua-9638	140	17	fertility	fertility	NOUN
aiua-9638	140	18	and	and	CCONJ
aiua-9638	140	19	sexual	sexual	ADJ
aiua-9638	140	20	function	function	NOUN
aiua-9638	140	21	.	.	PUNCT
aiua-9638	141	1	fertil	fertil	PROPN
aiua-9638	141	2	steril	steril	PROPN
aiua-9638	141	3	.	.	PROPN
aiua-9638	141	4	2017	2017	NUM
aiua-9638	141	5	;	;	PUNCT
aiua-9638	141	6	107:301	107:301	PROPN
aiua-9638	141	7	-	-	SYM
aiua-9638	141	8	4	4	NUM
aiua-9638	141	9	.	.	NOUN
aiua-9638	141	10	6	6	NUM
aiua-9638	141	11	.	.	PUNCT
aiua-9638	141	12	nguyen	nguyen	PROPN
aiua-9638	141	13	hmt	hmt	PROPN
aiua-9638	141	14	,	,	PUNCT
aiua-9638	141	15	gabrielson	gabrielson	NOUN
aiua-9638	141	16	at	at	ADP
aiua-9638	141	17	,	,	PUNCT
aiua-9638	141	18	hellstrom	hellstrom	NOUN
aiua-9638	141	19	wjg	wjg	VERB
aiua-9638	141	20	.	.	PUNCT
aiua-9638	142	1	erectile	erectile	ADJ
aiua-9638	142	2	dysfunction	dysfunction	NOUN
aiua-9638	142	3	in	in	ADP
aiua-9638	142	4	young	young	ADJ
aiua-9638	142	5	men	man	NOUN
aiua-9638	142	6	-	-	PUNCT
aiua-9638	142	7	a	a	DET
aiua-9638	142	8	review	review	NOUN
aiua-9638	142	9	of	of	ADP
aiua-9638	142	10	the	the	DET
aiua-9638	142	11	prevalence	prevalence	NOUN
aiua-9638	142	12	and	and	CCONJ
aiua-9638	142	13	risk	risk	NOUN
aiua-9638	142	14	factors	factor	NOUN
aiua-9638	142	15	.	.	PUNCT
aiua-9638	143	1	sex	sex	NOUN
aiua-9638	143	2	med	med	PROPN
aiua-9638	143	3	rev	rev	PROPN
aiua-9638	143	4	.	.	PROPN
aiua-9638	143	5	2017	2017	NUM
aiua-9638	143	6	;	;	PUNCT
aiua-9638	143	7	5:508	5:508	NUM
aiua-9638	143	8	-	-	SYM
aiua-9638	143	9	20	20	NUM
aiua-9638	143	10	.	.	PUNCT
aiua-9638	144	1	7	7	X
aiua-9638	144	2	.	.	X
aiua-9638	145	1	hsu	hsu	PROPN
aiua-9638	145	2	b	b	PROPN
aiua-9638	145	3	,	,	PUNCT
aiua-9638	145	4	hirani	hirani	PROPN
aiua-9638	145	5	v	v	NOUN
aiua-9638	145	6	,	,	PUNCT
aiua-9638	145	7	naganathan	naganathan	NOUN
aiua-9638	145	8	v	v	NOUN
aiua-9638	145	9	,	,	PUNCT
aiua-9638	145	10	et	et	PROPN
aiua-9638	145	11	al	al	PROPN
aiua-9638	145	12	.	.	PROPN
aiua-9638	145	13	sexual	sexual	ADJ
aiua-9638	145	14	function	function	NOUN
aiua-9638	145	15	and	and	CCONJ
aiua-9638	145	16	mortality	mortality	NOUN
aiua-9638	145	17	in	in	ADP
aiua-9638	145	18	older	old	ADJ
aiua-9638	145	19	men	man	NOUN
aiua-9638	145	20	:	:	PUNCT
aiua-9638	145	21	the	the	DET
aiua-9638	145	22	concord	concord	PROPN
aiua-9638	145	23	health	health	NOUN
aiua-9638	145	24	and	and	CCONJ
aiua-9638	145	25	ageing	ageing	NOUN
aiua-9638	145	26	in	in	ADP
aiua-9638	145	27	men	man	NOUN
aiua-9638	145	28	project	project	NOUN
aiua-9638	145	29	.	.	PUNCT
aiua-9638	146	1	j	j	PROPN
aiua-9638	146	2	gerontol	gerontol	VERB
aiua-9638	146	3	a	a	DET
aiua-9638	146	4	biol	biol	PROPN
aiua-9638	146	5	sci	sci	PROPN
aiua-9638	146	6	med	med	PROPN
aiua-9638	146	7	sci	sci	PROPN
aiua-9638	146	8	.	.	PROPN
aiua-9638	146	9	2017	2017	NUM
aiua-9638	146	10	;	;	PUNCT
aiua-9638	146	11	72:520	72:520	NUM
aiua-9638	146	12	-	-	SYM
aiua-9638	146	13	7	7	NUM
aiua-9638	146	14	.	.	NOUN
aiua-9638	146	15	8	8	NUM
aiua-9638	146	16	.	.	X
aiua-9638	147	1	dean	dean	PROPN
aiua-9638	147	2	rc	rc	PROPN
aiua-9638	147	3	,	,	PUNCT
aiua-9638	147	4	lue	lue	PROPN
aiua-9638	147	5	tf	tf	PROPN
aiua-9638	147	6	.	.	PUNCT
aiua-9638	147	7	physiology	physiology	NOUN
aiua-9638	147	8	of	of	ADP
aiua-9638	147	9	penile	penile	ADJ
aiua-9638	147	10	erection	erection	NOUN
aiua-9638	147	11	and	and	CCONJ
aiua-9638	147	12	pathophysiology	pathophysiology	NOUN
aiua-9638	147	13	of	of	ADP
aiua-9638	147	14	erectile	erectile	ADJ
aiua-9638	147	15	dysfunction	dysfunction	NOUN
aiua-9638	147	16	.	.	PUNCT
aiua-9638	148	1	urol	urol	PROPN
aiua-9638	148	2	clin	clin	PROPN
aiua-9638	148	3	north	north	PROPN
aiua-9638	148	4	am	am	PROPN
aiua-9638	148	5	.	.	PUNCT
aiua-9638	149	1	2005	2005	NUM
aiua-9638	149	2	;	;	PUNCT
aiua-9638	149	3	32:379	32:379	NUM
aiua-9638	149	4	-	-	SYM
aiua-9638	149	5	95	95	NUM
aiua-9638	149	6	.	.	PUNCT
aiua-9638	150	1	9	9	X
aiua-9638	150	2	.	.	X
aiua-9638	150	3	andersson	andersson	PROPN
aiua-9638	150	4	ke	ke	PROPN
aiua-9638	150	5	.	.	PUNCT
aiua-9638	151	1	mechanisms	mechanism	NOUN
aiua-9638	151	2	of	of	ADP
aiua-9638	151	3	penile	penile	ADJ
aiua-9638	151	4	erection	erection	NOUN
aiua-9638	151	5	and	and	CCONJ
aiua-9638	151	6	basis	basis	NOUN
aiua-9638	151	7	for	for	ADP
aiua-9638	151	8	pharmacological	pharmacological	ADJ
aiua-9638	151	9	treatment	treatment	NOUN
aiua-9638	151	10	of	of	ADP
aiua-9638	151	11	erectile	erectile	ADJ
aiua-9638	151	12	dysfunction	dysfunction	NOUN
aiua-9638	151	13	.	.	PUNCT
aiua-9638	152	1	pharmacol	pharmacol	PROPN
aiua-9638	152	2	rev	rev	PROPN
aiua-9638	152	3	.	.	PROPN
aiua-9638	152	4	2011	2011	NUM
aiua-9638	152	5	;	;	PUNCT
aiua-9638	152	6	63:811	63:811	NUM
aiua-9638	152	7	-	-	SYM
aiua-9638	152	8	59	59	NUM
aiua-9638	152	9	.	.	PUNCT
aiua-9638	153	1	10	10	NUM
aiua-9638	153	2	.	.	PUNCT
aiua-9638	154	1	kass	kass	PROPN
aiua-9638	154	2	da	da	PROPN
aiua-9638	154	3	,	,	PUNCT
aiua-9638	154	4	takimoto	takimoto	NOUN
aiua-9638	154	5	e	e	NOUN
aiua-9638	154	6	,	,	PUNCT
aiua-9638	154	7	nagayama	nagayama	NOUN
aiua-9638	154	8	t	t	PROPN
aiua-9638	154	9	,	,	PUNCT
aiua-9638	154	10	champion	champion	NOUN
aiua-9638	154	11	hc	hc	PROPN
aiua-9638	154	12	.	.	PROPN
aiua-9638	154	13	phosphodiesterase	phosphodiesterase	NOUN
aiua-9638	154	14	regulation	regulation	NOUN
aiua-9638	154	15	of	of	ADP
aiua-9638	154	16	nitric	nitric	ADJ
aiua-9638	154	17	oxide	oxide	NOUN
aiua-9638	154	18	signaling	signal	VERB
aiua-9638	154	19	.	.	PUNCT
aiua-9638	155	1	cardiovasc	cardiovasc	PROPN
aiua-9638	155	2	res	res	PROPN
aiua-9638	155	3	.	.	PUNCT
aiua-9638	155	4	2007	2007	NUM
aiua-9638	155	5	;	;	PUNCT
aiua-9638	155	6	75:303	75:303	NUM
aiua-9638	155	7	-	-	SYM
aiua-9638	155	8	14	14	NUM
aiua-9638	155	9	.	.	PUNCT
aiua-9638	156	1	11	11	NUM
aiua-9638	156	2	.	.	PUNCT
aiua-9638	157	1	allen	allen	PROPN
aiua-9638	157	2	ms	ms	PROPN
aiua-9638	157	3	,	,	PUNCT
aiua-9638	157	4	walter	walter	PROPN
aiua-9638	157	5	ee	ee	PROPN
aiua-9638	157	6	.	.	PROPN
aiua-9638	157	7	erectile	erectile	ADJ
aiua-9638	157	8	dysfunction	dysfunction	NOUN
aiua-9638	157	9	:	:	PUNCT
aiua-9638	157	10	an	an	DET
aiua-9638	157	11	umbrella	umbrella	NOUN
aiua-9638	157	12	review	review	NOUN
aiua-9638	157	13	of	of	ADP
aiua-9638	157	14	meta	meta	NOUN
aiua-9638	157	15	-	-	PUNCT
aiua-9638	157	16	analyses	analysis	NOUN
aiua-9638	157	17	of	of	ADP
aiua-9638	157	18	risk	risk	NOUN
aiua-9638	157	19	-	-	PUNCT
aiua-9638	157	20	factors	factor	NOUN
aiua-9638	157	21	,	,	PUNCT
aiua-9638	157	22	treatment	treatment	NOUN
aiua-9638	157	23	,	,	PUNCT
aiua-9638	157	24	and	and	CCONJ
aiua-9638	157	25	prevalence	prevalence	NOUN
aiua-9638	157	26	outcomes	outcome	NOUN
aiua-9638	157	27	.	.	PUNCT
aiua-9638	158	1	j	j	PROPN
aiua-9638	158	2	sex	sex	PROPN
aiua-9638	158	3	med	med	PROPN
aiua-9638	158	4	.	.	PUNCT
aiua-9638	158	5	2019	2019	NUM
aiua-9638	158	6	;	;	PUNCT
aiua-9638	158	7	16:531	16:531	NUM
aiua-9638	158	8	-	-	SYM
aiua-9638	158	9	541	541	NUM
aiua-9638	158	10	.	.	PUNCT
aiua-9638	159	1	12	12	NUM
aiua-9638	159	2	.	.	PUNCT
aiua-9638	160	1	karatza	karatza	PROPN
aiua-9638	160	2	aa	aa	PROPN
aiua-9638	160	3	,	,	PUNCT
aiua-9638	160	4	bush	bush	PROPN
aiua-9638	160	5	a	a	PROPN
aiua-9638	160	6	,	,	PUNCT
aiua-9638	160	7	magee	magee	PROPN
aiua-9638	160	8	ag	ag	PROPN
aiua-9638	160	9	.	.	PROPN
aiua-9638	160	10	safety	safety	NOUN
aiua-9638	160	11	and	and	CCONJ
aiua-9638	160	12	efficacy	efficacy	NOUN
aiua-9638	160	13	of	of	ADP
aiua-9638	160	14	sildenafil	sildenafil	NOUN
aiua-9638	160	15	therapy	therapy	NOUN
aiua-9638	160	16	in	in	ADP
aiua-9638	160	17	children	child	NOUN
aiua-9638	160	18	with	with	ADP
aiua-9638	160	19	pulmonary	pulmonary	ADJ
aiua-9638	160	20	hypertension	hypertension	NOUN
aiua-9638	160	21	.	.	PUNCT
aiua-9638	161	1	int	int	NOUN
aiua-9638	161	2	j	j	PROPN
aiua-9638	161	3	cardiol	cardiol	NOUN
aiua-9638	161	4	.	.	PUNCT
aiua-9638	162	1	2005	2005	NUM
aiua-9638	162	2	;	;	PUNCT
aiua-9638	162	3	100:267	100:267	NOUN
aiua-9638	162	4	-	-	PUNCT
aiua-9638	162	5	273	273	NUM
aiua-9638	162	6	.	.	NOUN
aiua-9638	163	1	13	13	NUM
aiua-9638	163	2	.	.	PUNCT
aiua-9638	163	3	lewis	lewis	PROPN
aiua-9638	163	4	rj	rj	PROPN
aiua-9638	163	5	,	,	PUNCT
aiua-9638	163	6	johnson	johnson	PROPN
aiua-9638	163	7	rd	rd	PROPN
aiua-9638	163	8	,	,	PUNCT
aiua-9638	163	9	blank	blank	ADJ
aiua-9638	163	10	cl	cl	NOUN
aiua-9638	163	11	.	.	PUNCT
aiua-9638	164	1	quantitative	quantitative	ADJ
aiua-9638	164	2	determination	determination	NOUN
aiua-9638	164	3	of	of	ADP
aiua-9638	164	4	sildenafil	sildenafil	NOUN
aiua-9638	164	5	(	(	PUNCT
aiua-9638	164	6	viagra	viagra	NOUN
aiua-9638	164	7	)	)	PUNCT
aiua-9638	164	8	and	and	CCONJ
aiua-9638	164	9	its	its	PRON
aiua-9638	164	10	metabolite	metabolite	NOUN
aiua-9638	164	11	(	(	PUNCT
aiua-9638	164	12	uk-103,320	uk-103,320	NOUN
aiua-9638	164	13	)	)	PUNCT
aiua-9638	164	14	in	in	ADP
aiua-9638	164	15	fluid	fluid	NOUN
aiua-9638	164	16	and	and	CCONJ
aiua-9638	164	17	tissue	tissue	NOUN
aiua-9638	164	18	specimens	specimen	NOUN
aiua-9638	164	19	obtained	obtain	VERB
aiua-9638	164	20	from	from	ADP
aiua-9638	164	21	six	six	NUM
aiua-9638	164	22	aviation	aviation	NOUN
aiua-9638	164	23	fatalities	fatality	NOUN
aiua-9638	164	24	.	.	PUNCT
aiua-9638	165	1	j	j	PROPN
aiua-9638	165	2	anal	anal	PROPN
aiua-9638	165	3	toxicol	toxicol	PROPN
aiua-9638	165	4	.	.	PUNCT
aiua-9638	166	1	2006	2006	NUM
aiua-9638	166	2	;	;	PUNCT
aiua-9638	166	3	30:14	30:14	NUM
aiua-9638	166	4	-	-	SYM
aiua-9638	166	5	20	20	NUM
aiua-9638	166	6	.	.	PUNCT
aiua-9638	167	1	14	14	NUM
aiua-9638	167	2	.	.	PUNCT
aiua-9638	168	1	palmieri	palmieri	PROPN
aiua-9638	168	2	a	a	PROPN
aiua-9638	168	3	,	,	PUNCT
aiua-9638	168	4	arcaniolo	arcaniolo	PROPN
aiua-9638	168	5	d	d	NOUN
aiua-9638	168	6	,	,	PUNCT
aiua-9638	168	7	palumbo	palumbo	PROPN
aiua-9638	168	8	f	f	X
aiua-9638	168	9	,	,	PUNCT
aiua-9638	168	10	et	et	PROPN
aiua-9638	168	11	al	al	PROPN
aiua-9638	168	12	.	.	PROPN
aiua-9638	168	13	low	low	PROPN
aiua-9638	168	14	intensity	intensity	PROPN
aiua-9638	168	15	shockwave	shockwave	PROPN
aiua-9638	168	16	therapy	therapy	NOUN
aiua-9638	168	17	in	in	ADP
aiua-9638	168	18	combination	combination	NOUN
aiua-9638	168	19	with	with	ADP
aiua-9638	168	20	phosphodiesterase-5	phosphodiesterase-5	NUM
aiua-9638	168	21	inhibitors	inhibitor	NOUN
aiua-9638	168	22	is	be	AUX
aiua-9638	168	23	an	an	DET
aiua-9638	168	24	effective	effective	ADJ
aiua-9638	168	25	and	and	CCONJ
aiua-9638	168	26	safe	safe	ADJ
aiua-9638	168	27	treatment	treatment	NOUN
aiua-9638	168	28	option	option	NOUN
aiua-9638	168	29	in	in	ADP
aiua-9638	168	30	patients	patient	NOUN
aiua-9638	168	31	with	with	ADP
aiua-9638	168	32	vasculogenic	vasculogenic	ADJ
aiua-9638	168	33	ed	ed	NOUN
aiua-9638	168	34	who	who	PRON
aiua-9638	168	35	are	be	AUX
aiua-9638	168	36	pde5i	pde5i	PROPN
aiua-9638	168	37	non	non	NOUN
aiua-9638	168	38	-	-	NOUN
aiua-9638	168	39	responders	responder	NOUN
aiua-9638	168	40	:	:	PUNCT
aiua-9638	168	41	a	a	DET
aiua-9638	168	42	multicenter	multicenter	ADJ
aiua-9638	168	43	single	single	ADJ
aiua-9638	168	44	-	-	PUNCT
aiua-9638	168	45	arm	arm	NOUN
aiua-9638	168	46	clinical	clinical	ADJ
aiua-9638	168	47	trial	trial	NOUN
aiua-9638	168	48	;	;	PUNCT
aiua-9638	168	49	sia	sia	PROPN
aiua-9638	168	50	-	-	ADJ
aiua-9638	168	51	low	low	ADJ
aiua-9638	168	52	intensity	intensity	NOUN
aiua-9638	168	53	shock	shock	NOUN
aiua-9638	168	54	wave	wave	NOUN
aiua-9638	168	55	for	for	ADP
aiua-9638	168	56	erectile	erectile	ADJ
aiua-9638	168	57	dysfunction	dysfunction	NOUN
aiua-9638	168	58	(	(	PUNCT
aiua-9638	168	59	led	lead	VERB
aiua-9638	168	60	)	)	PUNCT
aiua-9638	168	61	study	study	NOUN
aiua-9638	168	62	group	group	NOUN
aiua-9638	168	63	.	.	PUNCT
aiua-9638	169	1	int	int	PROPN
aiua-9638	169	2	j	j	PROPN
aiua-9638	169	3	impot	impot	NOUN
aiua-9638	169	4	res	re	NOUN
aiua-9638	169	5	.	.	PUNCT
aiua-9638	170	1	2020	2020	NUM
aiua-9638	170	2	jul	jul	PROPN
aiua-9638	170	3	18	18	NUM
aiua-9638	170	4	doi	doi	NOUN
aiua-9638	170	5	:	:	PUNCT
aiua-9638	170	6	10.1038	10.1038	NUM
aiua-9638	170	7	/	/	SYM
aiua-9638	170	8	s41443	s41443	PROPN
aiua-9638	170	9	-	-	PUNCT
aiua-9638	170	10	0200332	0200332	NUM
aiua-9638	170	11	-	-	PUNCT
aiua-9638	170	12	7	7	NUM
aiua-9638	170	13	.	.	NOUN
aiua-9638	170	14	15	15	NUM
aiua-9638	170	15	.	.	PUNCT
aiua-9638	171	1	corona	corona	NOUN
aiua-9638	171	2	g	g	PROPN
aiua-9638	171	3	,	,	PUNCT
aiua-9638	171	4	rastrelli	rastrelli	ADJ
aiua-9638	171	5	g	g	NOUN
aiua-9638	171	6	,	,	PUNCT
aiua-9638	171	7	burri	burri	NOUN
aiua-9638	171	8	a	a	NOUN
aiua-9638	171	9	,	,	PUNCT
aiua-9638	171	10	et	et	PROPN
aiua-9638	171	11	al	al	PROPN
aiua-9638	171	12	.	.	PUNCT
aiua-9638	172	1	first	first	ADJ
aiua-9638	172	2	-	-	PUNCT
aiua-9638	172	3	generation	generation	NOUN
aiua-9638	172	4	phosphodiesterase	phosphodiesterase	NOUN
aiua-9638	172	5	type	type	NOUN
aiua-9638	172	6	5	5	NUM
aiua-9638	172	7	inhibitors	inhibitor	NOUN
aiua-9638	172	8	dropout	dropout	NOUN
aiua-9638	172	9	:	:	PUNCT
aiua-9638	172	10	a	a	DET
aiua-9638	172	11	comprehensive	comprehensive	ADJ
aiua-9638	172	12	review	review	NOUN
aiua-9638	172	13	and	and	CCONJ
aiua-9638	172	14	meta	meta	ADJ
aiua-9638	172	15	-	-	PUNCT
aiua-9638	172	16	analysis	analysis	NOUN
aiua-9638	172	17	.	.	PUNCT
aiua-9638	173	1	andrology	andrology	NOUN
aiua-9638	173	2	.	.	PUNCT
aiua-9638	174	1	2016	2016	NUM
aiua-9638	174	2	;	;	PUNCT
aiua-9638	174	3	4:1002	4:1002	NUM
aiua-9638	174	4	-	-	SYM
aiua-9638	174	5	1009	1009	NUM
aiua-9638	174	6	.	.	PUNCT
aiua-9638	175	1	16	16	NUM
aiua-9638	175	2	.	.	PUNCT
aiua-9638	175	3	srivatsav	srivatsav	PROPN
aiua-9638	175	4	a	a	PRON
aiua-9638	175	5	,	,	PUNCT
aiua-9638	175	6	balasubramanian	balasubramanian	PROPN
aiua-9638	175	7	a	a	X
aiua-9638	175	8	,	,	PUNCT
aiua-9638	175	9	pathak	pathak	PROPN
aiua-9638	175	10	ui	ui	PROPN
aiua-9638	175	11	,	,	PUNCT
aiua-9638	175	12	et	et	PROPN
aiua-9638	175	13	al	al	PROPN
aiua-9638	175	14	.	.	PROPN
aiua-9638	175	15	efficacy	efficacy	NOUN
aiua-9638	175	16	and	and	CCONJ
aiua-9638	175	17	safety	safety	NOUN
aiua-9638	175	18	of	of	ADP
aiua-9638	175	19	common	common	ADJ
aiua-9638	175	20	ingredients	ingredient	NOUN
aiua-9638	175	21	in	in	ADP
aiua-9638	175	22	aphrodisiacs	aphrodisiac	NOUN
aiua-9638	175	23	used	use	VERB
aiua-9638	175	24	for	for	ADP
aiua-9638	175	25	erectile	erectile	ADJ
aiua-9638	175	26	dysfunction	dysfunction	NOUN
aiua-9638	175	27	:	:	PUNCT
aiua-9638	175	28	a	a	DET
aiua-9638	175	29	review	review	NOUN
aiua-9638	175	30	.	.	PUNCT
aiua-9638	176	1	sex	sex	PROPN
aiua-9638	176	2	med	med	PROPN
aiua-9638	176	3	rev	rev	PROPN
aiua-9638	176	4	.	.	PROPN
aiua-9638	176	5	2020	2020	NUM
aiua-9638	176	6	;	;	PUNCT
aiua-9638	176	7	8:431	8:431	NUM
aiua-9638	176	8	-	-	SYM
aiua-9638	176	9	442	442	NUM
aiua-9638	176	10	.	.	PUNCT
aiua-9638	177	1	17	17	NUM
aiua-9638	177	2	.	.	PUNCT
aiua-9638	178	1	rosen	rosen	PROPN
aiua-9638	178	2	rc	rc	PROPN
aiua-9638	178	3	,	,	PUNCT
aiua-9638	178	4	riley	riley	PROPN
aiua-9638	178	5	a	a	PRON
aiua-9638	178	6	,	,	PUNCT
aiua-9638	178	7	wagner	wagner	PROPN
aiua-9638	178	8	g	g	PROPN
aiua-9638	178	9	,	,	PUNCT
aiua-9638	178	10	et	et	PROPN
aiua-9638	178	11	al	al	PROPN
aiua-9638	178	12	.	.	PUNCT
aiua-9638	179	1	the	the	DET
aiua-9638	179	2	international	international	ADJ
aiua-9638	179	3	index	index	NOUN
aiua-9638	179	4	of	of	ADP
aiua-9638	179	5	erectile	erectile	NOUN
aiua-9638	179	6	function	function	NOUN
aiua-9638	179	7	(	(	PUNCT
aiua-9638	179	8	iief	iief	ADJ
aiua-9638	179	9	):	):	PUNCT
aiua-9638	179	10	a	a	DET
aiua-9638	179	11	multidimensional	multidimensional	ADJ
aiua-9638	179	12	scale	scale	NOUN
aiua-9638	179	13	for	for	ADP
aiua-9638	179	14	assessment	assessment	NOUN
aiua-9638	179	15	of	of	ADP
aiua-9638	179	16	erectile	erectile	ADJ
aiua-9638	179	17	dysfunction	dysfunction	NOUN
aiua-9638	179	18	.	.	PUNCT
aiua-9638	180	1	urology	urology	NOUN
aiua-9638	180	2	.	.	PUNCT
aiua-9638	181	1	1997	1997	NUM
aiua-9638	181	2	;	;	PUNCT
aiua-9638	181	3	49:822	49:822	NUM
aiua-9638	181	4	-	-	SYM
aiua-9638	181	5	30	30	NUM
aiua-9638	181	6	.	.	PUNCT
aiua-9638	181	7	18	18	NUM
aiua-9638	181	8	.	.	PUNCT
aiua-9638	182	1	mirone	mirone	PROPN
aiua-9638	182	2	v	v	PROPN
aiua-9638	182	3	,	,	PUNCT
aiua-9638	182	4	d'emmanuele	d'emmanuele	PROPN
aiua-9638	182	5	di	di	PROPN
aiua-9638	182	6	villa	villa	PROPN
aiua-9638	182	7	bianca	bianca	PROPN
aiua-9638	183	1	r	r	PROPN
aiua-9638	183	2	,	,	PUNCT
aiua-9638	183	3	mitidieri	mitidieri	NOUN
aiua-9638	183	4	e	e	NOUN
aiua-9638	183	5	,	,	PUNCT
aiua-9638	183	6	et	et	PROPN
aiua-9638	183	7	al	al	PROPN
aiua-9638	183	8	.	.	PROPN
aiua-9638	184	1	platelet	platelet	PROPN
aiua-9638	184	2	cyclic	cyclic	PROPN
aiua-9638	184	3	guanosine	guanosine	NOUN
aiua-9638	184	4	monophosphate	monophosphate	NOUN
aiua-9638	184	5	as	as	ADP
aiua-9638	184	6	a	a	DET
aiua-9638	184	7	biomarker	biomarker	NOUN
aiua-9638	184	8	of	of	ADP
aiua-9638	184	9	phosphodiesterase	phosphodiesterase	NOUN
aiua-9638	184	10	type	type	NOUN
aiua-9638	184	11	5	5	NUM
aiua-9638	184	12	inhibitor	inhibitor	NOUN
aiua-9638	184	13	efficacy	efficacy	NOUN
aiua-9638	184	14	in	in	ADP
aiua-9638	184	15	the	the	DET
aiua-9638	184	16	treatment	treatment	NOUN
aiua-9638	184	17	of	of	ADP
aiua-9638	184	18	erectile	erectile	ADJ
aiua-9638	184	19	dysfunction	dysfunction	NOUN
aiua-9638	184	20	:	:	PUNCT
aiua-9638	184	21	a	a	DET
aiua-9638	184	22	randomized	randomized	ADJ
aiua-9638	184	23	placebo	placebo	NOUN
aiua-9638	184	24	-	-	PUNCT
aiua-9638	184	25	controlled	control	VERB
aiua-9638	184	26	study	study	NOUN
aiua-9638	184	27	.	.	PUNCT
aiua-9638	185	1	eur	eur	PROPN
aiua-9638	185	2	urol	urol	PROPN
aiua-9638	185	3	.	.	PUNCT
aiua-9638	185	4	2009	2009	NUM
aiua-9638	185	5	;	;	PUNCT
aiua-9638	185	6	56:1067	56:1067	X
aiua-9638	185	7	-	-	SYM
aiua-9638	185	8	73	73	NUM
aiua-9638	185	9	.	.	PUNCT
aiua-9638	186	1	19	19	NUM
aiua-9638	186	2	.	.	PUNCT
aiua-9638	187	1	d’emmanuele	d’emmanuele	PROPN
aiua-9638	187	2	di	di	PROPN
aiua-9638	187	3	villa	villa	PROPN
aiua-9638	187	4	bianca	bianca	PROPN
aiua-9638	188	1	r	r	PROPN
aiua-9638	188	2	,	,	PUNCT
aiua-9638	188	3	mitidieri	mitidieri	NOUN
aiua-9638	188	4	e	e	NOUN
aiua-9638	188	5	,	,	PUNCT
aiua-9638	188	6	mirone	mirone	PROPN
aiua-9638	188	7	v	v	NOUN
aiua-9638	188	8	,	,	PUNCT
aiua-9638	188	9	et	et	PROPN
aiua-9638	188	10	al	al	PROPN
aiua-9638	188	11	.	.	PUNCT
aiua-9638	189	1	an	an	DET
aiua-9638	189	2	ex	ex	X
aiua-9638	189	3	vivo	vivo	NOUN
aiua-9638	189	4	standardized	standardize	VERB
aiua-9638	189	5	assay	assay	PROPN
aiua-9638	189	6	to	to	PART
aiua-9638	189	7	measure	measure	VERB
aiua-9638	189	8	human	human	ADJ
aiua-9638	189	9	platelet	platelet	NOUN
aiua-9638	189	10	cgmp	cgmp	PROPN
aiua-9638	189	11	.	.	PUNCT
aiua-9638	190	1	j	j	PROPN
aiua-9638	190	2	pharmacol	pharmacol	PROPN
aiua-9638	190	3	toxicol	toxicol	PROPN
aiua-9638	190	4	methods	method	NOUN
aiua-9638	190	5	.	.	PUNCT
aiua-9638	191	1	2011	2011	NUM
aiua-9638	191	2	;	;	PUNCT
aiua-9638	191	3	64:164	64:164	NUM
aiua-9638	191	4	-	-	SYM
aiua-9638	191	5	7	7	NUM
aiua-9638	191	6	.	.	NOUN
aiua-9638	191	7	20	20	NUM
aiua-9638	191	8	.	.	PUNCT
aiua-9638	192	1	keefer	keefer	PROPN
aiua-9638	192	2	lk	lk	PROPN
aiua-9638	192	3	,	,	PUNCT
aiua-9638	192	4	nims	nims	PROPN
aiua-9638	192	5	rw	rw	NOUN
aiua-9638	192	6	,	,	PUNCT
aiua-9638	192	7	davies	davy	NOUN
aiua-9638	192	8	km	km	PROPN
aiua-9638	192	9	,	,	PUNCT
aiua-9638	192	10	wink	wink	NOUN
aiua-9638	192	11	da	da	PROPN
aiua-9638	192	12	.	.	PUNCT
aiua-9638	192	13	nonoates	nonoates	PROPN
aiua-9638	192	14	”	"	PUNCT
aiua-9638	192	15	(	(	PUNCT
aiua-9638	192	16	1	1	NUM
aiua-9638	192	17	-	-	PUNCT
aiua-9638	192	18	substituted	substitute	VERB
aiua-9638	192	19	diazen-1	diazen-1	PROPN
aiua-9638	192	20	-	-	PUNCT
aiua-9638	192	21	ium-1	ium-1	NOUN
aiua-9638	192	22	,	,	PUNCT
aiua-9638	192	23	2	2	NUM
aiua-9638	192	24	-	-	PUNCT
aiua-9638	192	25	diolates	diolate	NOUN
aiua-9638	192	26	)	)	PUNCT
aiua-9638	192	27	as	as	ADP
aiua-9638	192	28	nitric	nitric	ADJ
aiua-9638	192	29	oxide	oxide	NOUN
aiua-9638	192	30	donors	donor	NOUN
aiua-9638	192	31	:	:	PUNCT
aiua-9638	192	32	convenient	convenient	ADJ
aiua-9638	192	33	nitric	nitric	ADJ
aiua-9638	192	34	oxide	oxide	NOUN
aiua-9638	192	35	dosage	dosage	NOUN
aiua-9638	192	36	forms	form	NOUN
aiua-9638	192	37	.	.	PUNCT
aiua-9638	193	1	methods	method	NOUN
aiua-9638	193	2	enzymol	enzymol	PROPN
aiua-9638	193	3	.	.	PUNCT
aiua-9638	193	4	1996	1996	NUM
aiua-9638	193	5	;	;	PUNCT
aiua-9638	194	1	268:281	268:281	X
aiua-9638	194	2	-	-	SYM
aiua-9638	194	3	93	93	NUM
aiua-9638	194	4	.	.	PUNCT
aiua-9638	195	1	21	21	NUM
aiua-9638	195	2	.	.	X
aiua-9638	196	1	malviya	malviya	PROPN
aiua-9638	196	2	n	n	PROPN
aiua-9638	196	3	,	,	PUNCT
aiua-9638	196	4	malviya	malviya	PROPN
aiua-9638	196	5	s	s	PROPN
aiua-9638	196	6	,	,	PUNCT
aiua-9638	196	7	jain	jain	PROPN
aiua-9638	196	8	s	s	PROPN
aiua-9638	196	9	,	,	PUNCT
aiua-9638	196	10	vyas	vyas	PROPN
aiua-9638	196	11	s.	s.	PROPN
aiua-9638	197	1	a	a	DET
aiua-9638	197	2	review	review	NOUN
aiua-9638	197	3	of	of	ADP
aiua-9638	197	4	the	the	DET
aiua-9638	197	5	potential	potential	NOUN
aiua-9638	197	6	of	of	ADP
aiua-9638	197	7	medicinal	medicinal	ADJ
aiua-9638	197	8	plants	plant	NOUN
aiua-9638	197	9	in	in	ADP
aiua-9638	197	10	the	the	DET
aiua-9638	197	11	management	management	NOUN
aiua-9638	197	12	and	and	CCONJ
aiua-9638	197	13	treatment	treatment	NOUN
aiua-9638	197	14	of	of	ADP
aiua-9638	197	15	male	male	ADJ
aiua-9638	197	16	sexual	sexual	ADJ
aiua-9638	197	17	dysfunction	dysfunction	NOUN
aiua-9638	197	18	.	.	PUNCT
aiua-9638	198	1	andrologia	andrologia	NOUN
aiua-9638	198	2	.	.	PUNCT
aiua-9638	199	1	2016	2016	NUM
aiua-9638	199	2	;	;	PUNCT
aiua-9638	199	3	48:880	48:880	NUM
aiua-9638	199	4	-	-	SYM
aiua-9638	199	5	93	93	NUM
aiua-9638	199	6	.	.	PUNCT
aiua-9638	200	1	22	22	NUM
aiua-9638	200	2	.	.	PUNCT
aiua-9638	201	1	jang	jang	PROPN
aiua-9638	201	2	dj	dj	PROPN
aiua-9638	201	3	,	,	PUNCT
aiua-9638	201	4	lee	lee	PROPN
aiua-9638	201	5	ms	ms	PROPN
aiua-9638	201	6	,	,	PUNCT
aiua-9638	201	7	shin	shin	PROPN
aiua-9638	201	8	bc	bc	PROPN
aiua-9638	201	9	,	,	PUNCT
aiua-9638	201	10	et	et	PROPN
aiua-9638	201	11	al	al	PROPN
aiua-9638	201	12	.	.	PROPN
aiua-9638	201	13	red	red	PROPN
aiua-9638	201	14	ginseng	ginseng	NOUN
aiua-9638	201	15	for	for	ADP
aiua-9638	201	16	treating	treat	VERB
aiua-9638	201	17	erectile	erectile	ADJ
aiua-9638	201	18	dysfunction	dysfunction	NOUN
aiua-9638	201	19	:	:	PUNCT
aiua-9638	201	20	a	a	DET
aiua-9638	201	21	systematic	systematic	ADJ
aiua-9638	201	22	review	review	NOUN
aiua-9638	201	23	.	.	PUNCT
aiua-9638	202	1	br	br	PROPN
aiua-9638	203	1	j	j	PROPN
aiua-9638	203	2	clin	clin	PROPN
aiua-9638	203	3	pharmacol	pharmacol	PROPN
aiua-9638	203	4	.	.	PROPN
aiua-9638	203	5	2008	2008	NUM
aiua-9638	203	6	;	;	PUNCT
aiua-9638	203	7	66:444	66:444	NUM
aiua-9638	203	8	-	-	SYM
aiua-9638	203	9	450	450	NUM
aiua-9638	203	10	.	.	NUM
aiua-9638	203	11	23	23	NUM
aiua-9638	203	12	.	.	PUNCT
aiua-9638	204	1	kulaputana	kulaputana	PROPN
aiua-9638	204	2	o	o	PROPN
aiua-9638	204	3	,	,	PUNCT
aiua-9638	204	4	thanakomsirichot	thanakomsirichot	PROPN
aiua-9638	204	5	s	s	PART
aiua-9638	204	6	,	,	PUNCT
aiua-9638	204	7	anomasiri	anomasiri	PROPN
aiua-9638	204	8	w.	w.	PROPN
aiua-9638	204	9	ginseng	ginseng	PROPN
aiua-9638	204	10	supplementation	supplementation	NOUN
aiua-9638	204	11	does	do	AUX
aiua-9638	204	12	not	not	PART
aiua-9638	204	13	change	change	VERB
aiua-9638	204	14	lactate	lactate	NOUN
aiua-9638	204	15	threshold	threshold	NOUN
aiua-9638	204	16	and	and	CCONJ
aiua-9638	204	17	physical	physical	ADJ
aiua-9638	204	18	performances	performance	NOUN
aiua-9638	204	19	in	in	ADP
aiua-9638	204	20	physically	physically	ADV
aiua-9638	204	21	active	active	ADJ
aiua-9638	204	22	thai	thai	ADJ
aiua-9638	204	23	men	man	NOUN
aiua-9638	204	24	.	.	PUNCT
aiua-9638	205	1	j	j	PROPN
aiua-9638	205	2	med	med	PROPN
aiua-9638	205	3	assoc	assoc	PROPN
aiua-9638	205	4	thai	thai	PROPN
aiua-9638	205	5	.	.	PUNCT
aiua-9638	206	1	2007	2007	NUM
aiua-9638	206	2	;	;	PUNCT
aiua-9638	206	3	90:1172	90:1172	NOUN
aiua-9638	206	4	-	-	SYM
aiua-9638	206	5	1179	1179	NUM
aiua-9638	206	6	.	.	PUNCT
aiua-9638	207	1	24	24	NUM
aiua-9638	207	2	.	.	PUNCT
aiua-9638	208	1	helms	helms	PROPN
aiua-9638	208	2	s.	s.	PROPN
aiua-9638	208	3	cancer	cancer	PROPN
aiua-9638	208	4	prevention	prevention	PROPN
aiua-9638	208	5	and	and	CCONJ
aiua-9638	208	6	therapeutics	therapeutic	NOUN
aiua-9638	208	7	:	:	PUNCT
aiua-9638	208	8	panax	panax	PROPN
aiua-9638	208	9	ginseng	ginseng	PROPN
aiua-9638	208	10	.	.	PUNCT
aiua-9638	209	1	altern	altern	PROPN
aiua-9638	209	2	med	med	PROPN
aiua-9638	209	3	rev	rev	PROPN
aiua-9638	209	4	.	.	PROPN
aiua-9638	209	5	2004	2004	NUM
aiua-9638	209	6	;	;	PUNCT
aiua-9638	209	7	9:259	9:259	NOUN
aiua-9638	209	8	-	-	SYM
aiua-9638	209	9	274	274	NUM
aiua-9638	209	10	.	.	PUNCT
aiua-9638	210	1	25	25	NUM
aiua-9638	210	2	.	.	PUNCT
aiua-9638	211	1	kim	kim	PROPN
aiua-9638	211	2	s	s	PROPN
aiua-9638	211	3	,	,	PUNCT
aiua-9638	211	4	shin	shin	PROPN
aiua-9638	211	5	bc	bc	PROPN
aiua-9638	211	6	,	,	PUNCT
aiua-9638	211	7	lee	lee	PROPN
aiua-9638	211	8	ms	ms	PROPN
aiua-9638	211	9	,	,	PUNCT
aiua-9638	211	10	et	et	PROPN
aiua-9638	211	11	al	al	PROPN
aiua-9638	211	12	.	.	PROPN
aiua-9638	211	13	red	red	PROPN
aiua-9638	211	14	ginseng	ginseng	PROPN
aiua-9638	211	15	for	for	ADP
aiua-9638	211	16	type	type	NOUN
aiua-9638	211	17	2	2	NUM
aiua-9638	211	18	diabetes	diabetes	NOUN
aiua-9638	211	19	mellitus	mellitus	NOUN
aiua-9638	211	20	:	:	PUNCT
aiua-9638	211	21	a	a	DET
aiua-9638	211	22	systematic	systematic	ADJ
aiua-9638	211	23	review	review	NOUN
aiua-9638	211	24	of	of	ADP
aiua-9638	211	25	randomized	randomized	ADJ
aiua-9638	211	26	controlled	control	VERB
aiua-9638	211	27	trials	trial	NOUN
aiua-9638	211	28	.	.	PUNCT
aiua-9638	212	1	chin	chin	PROPN
aiua-9638	212	2	j	j	PROPN
aiua-9638	212	3	integr	integr	PROPN
aiua-9638	212	4	med	me	VERB
aiua-9638	212	5	.	.	PUNCT
aiua-9638	213	1	2011	2011	NUM
aiua-9638	213	2	;	;	PUNCT
aiua-9638	213	3	17:937	17:937	NUM
aiua-9638	213	4	-	-	SYM
aiua-9638	213	5	944	944	NUM
aiua-9638	213	6	.	.	NOUN
aiua-9638	214	1	26	26	NUM
aiua-9638	214	2	.	.	PUNCT
aiua-9638	215	1	rhee	rhee	PROPN
aiua-9638	215	2	my	my	PROPN
aiua-9638	215	3	,	,	PUNCT
aiua-9638	215	4	kim	kim	PROPN
aiua-9638	215	5	ys	ys	PROPN
aiua-9638	215	6	,	,	PUNCT
aiua-9638	215	7	bae	bae	PROPN
aiua-9638	215	8	jh	jh	PROPN
aiua-9638	215	9	,	,	PUNCT
aiua-9638	215	10	et	et	PROPN
aiua-9638	215	11	al	al	PROPN
aiua-9638	215	12	.	.	PROPN
aiua-9638	215	13	effect	effect	NOUN
aiua-9638	215	14	of	of	ADP
aiua-9638	215	15	korean	korean	ADJ
aiua-9638	215	16	red	red	ADJ
aiua-9638	215	17	ginseng	ginseng	NOUN
aiua-9638	215	18	on	on	ADP
aiua-9638	215	19	arterial	arterial	ADJ
aiua-9638	215	20	stiffness	stiffness	NOUN
aiua-9638	215	21	in	in	ADP
aiua-9638	215	22	subjects	subject	NOUN
aiua-9638	215	23	with	with	ADP
aiua-9638	215	24	hypertension	hypertension	NOUN
aiua-9638	215	25	.	.	PUNCT
aiua-9638	216	1	j	j	PROPN
aiua-9638	216	2	altern	altern	PROPN
aiua-9638	216	3	complement	complement	PROPN
aiua-9638	216	4	med	me	VERB
aiua-9638	216	5	.	.	PUNCT
aiua-9638	216	6	2011	2011	NUM
aiua-9638	216	7	;	;	PUNCT
aiua-9638	216	8	17:45	17:45	NUM
aiua-9638	216	9	-	-	SYM
aiua-9638	216	10	49	49	NUM
aiua-9638	216	11	.	.	PUNCT
aiua-9638	217	1	27	27	NUM
aiua-9638	217	2	.	.	X
aiua-9638	217	3	de	de	PROPN
aiua-9638	217	4	andrade	andrade	PROPN
aiua-9638	217	5	e	e	PROPN
aiua-9638	217	6	,	,	PUNCT
aiua-9638	217	7	de	de	PROPN
aiua-9638	217	8	mesquita	mesquita	PROPN
aiua-9638	217	9	aa	aa	PROPN
aiua-9638	217	10	,	,	PUNCT
aiua-9638	217	11	claro	claro	VERB
aiua-9638	217	12	jde	jde	PROPN
aiua-9638	217	13	a	a	PRON
aiua-9638	217	14	,	,	PUNCT
aiua-9638	217	15	et	et	PROPN
aiua-9638	217	16	al	al	PROPN
aiua-9638	217	17	.	.	PROPN
aiua-9638	217	18	study	study	NOUN
aiua-9638	217	19	of	of	ADP
aiua-9638	217	20	the	the	DET
aiua-9638	217	21	efficacy	efficacy	NOUN
aiua-9638	217	22	of	of	ADP
aiua-9638	217	23	korean	korean	ADJ
aiua-9638	217	24	red	red	PROPN
aiua-9638	217	25	ginseng	ginseng	NOUN
aiua-9638	217	26	in	in	ADP
aiua-9638	217	27	the	the	DET
aiua-9638	217	28	treatment	treatment	NOUN
aiua-9638	217	29	of	of	ADP
aiua-9638	217	30	erectile	erectile	ADJ
aiua-9638	217	31	dysfunction	dysfunction	NOUN
aiua-9638	217	32	.	.	PUNCT
aiua-9638	218	1	asian	asian	PROPN
aiua-9638	218	2	j	j	PROPN
aiua-9638	218	3	androl	androl	PROPN
aiua-9638	218	4	.	.	PROPN
aiua-9638	218	5	2007	2007	NUM
aiua-9638	218	6	;	;	PUNCT
aiua-9638	218	7	9:241	9:241	NUM
aiua-9638	218	8	-	-	SYM
aiua-9638	218	9	4	4	NUM
aiua-9638	218	10	.	.	NOUN
aiua-9638	218	11	28	28	NUM
aiua-9638	218	12	.	.	PUNCT
aiua-9638	219	1	atawodi	atawodi	PROPN
aiua-9638	219	2	se	se	PROPN
aiua-9638	219	3	,	,	PUNCT
aiua-9638	219	4	atawodi	atawodi	PROPN
aiua-9638	219	5	jc	jc	PROPN
aiua-9638	219	6	,	,	PUNCT
aiua-9638	219	7	idakwo	idakwo	PROPN
aiua-9638	219	8	ga	ga	PROPN
aiua-9638	219	9	,	,	PUNCT
aiua-9638	219	10	et	et	PROPN
aiua-9638	219	11	al	al	PROPN
aiua-9638	219	12	.	.	PUNCT
aiua-9638	219	13	evaluation	evaluation	NOUN
aiua-9638	219	14	of	of	ADP
aiua-9638	219	15	the	the	DET
aiua-9638	219	16	polyphenol	polyphenol	NOUN
aiua-9638	219	17	content	content	NOUN
aiua-9638	219	18	and	and	CCONJ
aiua-9638	219	19	antioxidant	antioxidant	ADJ
aiua-9638	219	20	properties	property	NOUN
aiua-9638	219	21	of	of	ADP
aiua-9638	219	22	methanol	methanol	NOUN
aiua-9638	219	23	extracts	extract	NOUN
aiua-9638	219	24	of	of	ADP
aiua-9638	219	25	the	the	DET
aiua-9638	219	26	leaves	leave	NOUN
aiua-9638	219	27	,	,	PUNCT
aiua-9638	219	28	stem	stem	NOUN
aiua-9638	219	29	,	,	PUNCT
aiua-9638	219	30	and	and	CCONJ
aiua-9638	219	31	root	root	NOUN
aiua-9638	219	32	barks	bark	NOUN
aiua-9638	219	33	of	of	ADP
aiua-9638	219	34	moringa	moringa	PROPN
aiua-9638	219	35	oleifera	oleifera	PROPN
aiua-9638	219	36	lam	lam	PROPN
aiua-9638	219	37	.	.	PUNCT
aiua-9638	220	1	j	j	PROPN
aiua-9638	220	2	med	med	PROPN
aiua-9638	220	3	food	food	NOUN
aiua-9638	220	4	.	.	PUNCT
aiua-9638	221	1	2010	2010	NUM
aiua-9638	221	2	;	;	PUNCT
aiua-9638	221	3	13:710	13:710	NUM
aiua-9638	221	4	-	-	SYM
aiua-9638	221	5	716	716	NUM
aiua-9638	221	6	.	.	NUM
aiua-9638	222	1	29	29	NUM
aiua-9638	222	2	.	.	PUNCT
aiua-9638	223	1	jaiswal	jaiswal	PROPN
aiua-9638	223	2	d	d	PROPN
aiua-9638	223	3	,	,	PUNCT
aiua-9638	223	4	kumar	kumar	PROPN
aiua-9638	223	5	rp	rp	PROPN
aiua-9638	223	6	,	,	PUNCT
aiua-9638	223	7	kumar	kumar	PROPN
aiua-9638	223	8	a	a	PROPN
aiua-9638	223	9	,	,	PUNCT
aiua-9638	223	10	et	et	PROPN
aiua-9638	223	11	al	al	PROPN
aiua-9638	223	12	.	.	PROPN
aiua-9638	223	13	effect	effect	NOUN
aiua-9638	223	14	of	of	ADP
aiua-9638	223	15	moringa	moringa	PROPN
aiua-9638	223	16	oleifera	oleifera	INTJ
aiua-9638	224	1	lam	lam	PROPN
aiua-9638	224	2	leaves	leave	VERB
aiua-9638	224	3	aqueous	aqueous	ADJ
aiua-9638	224	4	extract	extract	NOUN
aiua-9638	224	5	therapy	therapy	NOUN
aiua-9638	224	6	on	on	ADP
aiua-9638	224	7	hyperglycemic	hyperglycemic	ADJ
aiua-9638	224	8	rats	rat	NOUN
aiua-9638	224	9	.	.	PUNCT
aiua-9638	225	1	j	j	PROPN
aiua-9638	225	2	ethnopharmacol	ethnopharmacol	PROPN
aiua-9638	225	3	.	.	PUNCT
aiua-9638	226	1	2009	2009	NUM
aiua-9638	226	2	;	;	PUNCT
aiua-9638	226	3	123:392	123:392	NOUN
aiua-9638	226	4	-	-	SYM
aiua-9638	226	5	396	396	NUM
aiua-9638	226	6	.	.	PUNCT
aiua-9638	227	1	archivio	archivio	NOUN
aiua-9638	227	2	italiano	italiano	X
aiua-9638	227	3	di	di	X
aiua-9638	227	4	urologia	urologia	PROPN
aiua-9638	227	5	e	e	PROPN
aiua-9638	227	6	andrologia	andrologia	NOUN
aiua-9638	227	7	2021	2021	NUM
aiua-9638	227	8	;	;	PUNCT
aiua-9638	227	9	93	93	NUM
aiua-9638	227	10	,	,	PUNCT
aiua-9638	227	11	2	2	NUM
aiua-9638	227	12	v.	v.	ADP
aiua-9638	227	13	mirone	mirone	PROPN
aiua-9638	227	14	,	,	PUNCT
aiua-9638	227	15	l.	l.	PROPN
aiua-9638	227	16	napolitano	napolitano	PROPN
aiua-9638	227	17	,	,	PUNCT
aiua-9638	227	18	r.	r.	PROPN
aiua-9638	227	19	d’emmanuele	d’emmanuele	PROPN
aiua-9638	227	20	di	di	PROPN
aiua-9638	227	21	villa	villa	PROPN
aiua-9638	227	22	bianca	bianca	PROPN
aiua-9638	227	23	,	,	PUNCT
aiua-9638	227	24	et	et	PROPN
aiua-9638	227	25	al	al	PROPN
aiua-9638	227	26	.	.	PROPN
aiua-9638	227	27	226	226	NUM
aiua-9638	227	28	30	30	NUM
aiua-9638	227	29	.	.	PUNCT
aiua-9638	228	1	jung	jung	PROPN
aiua-9638	228	2	il	il	PROPN
aiua-9638	228	3	.	.	PROPN
aiua-9638	228	4	soluble	soluble	ADJ
aiua-9638	228	5	extract	extract	NOUN
aiua-9638	228	6	of	of	ADP
aiua-9638	228	7	moringa	moringa	PROPN
aiua-9638	228	8	oleifera	oleifera	NOUN
aiua-9638	228	9	leaves	leave	VERB
aiua-9638	228	10	with	with	ADP
aiua-9638	228	11	a	a	DET
aiua-9638	228	12	new	new	ADJ
aiua-9638	228	13	anticancer	anticancer	NOUN
aiua-9638	228	14	activity	activity	NOUN
aiua-9638	228	15	.	.	PUNCT
aiua-9638	229	1	plosone	plosone	PROPN
aiua-9638	229	2	2014;9	2014;9	NUM
aiua-9638	229	3	:	:	PUNCT
aiua-9638	229	4	e95492	e95492	PROPN
aiua-9638	229	5	31	31	NUM
aiua-9638	229	6	.	.	PUNCT
aiua-9638	230	1	al	al	PROPN
aiua-9638	230	2	-	-	PUNCT
aiua-9638	230	3	roujeaie	roujeaie	PROPN
aiua-9638	230	4	as	as	ADP
aiua-9638	230	5	,	,	PUNCT
aiua-9638	230	6	abuohashish	abuohashish	PROPN
aiua-9638	230	7	hm	hm	INTJ
aiua-9638	230	8	,	,	PUNCT
aiua-9638	230	9	ahmed	ahmed	PROPN
aiua-9638	230	10	mm	mm	PROPN
aiua-9638	230	11	,	,	PUNCT
aiua-9638	230	12	alkhamees	alkhamees	PROPN
aiua-9638	230	13	oa	oa	INTJ
aiua-9638	230	14	.	.	NOUN
aiua-9638	230	15	effect	effect	NOUN
aiua-9638	230	16	of	of	ADP
aiua-9638	230	17	rutin	rutin	NOUN
aiua-9638	230	18	on	on	ADP
aiua-9638	230	19	diabetic	diabetic	NOUN
aiua-9638	230	20	-	-	PUNCT
aiua-9638	230	21	induced	induce	VERB
aiua-9638	230	22	erectile	erectile	NOUN
aiua-9638	230	23	dysfunction	dysfunction	NOUN
aiua-9638	230	24	:	:	PUNCT
aiua-9638	230	25	possible	possible	ADJ
aiua-9638	230	26	involvement	involvement	NOUN
aiua-9638	230	27	of	of	ADP
aiua-9638	230	28	testicular	testicular	ADJ
aiua-9638	230	29	biomarkers	biomarker	NOUN
aiua-9638	230	30	in	in	ADP
aiua-9638	230	31	male	male	ADJ
aiua-9638	230	32	rats	rat	NOUN
aiua-9638	230	33	.	.	PUNCT
aiua-9638	231	1	andrologia	andrologia	NOUN
aiua-9638	231	2	.	.	PUNCT
aiua-9638	232	1	2017	2017	NUM
aiua-9638	232	2	;	;	PUNCT
aiua-9638	232	3	49	49	NUM
aiua-9638	232	4	.	.	PUNCT
aiua-9638	233	1	32	32	NUM
aiua-9638	233	2	.	.	PUNCT
aiua-9638	234	1	oboh	oboh	NOUN
aiua-9638	234	2	g	g	PROPN
aiua-9638	234	3	,	,	PUNCT
aiua-9638	234	4	adebayo	adebayo	PROPN
aiua-9638	234	5	aa	aa	PROPN
aiua-9638	234	6	,	,	PUNCT
aiua-9638	234	7	ademosun	ademosun	PROPN
aiua-9638	234	8	ao	ao	PROPN
aiua-9638	234	9	,	,	PUNCT
aiua-9638	234	10	boligon	boligon	NOUN
aiua-9638	234	11	aa	aa	NOUN
aiua-9638	234	12	.	.	PUNCT
aiua-9638	235	1	in	in	ADP
aiua-9638	235	2	vitro	vitro	X
aiua-9638	235	3	inhibition	inhibition	NOUN
aiua-9638	235	4	of	of	ADP
aiua-9638	235	5	phosphodiesterase-5	phosphodiesterase-5	NUM
aiua-9638	235	6	and	and	CCONJ
aiua-9638	235	7	arginase	arginase	ADJ
aiua-9638	235	8	activities	activity	NOUN
aiua-9638	235	9	from	from	ADP
aiua-9638	235	10	rat	rat	NOUN
aiua-9638	235	11	penile	penile	ADJ
aiua-9638	235	12	tissue	tissue	NOUN
aiua-9638	235	13	by	by	ADP
aiua-9638	235	14	two	two	NUM
aiua-9638	235	15	nigerian	nigerian	ADJ
aiua-9638	235	16	herbs	herb	NOUN
aiua-9638	235	17	(	(	PUNCT
aiua-9638	235	18	hunteria	hunteria	PROPN
aiua-9638	235	19	umbellata	umbellata	PROPN
aiua-9638	235	20	and	and	CCONJ
aiua-9638	235	21	anogeissus	anogeissus	NOUN
aiua-9638	235	22	leiocarpus	leiocarpus	PROPN
aiua-9638	235	23	)	)	PUNCT
aiua-9638	235	24	.	.	PUNCT
aiua-9638	236	1	j	j	PROPN
aiua-9638	236	2	basic	basic	ADJ
aiua-9638	236	3	clin	clin	PROPN
aiua-9638	236	4	physiol	physiol	PROPN
aiua-9638	236	5	pharmacol	pharmacol	PROPN
aiua-9638	236	6	.	.	PROPN
aiua-9638	237	1	2017	2017	NUM
aiua-9638	237	2	;	;	PUNCT
aiua-9638	237	3	28:393	28:393	NUM
aiua-9638	237	4	-	-	SYM
aiua-9638	237	5	401	401	NUM
aiua-9638	237	6	.	.	PUNCT
aiua-9638	238	1	33	33	NUM
aiua-9638	238	2	.	.	PUNCT
aiua-9638	239	1	zhang	zhang	PROPN
aiua-9638	239	2	y	y	PROPN
aiua-9638	239	3	,	,	PUNCT
aiua-9638	239	4	huang	huang	PROPN
aiua-9638	239	5	c	c	PROPN
aiua-9638	239	6	,	,	PUNCT
aiua-9638	239	7	liu	liu	PROPN
aiua-9638	239	8	s	s	PROPN
aiua-9638	239	9	,	,	PUNCT
aiua-9638	239	10	et	et	PROPN
aiua-9638	239	11	al	al	PROPN
aiua-9638	239	12	.	.	PUNCT
aiua-9638	239	13	effects	effect	NOUN
aiua-9638	239	14	of	of	ADP
aiua-9638	239	15	quercetin	quercetin	NOUN
aiua-9638	239	16	on	on	ADP
aiua-9638	239	17	intracavernous	intracavernous	ADJ
aiua-9638	239	18	pressure	pressure	NOUN
aiua-9638	239	19	and	and	CCONJ
aiua-9638	239	20	expression	expression	NOUN
aiua-9638	239	21	of	of	ADP
aiua-9638	239	22	nitrogen	nitrogen	NOUN
aiua-9638	239	23	synthase	synthase	NOUN
aiua-9638	239	24	isoforms	isoform	NOUN
aiua-9638	239	25	in	in	ADP
aiua-9638	239	26	arterial	arterial	ADJ
aiua-9638	239	27	erectile	erectile	ADJ
aiua-9638	239	28	dysfunction	dysfunction	NOUN
aiua-9638	239	29	rat	rat	NOUN
aiua-9638	239	30	model	model	NOUN
aiua-9638	239	31	.	.	PUNCT
aiua-9638	240	1	int	int	PROPN
aiua-9638	241	1	j	j	PROPN
aiua-9638	241	2	clin	clin	PROPN
aiua-9638	241	3	exp	exp	PROPN
aiua-9638	241	4	med	med	PROPN
aiua-9638	241	5	.	.	PROPN
aiua-9638	241	6	2015	2015	NUM
aiua-9638	241	7	;	;	PUNCT
aiua-9638	241	8	8:7599	8:7599	NUM
aiua-9638	241	9	-	-	SYM
aiua-9638	241	10	605	605	NUM
aiua-9638	241	11	.	.	PUNCT
aiua-9638	242	1	34	34	NUM
aiua-9638	242	2	.	.	PUNCT
aiua-9638	243	1	nova	nova	PROPN
aiua-9638	243	2	e	e	X
aiua-9638	243	3	,	,	PUNCT
aiua-9638	243	4	redondo	redondo	PROPN
aiua-9638	243	5	-	-	PUNCT
aiua-9638	243	6	useros	useros	PROPN
aiua-9638	243	7	n	n	CCONJ
aiua-9638	243	8	,	,	PUNCT
aiua-9638	243	9	martínez	martínez	NOUN
aiua-9638	243	10	-	-	PUNCT
aiua-9638	243	11	garcía	garcía	PROPN
aiua-9638	243	12	rm	rm	PROPN
aiua-9638	243	13	,	,	PUNCT
aiua-9638	243	14	et	et	PROPN
aiua-9638	243	15	al	al	PROPN
aiua-9638	243	16	.	.	PROPN
aiua-9638	243	17	potential	potential	NOUN
aiua-9638	243	18	of	of	ADP
aiua-9638	243	19	moringa	moringa	PROPN
aiua-9638	243	20	oleifera	oleifera	NOUN
aiua-9638	243	21	to	to	PART
aiua-9638	243	22	improve	improve	VERB
aiua-9638	243	23	glucose	glucose	NOUN
aiua-9638	243	24	control	control	NOUN
aiua-9638	243	25	for	for	ADP
aiua-9638	243	26	the	the	DET
aiua-9638	243	27	prevention	prevention	NOUN
aiua-9638	243	28	of	of	ADP
aiua-9638	243	29	diabetes	diabetes	NOUN
aiua-9638	243	30	and	and	CCONJ
aiua-9638	243	31	related	relate	VERB
aiua-9638	243	32	metabolic	metabolic	NOUN
aiua-9638	243	33	alterations	alteration	NOUN
aiua-9638	243	34	:	:	PUNCT
aiua-9638	243	35	a	a	DET
aiua-9638	243	36	systematic	systematic	ADJ
aiua-9638	243	37	review	review	NOUN
aiua-9638	243	38	of	of	ADP
aiua-9638	243	39	animal	animal	NOUN
aiua-9638	243	40	and	and	CCONJ
aiua-9638	243	41	human	human	ADJ
aiua-9638	243	42	studies	study	NOUN
aiua-9638	243	43	.	.	PUNCT
aiua-9638	244	1	nutrients	nutrient	NOUN
aiua-9638	244	2	.	.	PUNCT
aiua-9638	245	1	2020	2020	NUM
aiua-9638	245	2	;	;	PUNCT
aiua-9638	245	3	12:2050	12:2050	NUM
aiua-9638	245	4	.	.	NOUN
aiua-9638	246	1	35	35	NUM
aiua-9638	246	2	.	.	PUNCT
aiua-9638	247	1	beavo	beavo	PROPN
aiua-9638	247	2	ja	ja	PROPN
aiua-9638	247	3	.	.	PUNCT
aiua-9638	248	1	cyclic	cyclic	ADJ
aiua-9638	248	2	nucleotide	nucleotide	NOUN
aiua-9638	248	3	phosphodiesterases	phosphodiesterase	NOUN
aiua-9638	248	4	:	:	PUNCT
aiua-9638	248	5	functional	functional	ADJ
aiua-9638	248	6	implications	implication	NOUN
aiua-9638	248	7	of	of	ADP
aiua-9638	248	8	multiple	multiple	ADJ
aiua-9638	248	9	isoforms	isoform	NOUN
aiua-9638	248	10	.	.	PUNCT
aiua-9638	249	1	physiol	physiol	PROPN
aiua-9638	249	2	rev	rev	PROPN
aiua-9638	249	3	.	.	PROPN
aiua-9638	249	4	1995	1995	NUM
aiua-9638	249	5	;	;	PUNCT
aiua-9638	249	6	75:725	75:725	NUM
aiua-9638	249	7	-	-	SYM
aiua-9638	249	8	48	48	NUM
aiua-9638	249	9	.	.	PUNCT
aiua-9638	250	1	36	36	NUM
aiua-9638	250	2	.	.	PUNCT
aiua-9638	250	3	wallis	wallis	PROPN
aiua-9638	250	4	rm	rm	PROPN
aiua-9638	250	5	,	,	PUNCT
aiua-9638	250	6	corbin	corbin	PROPN
aiua-9638	250	7	jd	jd	PROPN
aiua-9638	250	8	,	,	PUNCT
aiua-9638	250	9	francis	francis	PROPN
aiua-9638	250	10	sh	sh	PROPN
aiua-9638	250	11	,	,	PUNCT
aiua-9638	250	12	ellis	ellis	PROPN
aiua-9638	251	1	p.	p.	PROPN
aiua-9638	251	2	tissue	tissue	NOUN
aiua-9638	251	3	distribution	distribution	NOUN
aiua-9638	251	4	of	of	ADP
aiua-9638	251	5	phosphodiesterase	phosphodiesterase	NOUN
aiua-9638	251	6	families	family	NOUN
aiua-9638	251	7	and	and	CCONJ
aiua-9638	251	8	the	the	DET
aiua-9638	251	9	effects	effect	NOUN
aiua-9638	251	10	of	of	ADP
aiua-9638	251	11	sildenafil	sildenafil	NOUN
aiua-9638	251	12	on	on	ADP
aiua-9638	251	13	tissue	tissue	NOUN
aiua-9638	251	14	cyclic	cyclic	ADJ
aiua-9638	251	15	nucleotides	nucleotide	NOUN
aiua-9638	251	16	,	,	PUNCT
aiua-9638	251	17	platelet	platelet	NOUN
aiua-9638	251	18	function	function	NOUN
aiua-9638	251	19	,	,	PUNCT
aiua-9638	251	20	and	and	CCONJ
aiua-9638	251	21	the	the	DET
aiua-9638	251	22	contractile	contractile	NOUN
aiua-9638	251	23	responses	response	NOUN
aiua-9638	251	24	of	of	ADP
aiua-9638	251	25	trabeculae	trabeculae	NOUN
aiua-9638	251	26	carneae	carneae	ADJ
aiua-9638	251	27	and	and	CCONJ
aiua-9638	251	28	aortic	aortic	ADJ
aiua-9638	251	29	rings	ring	NOUN
aiua-9638	251	30	in	in	ADP
aiua-9638	251	31	vitro	vitro	X
aiua-9638	251	32	.	.	PUNCT
aiua-9638	252	1	am	be	AUX
aiua-9638	252	2	j	j	PROPN
aiua-9638	252	3	cardiol	cardiol	NOUN
aiua-9638	252	4	.	.	PUNCT
aiua-9638	253	1	1999	1999	NUM
aiua-9638	253	2	;	;	PUNCT
aiua-9638	253	3	83:3c-12c	83:3c-12c	NUM
aiua-9638	253	4	.	.	PUNCT
aiua-9638	254	1	37	37	NUM
aiua-9638	254	2	.	.	X
aiua-9638	254	3	dunkern	dunkern	PROPN
aiua-9638	254	4	tr	tr	VERB
aiua-9638	254	5	,	,	PUNCT
aiua-9638	254	6	hatzelmann	hatzelmann	NOUN
aiua-9638	254	7	a.	a.	NOUN
aiua-9638	254	8	the	the	DET
aiua-9638	254	9	effect	effect	NOUN
aiua-9638	254	10	of	of	ADP
aiua-9638	254	11	sildenafil	sildenafil	NOUN
aiua-9638	254	12	on	on	ADP
aiua-9638	254	13	human	human	ADJ
aiua-9638	254	14	platelet	platelet	NOUN
aiua-9638	254	15	secretory	secretory	ADJ
aiua-9638	254	16	function	function	NOUN
aiua-9638	254	17	is	be	AUX
aiua-9638	254	18	controlled	control	VERB
aiua-9638	254	19	by	by	ADP
aiua-9638	254	20	a	a	DET
aiua-9638	254	21	complex	complex	ADJ
aiua-9638	254	22	interplay	interplay	NOUN
aiua-9638	254	23	between	between	ADP
aiua-9638	254	24	phosphodiesterases	phosphodiesterase	NOUN
aiua-9638	254	25	2	2	NUM
aiua-9638	254	26	,	,	PUNCT
aiua-9638	254	27	3	3	NUM
aiua-9638	254	28	and	and	CCONJ
aiua-9638	254	29	5	5	NUM
aiua-9638	254	30	.	.	PUNCT
aiua-9638	254	31	cell	cell	NOUN
aiua-9638	254	32	signal	signal	NOUN
aiua-9638	254	33	.	.	PUNCT
aiua-9638	255	1	2005	2005	NUM
aiua-9638	255	2	;	;	PUNCT
aiua-9638	255	3	17:331	17:331	NUM
aiua-9638	255	4	-	-	SYM
aiua-9638	255	5	9	9	NUM
aiua-9638	255	6	.	.	NUM
aiua-9638	256	1	38	38	NUM
aiua-9638	256	2	.	.	PUNCT
aiua-9638	257	1	francis	francis	PROPN
aiua-9638	257	2	sh	sh	PROPN
aiua-9638	257	3	,	,	PUNCT
aiua-9638	257	4	morris	morris	PROPN
aiua-9638	257	5	gz	gz	PROPN
aiua-9638	257	6	,	,	PUNCT
aiua-9638	257	7	corbin	corbin	PROPN
aiua-9638	257	8	jd	jd	PROPN
aiua-9638	257	9	.	.	PUNCT
aiua-9638	258	1	molecular	molecular	ADJ
aiua-9638	258	2	mechanisms	mechanism	NOUN
aiua-9638	258	3	that	that	PRON
aiua-9638	258	4	could	could	AUX
aiua-9638	258	5	contribute	contribute	VERB
aiua-9638	258	6	to	to	ADP
aiua-9638	258	7	prolonged	prolonged	ADJ
aiua-9638	258	8	effectiveness	effectiveness	NOUN
aiua-9638	258	9	of	of	ADP
aiua-9638	258	10	pde5	pde5	NOUN
aiua-9638	258	11	inhibitors	inhibitor	NOUN
aiua-9638	258	12	to	to	PART
aiua-9638	258	13	improve	improve	VERB
aiua-9638	258	14	erectile	erectile	ADJ
aiua-9638	258	15	function	function	NOUN
aiua-9638	258	16	.	.	PUNCT
aiua-9638	259	1	int	int	NOUN
aiua-9638	259	2	j	j	PROPN
aiua-9638	259	3	impot	impot	NOUN
aiua-9638	259	4	res	re	NOUN
aiua-9638	259	5	.	.	PUNCT
aiua-9638	259	6	2008	2008	NUM
aiua-9638	259	7	;	;	PUNCT
aiua-9638	259	8	20:333	20:333	NUM
aiua-9638	259	9	-	-	SYM
aiua-9638	259	10	42	42	NUM
aiua-9638	259	11	.	.	PUNCT
aiua-9638	260	1	39	39	NUM
aiua-9638	260	2	.	.	PUNCT
aiua-9638	261	1	moncada	moncada	PROPN
aiua-9638	261	2	i	i	PROPN
aiua-9638	261	3	,	,	PUNCT
aiua-9638	261	4	jara	jara	PROPN
aiua-9638	261	5	j	j	PROPN
aiua-9638	261	6	,	,	PUNCT
aiua-9638	261	7	subirà	subirà	NOUN
aiua-9638	261	8	d	d	PROPN
aiua-9638	261	9	,	,	PUNCT
aiua-9638	261	10	et	et	PROPN
aiua-9638	261	11	al	al	PROPN
aiua-9638	261	12	.	.	PROPN
aiua-9638	261	13	efficacy	efficacy	NOUN
aiua-9638	261	14	of	of	ADP
aiua-9638	261	15	sildenafil	sildenafil	NOUN
aiua-9638	261	16	citrate	citrate	NOUN
aiua-9638	261	17	at	at	ADP
aiua-9638	261	18	12	12	NUM
aiua-9638	261	19	hours	hour	NOUN
aiua-9638	261	20	after	after	ADP
aiua-9638	261	21	dosing	dose	VERB
aiua-9638	261	22	:	:	PUNCT
aiua-9638	261	23	re	re	VERB
aiua-9638	261	24	-	-	VERB
aiua-9638	261	25	exploring	explore	VERB
aiua-9638	261	26	the	the	DET
aiua-9638	261	27	therapeutic	therapeutic	ADJ
aiua-9638	261	28	window	window	NOUN
aiua-9638	261	29	.	.	PUNCT
aiua-9638	262	1	eur	eur	PROPN
aiua-9638	262	2	urol	urol	PROPN
aiua-9638	262	3	.	.	PUNCT
aiua-9638	263	1	2004	2004	NUM
aiua-9638	263	2	;	;	PUNCT
aiua-9638	263	3	46:357	46:357	NUM
aiua-9638	263	4	-	-	SYM
aiua-9638	263	5	61	61	NUM
aiua-9638	263	6	.	.	PUNCT
aiua-9638	263	7	40	40	NUM
aiua-9638	263	8	.	.	PUNCT
aiua-9638	264	1	young	young	PROPN
aiua-9638	264	2	jm	jm	PROPN
aiua-9638	264	3	,	,	PUNCT
aiua-9638	264	4	feldman	feldman	PROPN
aiua-9638	264	5	ra	ra	PROPN
aiua-9638	264	6	,	,	PUNCT
aiua-9638	264	7	auerbach	auerbach	PROPN
aiua-9638	264	8	sm	sm	PROPN
aiua-9638	264	9	,	,	PUNCT
aiua-9638	264	10	et	et	PROPN
aiua-9638	264	11	al	al	PROPN
aiua-9638	264	12	.	.	PUNCT
aiua-9638	265	1	tadalafil	tadalafil	PROPN
aiua-9638	265	2	improved	improve	VERB
aiua-9638	265	3	erectile	erectile	NOUN
aiua-9638	265	4	function	function	NOUN
aiua-9638	265	5	at	at	ADP
aiua-9638	265	6	twenty	twenty	NUM
aiua-9638	265	7	-	-	PUNCT
aiua-9638	265	8	four	four	NUM
aiua-9638	265	9	and	and	CCONJ
aiua-9638	265	10	thirty	thirty	NUM
aiua-9638	265	11	-	-	PUNCT
aiua-9638	265	12	six	six	NUM
aiua-9638	265	13	hours	hour	NOUN
aiua-9638	265	14	after	after	ADP
aiua-9638	265	15	dosing	dose	VERB
aiua-9638	265	16	in	in	ADP
aiua-9638	265	17	men	man	NOUN
aiua-9638	265	18	with	with	ADP
aiua-9638	265	19	erectile	erectile	ADJ
aiua-9638	265	20	dysfunction	dysfunction	NOUN
aiua-9638	265	21	:	:	PUNCT
aiua-9638	265	22	us	us	PROPN
aiua-9638	265	23	trial	trial	NOUN
aiua-9638	265	24	.	.	PUNCT
aiua-9638	266	1	j	j	PROPN
aiua-9638	266	2	androl	androl	PROPN
aiua-9638	266	3	.	.	PROPN
aiua-9638	266	4	2005	2005	NUM
aiua-9638	266	5	;	;	PUNCT
aiua-9638	266	6	26:310	26:310	NUM
aiua-9638	266	7	-	-	SYM
aiua-9638	266	8	8	8	NUM
aiua-9638	266	9	.	.	NOUN
aiua-9638	266	10	41	41	NUM
aiua-9638	266	11	.	.	PUNCT
aiua-9638	267	1	shabsigh	shabsigh	ADJ
aiua-9638	267	2	r	r	NOUN
aiua-9638	267	3	,	,	PUNCT
aiua-9638	267	4	seftel	seftel	NOUN
aiua-9638	267	5	ad	ad	NOUN
aiua-9638	267	6	,	,	PUNCT
aiua-9638	267	7	rosen	rosen	PROPN
aiua-9638	267	8	rc	rc	PROPN
aiua-9638	267	9	,	,	PUNCT
aiua-9638	267	10	et	et	PROPN
aiua-9638	267	11	al	al	PROPN
aiua-9638	267	12	.	.	PROPN
aiua-9638	267	13	review	review	NOUN
aiua-9638	267	14	of	of	ADP
aiua-9638	267	15	time	time	NOUN
aiua-9638	267	16	of	of	ADP
aiua-9638	267	17	onset	onset	NOUN
aiua-9638	267	18	and	and	CCONJ
aiua-9638	267	19	duration	duration	NOUN
aiua-9638	267	20	of	of	ADP
aiua-9638	267	21	clinical	clinical	ADJ
aiua-9638	267	22	efficacy	efficacy	NOUN
aiua-9638	267	23	of	of	ADP
aiua-9638	267	24	phosphodiesterase	phosphodiesterase	NOUN
aiua-9638	267	25	type	type	NOUN
aiua-9638	267	26	5	5	NUM
aiua-9638	267	27	inhibitors	inhibitor	NOUN
aiua-9638	267	28	in	in	ADP
aiua-9638	267	29	treatment	treatment	NOUN
aiua-9638	267	30	of	of	ADP
aiua-9638	267	31	erectile	erectile	ADJ
aiua-9638	267	32	dysfunction	dysfunction	NOUN
aiua-9638	267	33	.	.	PUNCT
aiua-9638	268	1	urology	urology	NOUN
aiua-9638	268	2	.	.	PUNCT
aiua-9638	269	1	2006	2006	NUM
aiua-9638	269	2	;	;	PUNCT
aiua-9638	269	3	68:689	68:689	NUM
aiua-9638	269	4	-	-	SYM
aiua-9638	269	5	96	96	NUM
aiua-9638	269	6	.	.	PUNCT
aiua-9638	270	1	42	42	NUM
aiua-9638	270	2	.	.	PUNCT
aiua-9638	270	3	direk	direk	PROPN
aiua-9638	270	4	aekthammarat	aekthammarat	NOUN
aiua-9638	270	5	,	,	PUNCT
aiua-9638	270	6	panot	panot	NOUN
aiua-9638	270	7	tangsucharit	tangsucharit	PROPN
aiua-9638	270	8	,	,	PUNCT
aiua-9638	270	9	patchareewan	patchareewan	NOUN
aiua-9638	270	10	pannangpetch	pannangpetch	NOUN
aiua-9638	270	11	,	,	PUNCT
aiua-9638	270	12	thanaporn	thanaporn	ADJ
aiua-9638	270	13	sriwantana	sriwantana	NOUN
aiua-9638	270	14	,	,	PUNCT
aiua-9638	270	15	nathawut	nathawut	PROPN
aiua-9638	270	16	sibmooh	sibmooh	NOUN
aiua-9638	270	17	.	.	PUNCT
aiua-9638	271	1	moringa	moringa	PROPN
aiua-9638	271	2	oleifera	oleifera	ADP
aiua-9638	271	3	leaf	leaf	NOUN
aiua-9638	271	4	extract	extract	NOUN
aiua-9638	271	5	enhances	enhance	VERB
aiua-9638	271	6	endothelial	endothelial	ADJ
aiua-9638	271	7	nitric	nitric	ADJ
aiua-9638	271	8	oxide	oxide	NOUN
aiua-9638	271	9	production	production	NOUN
aiua-9638	271	10	leading	lead	VERB
aiua-9638	271	11	to	to	ADP
aiua-9638	271	12	relaxation	relaxation	NOUN
aiua-9638	271	13	of	of	ADP
aiua-9638	271	14	resistance	resistance	NOUN
aiua-9638	271	15	artery	artery	NOUN
aiua-9638	271	16	and	and	CCONJ
aiua-9638	271	17	lowering	lower	VERB
aiua-9638	271	18	of	of	ADP
aiua-9638	271	19	arterial	arterial	ADJ
aiua-9638	271	20	blood	blood	NOUN
aiua-9638	271	21	pressure	pressure	NOUN
aiua-9638	271	22	.	.	PUNCT
aiua-9638	272	1	biomed	biome	VERB
aiua-9638	272	2	pharmacother	pharmacother	ADJ
aiua-9638	272	3	.	.	PUNCT
aiua-9638	273	1	2020	2020	NUM
aiua-9638	273	2	;	;	PUNCT
aiua-9638	274	1	130:110605	130:110605	X
aiua-9638	274	2	.	.	NOUN
aiua-9638	274	3	43	43	NUM
aiua-9638	274	4	.	.	PUNCT
aiua-9638	275	1	nandave	nandave	PROPN
aiua-9638	275	2	m	m	PROPN
aiua-9638	275	3	,	,	PUNCT
aiua-9638	275	4	ojha	ojha	PROPN
aiua-9638	275	5	sk	sk	PROPN
aiua-9638	275	6	,	,	PUNCT
aiua-9638	275	7	joshi	joshi	PROPN
aiua-9638	275	8	s	s	PROPN
aiua-9638	275	9	,	,	PUNCT
aiua-9638	275	10	et	et	PROPN
aiua-9638	275	11	al	al	PROPN
aiua-9638	275	12	.	.	PUNCT
aiua-9638	276	1	moringa	moringa	PROPN
aiua-9638	276	2	oleifera	oleifera	ADP
aiua-9638	276	3	leaf	leaf	NOUN
aiua-9638	276	4	extract	extract	NOUN
aiua-9638	276	5	prevents	prevent	VERB
aiua-9638	276	6	isoproterenol	isoproterenol	NOUN
aiua-9638	276	7	-	-	PUNCT
aiua-9638	276	8	induced	induce	VERB
aiua-9638	276	9	myocardial	myocardial	ADJ
aiua-9638	276	10	damage	damage	NOUN
aiua-9638	276	11	in	in	ADP
aiua-9638	276	12	rats	rat	NOUN
aiua-9638	276	13	:	:	PUNCT
aiua-9638	276	14	evidence	evidence	NOUN
aiua-9638	276	15	for	for	ADP
aiua-9638	276	16	an	an	DET
aiua-9638	276	17	antioxidant	antioxidant	ADJ
aiua-9638	276	18	,	,	PUNCT
aiua-9638	276	19	antiperoxidative	antiperoxidative	ADJ
aiua-9638	276	20	,	,	PUNCT
aiua-9638	276	21	and	and	CCONJ
aiua-9638	276	22	cardioprotective	cardioprotective	ADJ
aiua-9638	276	23	intervention	intervention	NOUN
aiua-9638	276	24	.	.	PUNCT
aiua-9638	277	1	journal	journal	NOUN
aiua-9638	277	2	of	of	ADP
aiua-9638	277	3	medicinal	medicinal	ADJ
aiua-9638	277	4	food	food	NOUN
aiua-9638	277	5	.	.	PUNCT
aiua-9638	278	1	2009	2009	NUM
aiua-9638	278	2	;	;	PUNCT
aiua-9638	278	3	12:47	12:47	NUM
aiua-9638	278	4	-	-	SYM
aiua-9638	278	5	55	55	NUM
aiua-9638	278	6	.	.	PUNCT
aiua-9638	279	1	correspondence	correspondence	NOUN
aiua-9638	279	2	vincenzo	vincenzo	PROPN
aiua-9638	279	3	mirone	mirone	PROPN
aiua-9638	279	4	,	,	PUNCT
aiua-9638	279	5	md	md	PROPN
aiua-9638	279	6	luigi	luigi	PROPN
aiua-9638	279	7	napolitano	napolitano	PROPN
aiua-9638	279	8	,	,	PUNCT
aiua-9638	279	9	md	md	PROPN
aiua-9638	279	10	(	(	PUNCT
aiua-9638	279	11	corresponding	correspond	VERB
aiua-9638	279	12	author	author	NOUN
aiua-9638	279	13	)	)	PUNCT
aiua-9638	279	14	nluigi89@libero.it	nluigi89@libero.it	PROPN
aiua-9638	280	1	roberto	roberto	PROPN
aiua-9638	280	2	la	la	PROPN
aiua-9638	280	3	rocca	rocca	PROPN
aiua-9638	280	4	,	,	PUNCT
aiua-9638	280	5	md	md	PROPN
aiua-9638	280	6	robertolarocca87@gmail.com	robertolarocca87@gmail.com	PROPN
aiua-9638	280	7	giuseppe	giuseppe	PROPN
aiua-9638	280	8	celentano	celentano	PROPN
aiua-9638	280	9	,	,	PUNCT
aiua-9638	280	10	md	md	PROPN
aiua-9638	280	11	department	department	PROPN
aiua-9638	280	12	of	of	ADP
aiua-9638	280	13	neurosciences	neuroscience	NOUN
aiua-9638	280	14	,	,	PUNCT
aiua-9638	280	15	sciences	science	NOUN
aiua-9638	280	16	of	of	ADP
aiua-9638	280	17	reproduction	reproduction	NOUN
aiua-9638	280	18	,	,	PUNCT
aiua-9638	280	19	and	and	CCONJ
aiua-9638	280	20	odontostomatology	odontostomatology	NOUN
aiua-9638	280	21	,	,	PUNCT
aiua-9638	280	22	university	university	PROPN
aiua-9638	280	23	of	of	ADP
aiua-9638	280	24	naples	naples	PROPN
aiua-9638	280	25	federico	federico	PROPN
aiua-9638	280	26	ii	ii	PROPN
aiua-9638	280	27	via	via	ADP
aiua-9638	280	28	sergio	sergio	PROPN
aiua-9638	280	29	pansini	pansini	PROPN
aiua-9638	280	30	5	5	NUM
aiua-9638	280	31	,	,	PUNCT
aiua-9638	280	32	80131	80131	NUM
aiua-9638	280	33	naples	naples	PROPN
aiua-9638	280	34	(	(	PUNCT
aiua-9638	280	35	italy	italy	PROPN
aiua-9638	280	36	)	)	PUNCT
aiua-9638	280	37	roberta	roberta	PROPN
aiua-9638	280	38	d’emmanuele	d’emmanuele	PROPN
aiua-9638	280	39	di	di	PROPN
aiua-9638	280	40	villa	villa	PROPN
aiua-9638	280	41	bianca	bianca	PROPN
aiua-9638	280	42	,	,	PUNCT
aiua-9638	280	43	md	md	PROPN
aiua-9638	280	44	emma	emma	PROPN
aiua-9638	280	45	mitidieri	mitidieri	PROPN
aiua-9638	280	46	,	,	PUNCT
aiua-9638	280	47	md	md	PROPN
aiua-9638	280	48	raffaella	raffaella	PROPN
aiua-9638	280	49	sorrentino	sorrentino	PROPN
aiua-9638	280	50	,	,	PUNCT
aiua-9638	280	51	md	md	PROPN
aiua-9638	280	52	domenico	domenico	PROPN
aiua-9638	280	53	vanacore	vanacore	ADV
aiua-9638	280	54	,	,	PUNCT
aiua-9638	280	55	md	md	PROPN
aiua-9638	280	56	carlotta	carlotta	PROPN
aiua-9638	280	57	turnaturi	turnaturi	PROPN
aiua-9638	280	58	,	,	PUNCT
aiua-9638	280	59	md	md	PROPN
aiua-9638	280	60	giuseppe	giuseppe	PROPN
aiua-9638	280	61	cirino	cirino	PROPN
aiua-9638	280	62	,	,	PUNCT
aiua-9638	280	63	md	md	PROPN
aiua-9638	280	64	department	department	PROPN
aiua-9638	280	65	of	of	ADP
aiua-9638	280	66	pharmacy	pharmacy	NOUN
aiua-9638	280	67	,	,	PUNCT
aiua-9638	280	68	school	school	NOUN
aiua-9638	280	69	of	of	ADP
aiua-9638	280	70	medicine	medicine	NOUN
aiua-9638	280	71	and	and	CCONJ
aiua-9638	280	72	surgery	surgery	NOUN
aiua-9638	280	73	,	,	PUNCT
aiua-9638	280	74	university	university	NOUN
aiua-9638	280	75	of	of	ADP
aiua-9638	280	76	naples	naples	PROPN
aiua-9638	280	77	,	,	PUNCT
aiua-9638	280	78	federico	federico	PROPN
aiua-9638	280	79	ii	ii	PROPN
aiua-9638	280	80	,	,	PUNCT
aiua-9638	280	81	via	via	ADP
aiua-9638	280	82	d.	d.	PROPN
aiua-9638	280	83	montesano	montesano	PROPN
aiua-9638	280	84	,	,	PUNCT
aiua-9638	280	85	49	49	NUM
aiua-9638	280	86	,	,	PUNCT
aiua-9638	280	87	80131	80131	NUM
aiua-9638	280	88	naples	naples	PROPN
aiua-9638	280	89	(	(	PUNCT
aiua-9638	280	90	italy	italy	PROPN
aiua-9638	280	91	)	)	PUNCT
aiua-9638	280	92	arianna	arianna	PROPN
aiua-9638	280	93	vanelli	vanelli	PROPN
aiua-9638	280	94	,	,	PUNCT
aiua-9638	280	95	md	md	PROPN
aiua-9638	280	96	responsabile	responsabile	NOUN
aiua-9638	280	97	ricerca	ricerca	PROPN
aiua-9638	280	98	e	e	PROPN
aiua-9638	280	99	sviluppo	sviluppo	PROPN
aiua-9638	280	100	nutrilinea	nutrilinea	PROPN
aiua-9638	280	101	srl	srl	PROPN
aiua-9638	280	102	,	,	PUNCT
aiua-9638	280	103	varese	varese	PROPN
aiua-9638	280	104	(	(	PUNCT
aiua-9638	280	105	italy	italy	PROPN
aiua-9638	280	106	)	)	PUNCT
aiua-9638	280	107	davide	davide	PROPN
aiua-9638	280	108	arcaniolo	arcaniolo	PROPN
aiua-9638	280	109	,	,	PUNCT
aiua-9638	280	110	md	md	PROPN
aiua-9638	280	111	urology	urology	PROPN
aiua-9638	280	112	unit	unit	NOUN
aiua-9638	280	113	,	,	PUNCT
aiua-9638	280	114	department	department	NOUN
aiua-9638	280	115	of	of	ADP
aiua-9638	280	116	woman	woman	NOUN
aiua-9638	280	117	child	child	NOUN
aiua-9638	280	118	and	and	CCONJ
aiua-9638	280	119	of	of	ADP
aiua-9638	280	120	general	general	ADJ
aiua-9638	280	121	and	and	CCONJ
aiua-9638	280	122	specialist	specialist	ADJ
aiua-9638	280	123	surgery	surgery	NOUN
aiua-9638	280	124	,	,	PUNCT
aiua-9638	280	125	university	university	NOUN
aiua-9638	280	126	of	of	ADP
aiua-9638	280	127	campania	campania	PROPN
aiua-9638	280	128	"	"	PUNCT
aiua-9638	280	129	luigi	luigi	PROPN
aiua-9638	280	130	vanvitelli	vanvitelli	PROPN
aiua-9638	280	131	"	"	PUNCT
aiua-9638	280	132	,	,	PUNCT
aiua-9638	280	133	80131	80131	NUM
aiua-9638	280	134	naples	naples	PROPN
aiua-9638	280	135	(	(	PUNCT
aiua-9638	280	136	italy	italy	PROPN
aiua-9638	280	137	)	)	PUNCT